Compounds > iopromide
Page last updated: 2024-09-20

iopromide

Description

iopromide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3736
CHEMBL ID1725
CHEBI ID63578
SCHEMBL ID24546
SCHEMBL ID23673810
MeSH IDM0115091

Synonyms (114)

Synonym
AC-535
MLS002154045
smr001233368
n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-n-methyl-5-{[(methyloxy)acetyl]amino}benzene-1,3-dicarboxamide
iopromide
PRESTWICK2_000872
BPBIO1_001039
iopromidum [inn-latin]
1,3-benzenedicarboxamide, n,n'-bis(2,3-dihydroxypropyl)-5-((methoxyacetyl)amino)-n-methyl-2,4,6-triiodo-
n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-n-methylisophthalamide
ultravist
brn 7085608
einecs 277-385-9
zk 35760
iopromida [inn-spanish]
shl 414c
1,3-benzenedicarboxamide, n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-((methoxyacetyl)amino)-n-methyl-
NCGC00016923-01
cas-73334-07-3
NCGC00179367-01
BSPBIO_000943
PRESTWICK3_000872
AB00513942
proscope (tn)
73334-07-3
ultravist (tn)
iopromide (jan/usp/inn)
D01893
PRESTWICK0_000872
PRESTWICK1_000872
SPBIO_002864
proscope
chebi:63578 ,
zk-35760
CHEMBL1725
HMS1570P05
magnesium methanide propan-1-ide(1:1:1)
1-n,3-n-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-3-n-methylbenzene-1,3-dicarboxamide
n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-n-methylisophthalamide
HMS2097P05
lopromid
ultravist 300
iopromid
ultravist (pharmacy bulk)
iopromide [usan:usp:inn:ban]
bay 86-4877
712bac33mz ,
iopromidum
ultravist 300 in plastic container
bay86-4877
unii-712bac33mz
ultravist 370
ultravist 240
iopromida
ultravist 150
tox21_110684
dtxsid0023163 ,
dtxcid503163
HMS2233O23
S3207
c18h24i3n3o8
FT-0627283
HMS3370M05
iopromide [mi]
iopromide [mart.]
iopromide [ep impurity]
iopromide [usan]
iopromide [who-dd]
iopromide [orange book]
iopromide [ep monograph]
iopromide [inn]
iopromide [jan]
iopromide [usp-rs]
iopromide [vandf]
iopromide [usp monograph]
CCG-220872
DGAIEPBNLOQYER-UHFFFAOYSA-N
SCHEMBL24546
tox21_110684_1
NCGC00179367-03
n1,n3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-n1-methylisophthalamide
AKOS025402129
DB09156
n-(2,3-dihydroxypropyl)-3-[(2,3-dihydroxypropyl)(methyl)carbamoyl]-5-[(1-hydroxy-2-methoxyethylidene)amino]-2,4,6-triiodobenzene-1-carboximidic acid
sr-01000841262
SR-01000841262-2
iopromide, united states pharmacopeia (usp) reference standard
iopromide, analytical standard
iopromide, european pharmacopoeia (ep) reference standard
iopromide for system suitability 2, european pharmacopoeia (ep) reference standard
iopromide for system suitability 1, european pharmacopoeia (ep) reference standard
HMS3714P05
HY-B1362
CS-0013103
iopromid 100 microg/ml in acetonitrile
BCP08449
Q4202805
BS-17441
mfcd00867924
EN300-19767813
n1,n3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-n1-methylbenzene-1,3-dicarboxamide
SCHEMBL23673810
iopromide (usan:usp:inn:ban)
iopromida (inn-spanish)
iopromidum (inn-latin)
iopromide (mart.)
iopromide (usp-rs)
iopromide (ep monograph)
n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-((methoxyacetyl)amino)-n-methylisophthalamide
iopromide (ep impurity)
v08ab05
iopromide (usp monograph)
1,3-benzenedicarboxamide, n1,n3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-n1-methyl-
Z2681890595

Research Excerpts

Overview

ExcerptReference
"Iopromide is an X-ray and MRI contrast agent that is virtually non-biodegradable and persistent through typical wastewater treatment processes. "( Aga, DS; Keen, OS; Linden, KG; Love, NG, 2016)
"Iopromide was shown to be a well-tolerated contrast agent whose usage resulted in high image quality. "( Heinsohn, C; Kwon, ST; Lengsfeld, P; Liang, CH; Palkowitsch, P; Stauch, K; Zhang, SX, 2012)
"Iopromide is an X-ray contrast agent that has been detected frequently in effluents of wastewater treatment plants and in surface waters due to its persistence and high usage."( Aga, DS; Celiz, MD; Eichhorn, P; Pérez, S, 2006)
"Iopromide is a new nonionic contrast medium that has been extensively studied for both intravenous (i.v.) and intraarterial indications."( Bettmann, MA; Druy, EM; Jeans, W, 1994)
"Iopromide is a nonionic monomeric contrast agent. "( Amis, ES; Goldman, S; Hedgcock, M; Khazan, R; Landman, J; Lang, E; Leder, R; Newhouse, JH, 1994)
"Iopromide is a new monomeric, nonionic contrast agent that exhibits low osmolality and low viscosity in high concentration in aqueous solutions. "( Abrahams, J; Bernardino, M; Brunetti, J; Drayer, BP; Goldberg, SN; Golding, S, 1994)
"Iopromide is a new nonionic monomeric contrast medium for cerebral arteriography. "( Drayer, BP; Haughton, VM; Hilal, SK; Hyland, D; Maravilla, K; Osborn, AG; Papke, RA, 1994)
"Iopromide is a nonionic, iodinated, monomeric, radiographic contrast agent used in various indications, including coronary angiography and visceral and peripheral arteriography. "( Graf, LL; Hinderling, PH; Jacob, GB; Kressin, DC; Marlar, RA; Young, DA, 2001)
"Iopromide proved itself to be an x-ray contrast medium with a low rate of side effects, which can be effectively eliminated from the body by means of conventional dialysis."( Hollmann, HJ; Kierdorf, H; Kindler, J; Speck, U; Vorwerk, D; Winterscheid, R, 1989)
"Iopromide 300 is a good candidate for this examination, on the basis of the safety and efficacy evaluated in this study."( Kasbarian, M, 1989)

Effects

ExcerptReference
"Iopromide has an efficacy, safety, and tolerance profile comparable to that of iopamidol and iohexol at 300 mg I/mL for head and body CECT. "( Abrahams, J; Bernardino, M; Brunetti, J; Drayer, BP; Goldberg, SN; Golding, S, 1994)
"Iopromide has an efficacy, safety, and tolerance profile comparable to that of iopamidol and iohexol at 300 mg I/mL for head and body CECT. "( Abrahams, J; Bernardino, M; Brunetti, J; Drayer, BP; Goldberg, SN; Golding, S, 1994)

Roles (4)

RoleDescription
radioopaque mediumA substance having the property of absorbing, and therefore being opaque to, electromagnetic radiation, particularly X-rays.
nephrotoxic agentA role played by a chemical compound exihibiting itself through the ability to induce damage to the kidney in animals.
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organoiodine compoundAn organoiodine compound is a compound containing at least one carbon-iodine bond.
dicarboxylic acid diamide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
USP1 protein, partialHomo sapiens (human)Potency316.22800.031637.5844354.8130AID743255
farnesoid X nuclear receptorHomo sapiens (human)Potency0.37580.375827.485161.6524AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency12.58930.005428.02631,258.9301AID1346985
importin subunit beta-1 isoform 1Homo sapiens (human)Potency29.09295.804836.130665.1308AID540253
snurportin-1Homo sapiens (human)Potency29.09295.804836.130665.1308AID540253
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency29.09295.804816.996225.9290AID540253
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (91)

Assay IDTitleYearJournalArticle
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588216FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID588215FDA HLAED, alkaline phosphatase increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1079946Presence of at least one case with successful reintroduction. [column 'REINT' in source]
AID1079937Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1079947Comments (NB not yet translated). [column 'COMMENTAIRES' in source]
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID425652Total body clearance in human2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Physicochemical determinants of human renal clearance.
AID588218FDA HLAED, lactate dehydrogenase (LDH) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID1079943Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID588214FDA HLAED, liver enzyme composite activity2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID588217FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1079938Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]
AID588219FDA HLAED, gamma-glutamyl transferase (GGT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID1079944Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1079934Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID1079939Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1079933Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is
AID1079942Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1079945Animal toxicity known. [column 'TOXIC' in source]
AID1079941Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1079948Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]
AID425653Renal clearance in human2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Physicochemical determinants of human renal clearance.
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1079949Proposed mechanism(s) of liver damage. [column 'MEC' in source]
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1079940Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]
AID540211Fraction unbound in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID1079931Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1079935Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]
AID1079936Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]
AID1079932Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,454)

TimeframeStudies, This Drug (%)All Drugs %
pre-199059 (4.06)18.7374
1990's216 (14.86)18.2507
2000's417 (28.68)29.6817
2010's719 (49.45)24.3611
2020's43 (2.96)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials219 (13.24%)5.53%
Reviews30 (1.81%)6.00%
Case Studies128 (7.74%)4.05%
Observational8 (0.48%)0.25%
Other1,269 (76.72%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
bupropion[no description available]medium10aromatic ketone;
monochlorobenzenes;
secondary amino compound		antidepressant;
environmental contaminant;
xenobiotic
aminocaproic acid[no description available]medium20amino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid		antifibrinolytic drug;
hematologic agent;
metabolite
phenytoin[no description available]medium10imidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
tacrine[no description available]medium30acridines;
aromatic amine		EC 3.1.1.7 (acetylcholinesterase) inhibitor
acebutolol[no description available]medium30aromatic amide;
ethanolamines;
ether;
monocarboxylic acid amide;
propanolamine;
secondary amino compound		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympathomimetic agent
acetaminophen[no description available]medium40acetamides;
phenols		antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
acetohydroxamic acid[no description available]medium10acetohydroxamic acids;
carbohydroximic acid		algal metabolite;
EC 3.5.1.5 (urease) inhibitor
albuterol[no description available]medium50phenols;
phenylethanolamines;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
alendronate[no description available]medium101,1-bis(phosphonic acid);
primary amino compound		bone density conservation agent;
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
alprazolam[no description available]medium30organochlorine compound;
triazolobenzodiazepine		anticonvulsant;
anxiolytic drug;
GABA agonist;
muscle relaxant;
sedative;
xenobiotic
altretamine[no description available]medium10triamino-1,3,5-triazine
amantadine[no description available]medium30adamantanes;
primary aliphatic amine		analgesic;
antiparkinson drug;
antiviral drug;
dopaminergic agent;
NMDA receptor antagonist;
non-narcotic analgesic
amifostine anhydrous[no description available]medium10diamine;
organic thiophosphate		antioxidant;
prodrug;
radiation protective agent
aminoglutethimide[no description available]medium10dicarboximide;
piperidones;
substituted aniline		adrenergic agent;
anticonvulsant;
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
theophylline[no description available]medium50dimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
theophylline[no description available]medium52dimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
amiodarone[no description available]medium301-benzofurans;
aromatic ketone;
organoiodine compound;
tertiary amino compound		cardiovascular drug
amitriptyline[no description available]medium30carbotricyclic compound;
tertiary amine		adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
tropomyosin-related kinase B receptor agonist;
xenobiotic
amlexanox[no description available]medium10monocarboxylic acid;
pyridochromene		anti-allergic agent;
anti-ulcer drug;
non-steroidal anti-inflammatory drug
amlodipine[no description available]medium30dihydropyridine;
ethyl ester;
methyl ester;
monochlorobenzenes;
primary amino compound		antihypertensive agent;
calcium channel blocker;
vasodilator agent
amoxapine[no description available]medium10dibenzooxazepineadrenergic uptake inhibitor;
antidepressant;
dopaminergic antagonist;
geroprotector;
serotonin uptake inhibitor
anastrozole[no description available]medium10nitrile;
triazoles		antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
apraclonidine[no description available]medium10dichlorobenzene;
guanidines;
imidazolines		alpha-adrenergic agonist;
antiglaucoma drug;
beta-adrenergic agonist;
diagnostic agent;
ophthalmology drug
aspirin[no description available]medium40benzoic acids;
phenyl acetates;
salicylates		anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
astemizole[no description available]medium10benzimidazoles;
piperidines		anti-allergic agent;
anticoronaviral agent;
H1-receptor antagonist
atenolol[no description available]medium30ethanolamines;
monocarboxylic acid amide;
propanolamine		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
sympatholytic agent;
xenobiotic
azathioprine[no description available]medium10aryl sulfide;
C-nitro compound;
imidazoles;
thiopurine		antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug
azelaic acid[no description available]medium10alpha,omega-dicarboxylic acid;
dicarboxylic fatty acid		antibacterial agent;
antineoplastic agent;
dermatologic drug;
plant metabolite
azelastine[no description available]medium30monochlorobenzenes;
phthalazines;
tertiary amino compound		anti-allergic agent;
anti-asthmatic drug;
bronchodilator agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
H1-receptor antagonist;
platelet aggregation inhibitor
baclofen[no description available]medium10amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid;
monochlorobenzenes;
primary amino compound		central nervous system depressant;
GABA agonist;
muscle relaxant
bepridil[no description available]medium10pyrrolidines;
tertiary amine		anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
betaxolol[no description available]medium30propanolamineantihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
bicalutamide[no description available]medium10(trifluoromethyl)benzenes;
monocarboxylic acid amide;
monofluorobenzenes;
nitrile;
sulfone;
tertiary alcohol
bisoprolol[no description available]medium30secondary alcohol;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
brimonidine[no description available]medium10imidazoles;
quinoxaline derivative;
secondary amine		adrenergic agonist;
alpha-adrenergic agonist;
antihypertensive agent
bumetanide[no description available]medium30amino acid;
benzoic acids;
sulfonamide		diuretic;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
buspirone[no description available]medium10azaspiro compound;
N-alkylpiperazine;
N-arylpiperazine;
organic heteropolycyclic compound;
piperidones;
pyrimidines		anxiolytic drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
sedative;
serotonergic agonist
busulfan[no description available]medium30methanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
insect sterilant;
teratogenic agent
butenafine[no description available]medium10naphthalenes;
tertiary amine		antifungal drug;
EC 1.14.13.132 (squalene monooxygenase) inhibitor
verapamil[no description available]medium50aromatic ether;
nitrile;
polyether;
tertiary amino compound
carbamazepine[no description available]medium50dibenzoazepine;
ureas		analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
carmustine[no description available]medium20N-nitrosoureas;
organochlorine compound		alkylating agent;
antineoplastic agent
carteolol[no description available]medium10quinolone;
secondary alcohol		anti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
carvedilol[no description available]medium30carbazoles;
secondary alcohol;
secondary amino compound		alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
cetirizine[no description available]medium10ether;
monocarboxylic acid;
monochlorobenzenes;
piperazines		anti-allergic agent;
environmental contaminant;
H1-receptor antagonist;
xenobiotic
chlormezanone[no description available]medium101,3-thiazine;
lactam;
monochlorobenzenes;
sulfone		antipsychotic agent;
anxiolytic drug;
muscle relaxant
ciclopirox[no description available]medium10cyclic hydroxamic acid;
hydroxypyridone antifungal drug;
pyridone		antibacterial agent;
antiseborrheic
cinoxacin[no description available]medium10cinnolines;
oxacycle;
oxo carboxylic acid		antibacterial drug;
antiinfective agent
ciprofloxacin[no description available]medium40aminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion		antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
cisapride[no description available]medium10benzamides
clofazimine[no description available]medium10monochlorobenzenes;
phenazines		dye;
leprostatic drug;
non-steroidal anti-inflammatory drug
clomipramine[no description available]medium20dibenzoazepineanticoronaviral agent;
antidepressant;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
serotonergic antagonist;
serotonergic drug;
serotonin uptake inhibitor
clonidine[no description available]medium30clonidine;
imidazoline
chlorazepate[no description available]medium201,4-benzodiazepinoneanticonvulsant;
anxiolytic drug;
GABA modulator;
prodrug
cyclobenzaprine[no description available]medium10carbotricyclic compoundantidepressant;
muscle relaxant;
tranquilizing drug
diazepam[no description available]medium301,4-benzodiazepinone;
organochlorine compound		anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
diclofenac[no description available]medium50amino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound		antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
diflunisal[no description available]medium20monohydroxybenzoic acid;
organofluorine compound		non-narcotic analgesic;
non-steroidal anti-inflammatory drug
dipivefrin[no description available]medium10ethanolamines;
pivalate ester		adrenergic agonist;
antiglaucoma drug;
ophthalmology drug;
prodrug;
sympathomimetic agent
disopyramide[no description available]medium30monocarboxylic acid amide;
pyridines;
tertiary amino compound		anti-arrhythmia drug
disulfiram[no description available]medium10organic disulfide;
organosulfur acaricide		angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
valproic acid[no description available]medium30branched-chain fatty acid;
branched-chain saturated fatty acid		anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
doxazosin[no description available]medium20aromatic amine;
benzodioxine;
monocarboxylic acid amide;
N-acylpiperazine;
N-arylpiperazine;
quinazolines		alpha-adrenergic antagonist;
antihyperplasia drug;
antihypertensive agent;
antineoplastic agent;
vasodilator agent
doxepin[no description available]medium30dibenzooxepine;
tertiary amino compound		antidepressant
droperidol[no description available]medium10aromatic ketone;
benzimidazoles;
organofluorine compound		anaesthesia adjuvant;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic
econazole[no description available]medium10dichlorobenzene;
ether;
imidazoles;
monochlorobenzenes
enflurane[no description available]medium10ether;
organochlorine compound;
organofluorine compound		anaesthetic
enoxacin[no description available]medium201,8-naphthyridine derivative;
amino acid;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-arylpiperazine;
quinolone antibiotic		antibacterial drug;
DNA synthesis inhibitor
estazolam[no description available]medium10triazoles;
triazolobenzodiazepine		anticonvulsant;
anxiolytic drug;
GABA modulator
etidronate[no description available]medium101,1-bis(phosphonic acid)antineoplastic agent;
bone density conservation agent;
chelator
etodolac[no description available]medium10monocarboxylic acid;
organic heterotricyclic compound		antipyretic;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
brl 42810[no description available]medium102-aminopurines;
acetate ester		antiviral drug;
prodrug
felbamate[no description available]medium10carbamate esteranticonvulsant;
neuroprotective agent
felodipine[no description available]medium30dichlorobenzene;
dihydropyridine;
ethyl ester;
methyl ester		anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
fenfluramine[no description available]medium10(trifluoromethyl)benzenes;
secondary amino compound		appetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
fentanyl[no description available]medium40anilide;
monocarboxylic acid amide;
piperidines		adjuvant;
anaesthesia adjuvant;
anaesthetic;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
fentanyl[no description available]medium41anilide;
monocarboxylic acid amide;
piperidines		adjuvant;
anaesthesia adjuvant;
anaesthetic;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
fexofenadine[no description available]medium10piperidines;
tertiary amine		anti-allergic agent;
H1-receptor antagonist
flecainide[no description available]medium30aromatic ether;
monocarboxylic acid amide;
organofluorine compound;
piperidines		anti-arrhythmia drug
fluconazole[no description available]medium30conazole antifungal drug;
difluorobenzene;
tertiary alcohol;
triazole antifungal drug		environmental contaminant;
P450 inhibitor;
xenobiotic
flucytosine[no description available]medium30aminopyrimidine;
nucleoside analogue;
organofluorine compound;
pyrimidine antifungal drug;
pyrimidone		prodrug
fluphenazine[no description available]medium10N-alkylpiperazine;
organofluorine compound;
phenothiazines		anticoronaviral agent;
dopaminergic antagonist;
phenothiazine antipsychotic drug
flumazenil[no description available]medium30ethyl ester;
imidazobenzodiazepine;
organofluorine compound		antidote to benzodiazepine poisoning;
GABA antagonist
fluorouracil[no description available]medium30nucleobase analogue;
organofluorine compound		antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
fluoxetine[no description available]medium10(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
fluphenazine depot[no description available]medium10decanoate ester;
N-alkylpiperazine;
organofluorine compound;
phenothiazines		dopaminergic antagonist;
phenothiazine antipsychotic drug;
prodrug
fluphenazine enanthate[no description available]medium10phenothiazines
flurbiprofen[no description available]medium10fluorobiphenyl;
monocarboxylic acid		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
flutamide[no description available]medium10(trifluoromethyl)benzenes;
monocarboxylic acid amide		androgen antagonist;
antineoplastic agent
foscarnet[no description available]medium30carboxylic acid;
one-carbon compound;
phosphonic acids		antiviral drug;
geroprotector;
HIV-1 reverse transcriptase inhibitor;
sodium-dependent Pi-transporter inhibitor
furosemide[no description available]medium80chlorobenzoic acid;
furans;
sulfonamide		environmental contaminant;
loop diuretic;
xenobiotic
furosemide[no description available]medium81chlorobenzoic acid;
furans;
sulfonamide		environmental contaminant;
loop diuretic;
xenobiotic
gabapentin[no description available]medium30gamma-amino acidanticonvulsant;
calcium channel blocker;
environmental contaminant;
xenobiotic
gemfibrozil[no description available]medium10aromatic etherantilipemic drug
glimepiride[no description available]medium30sulfonamide
glipizide[no description available]medium30aromatic amide;
monocarboxylic acid amide;
N-sulfonylurea;
pyrazines		EC 2.7.1.33 (pantothenate kinase) inhibitor;
hypoglycemic agent;
insulin secretagogue
glyburide[no description available]medium30monochlorobenzenes;
N-sulfonylurea		anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
granisetron[no description available]medium30aromatic amide;
indazoles
guanfacine[no description available]medium30acetamides
haloperidol[no description available]medium30aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol		antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
halothane[no description available]medium10haloalkane;
organobromine compound;
organochlorine compound;
organofluorine compound		inhalation anaesthetic
hydrochlorothiazide[no description available]medium10benzothiadiazine;
organochlorine compound;
sulfonamide		antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
hydroxyurea[no description available]medium30one-carbon compound;
ureas		antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
hydroxyzine[no description available]medium10hydroxyether;
monochlorobenzenes;
N-alkylpiperazine		anticoronaviral agent;
antipruritic drug;
anxiolytic drug;
dermatologic drug;
H1-receptor antagonist
ibuprofen[no description available]medium40monocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
phenelzine[no description available]medium10primary amine
ifosfamide[no description available]medium30ifosfamidesalkylating agent;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
xenobiotic
amrinone[no description available]medium30bipyridinesEC 3.1.4.* (phosphoric diester hydrolase) inhibitor
indapamide[no description available]medium10indoles;
organochlorine compound;
sulfonamide		antihypertensive agent;
diuretic
indomethacin[no description available]medium40aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole		analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
iodixanol[no description available]high1160organoiodine compoundradioopaque medium
iodixanol[no description available]high11628organoiodine compoundradioopaque medium
iohexol[no description available]high1,6320benzenedicarboxamide;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
iohexol[no description available]high1,632203benzenedicarboxamide;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
ioversol[no description available]medium320amidobenzoic acid
ioversol[no description available]medium325amidobenzoic acid
isoflurane[no description available]medium10organofluorine compoundinhalation anaesthetic
isoniazid[no description available]medium20carbohydrazideantitubercular agent;
drug allergen
isradipine[no description available]medium30benzoxadiazole;
dihydropyridine;
isopropyl ester;
methyl ester
itraconazole[no description available]medium30piperazines
ketoconazole[no description available]medium10dichlorobenzene;
dioxolane;
ether;
imidazoles;
N-acylpiperazine;
N-arylpiperazine
ketoprofen[no description available]medium30benzophenones;
oxo monocarboxylic acid		antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
ketorolac[no description available]medium30amino acid;
aromatic ketone;
monocarboxylic acid;
pyrrolizines;
racemate		analgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
labetalol[no description available]medium30benzamides;
benzenes;
phenols;
primary carboxamide;
salicylamides;
secondary alcohol;
secondary amino compound
lamotrigine[no description available]medium101,2,4-triazines;
dichlorobenzene;
primary arylamine		anticonvulsant;
antidepressant;
antimanic drug;
calcium channel blocker;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
excitatory amino acid antagonist;
geroprotector;
non-narcotic analgesic;
xenobiotic
lansoprazole[no description available]medium30benzimidazoles;
pyridines;
sulfoxide		anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
lomefloxacin[no description available]medium10fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antimicrobial agent;
antitubercular agent;
photosensitizing agent
loratadine[no description available]medium10benzocycloheptapyridine;
ethyl ester;
N-acylpiperidine;
organochlorine compound;
tertiary carboxamide		anti-allergic agent;
cholinergic antagonist;
geroprotector;
H1-receptor antagonist
losartan[no description available]medium30biphenylyltetrazole;
imidazoles		angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
loxapine[no description available]medium10dibenzooxazepineantipsychotic agent;
dopaminergic antagonist
maprotiline[no description available]medium20anthracenes
mebendazole[no description available]medium30aromatic ketone;
benzimidazoles;
carbamate ester		antinematodal drug;
microtubule-destabilising agent;
tubulin modulator
meclofenamic acid[no description available]medium10aminobenzoic acid;
organochlorine compound;
secondary amino compound		analgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
mefenamic acid[no description available]medium10aminobenzoic acid;
secondary amino compound		analgesic;
antipyretic;
antirheumatic drug;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
mefloquine hydrochloride[no description available]medium10organofluorine compound;
piperidines;
quinolines;
secondary alcohol
mesalamine[no description available]medium20amino acid;
aromatic amine;
monocarboxylic acid;
monohydroxybenzoic acid;
phenols		non-steroidal anti-inflammatory drug
metformin[no description available]medium30guanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
metoclopramide[no description available]medium30benzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound		antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic
metoprolol[no description available]medium30aromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound		antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
metronidazole[no description available]medium30C-nitro compound;
imidazoles;
primary alcohol		antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
mexiletine[no description available]medium30aromatic ether;
primary amino compound		anti-arrhythmia drug
midazolam[no description available]medium30imidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound		anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
midodrine[no description available]medium10amino acid amide;
aromatic ether;
secondary alcohol		alpha-adrenergic agonist;
prodrug;
sympathomimetic agent;
vasoconstrictor agent
minoxidil[no description available]medium10dialkylarylamine;
tertiary amino compound
mirtazapine[no description available]medium30benzazepine;
tetracyclic antidepressant		alpha-adrenergic antagonist;
anxiolytic drug;
H1-receptor antagonist;
histamine antagonist;
oneirogen;
serotonergic antagonist
mitoxantrone[no description available]medium30dihydroxyanthraquinoneanalgesic;
antineoplastic agent
nabumetone[no description available]medium10methoxynaphthalene;
methyl ketone		cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
nefazodone[no description available]medium30aromatic ether;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazoles		alpha-adrenergic antagonist;
analgesic;
antidepressant;
serotonergic antagonist;
serotonin uptake inhibitor
nevirapine[no description available]medium30cyclopropanes;
dipyridodiazepine		antiviral drug;
HIV-1 reverse transcriptase inhibitor
nicardipine[no description available]medium30benzenes;
C-nitro compound;
diester;
dihydropyridine;
methyl ester;
tertiary amino compound
nifedipine[no description available]medium30C-nitro compound;
dihydropyridine;
methyl ester		calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
nilutamide[no description available]medium10(trifluoromethyl)benzenes;
C-nitro compound;
imidazolidinone		androgen antagonist;
antineoplastic agent
nimodipine[no description available]medium302-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester		antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
nisoldipine[no description available]medium30C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
methyl ester
nizatidine[no description available]medium301,3-thiazoles;
C-nitro compound;
carboxamidine;
organic sulfide;
tertiary amino compound		anti-ulcer drug;
cholinergic drug;
H2-receptor antagonist
masoprocol[no description available]medium10catechols;
lignan;
tetrol		antioxidant;
ferroptosis inhibitor;
geroprotector;
plant metabolite
norfloxacin[no description available]medium10fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antibacterial drug;
DNA synthesis inhibitor;
environmental contaminant;
xenobiotic
nortriptyline[no description available]medium30organic tricyclic compound;
secondary amine		adrenergic uptake inhibitor;
analgesic;
antidepressant;
antineoplastic agent;
apoptosis inducer;
drug metabolite
ofloxacin[no description available]medium403-oxo monocarboxylic acid;
N-arylpiperazine;
N-methylpiperazine;
organofluorine compound;
oxazinoquinoline
omeprazole[no description available]medium30aromatic ether;
benzimidazoles;
pyridines;
sulfoxide
ondansetron[no description available]medium20carbazoles
oxaprozin[no description available]medium101,3-oxazoles;
monocarboxylic acid		analgesic;
non-steroidal anti-inflammatory drug
pamidronate[no description available]medium20phosphonoacetic acid
pemoline[no description available]medium101,3-oxazolescentral nervous system stimulant
pentamidine[no description available]medium20aromatic ether;
carboxamidine;
diether		anti-inflammatory agent;
antifungal agent;
calmodulin antagonist;
chemokine receptor 5 antagonist;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
NMDA receptor antagonist;
S100 calcium-binding protein B inhibitor;
trypanocidal drug;
xenobiotic
pentoxifylline[no description available]medium20oxopurine
perphenazine[no description available]medium30N-(2-hydroxyethyl)piperazine;
N-alkylpiperazine;
organochlorine compound;
phenothiazines		antiemetic;
dopaminergic antagonist;
phenothiazine antipsychotic drug
pindolol[no description available]medium30indoles;
secondary amine		antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
pirbuterol[no description available]medium10pyridines
prazepam[no description available]medium10benzodiazepine
praziquantel[no description available]medium10isoquinolines
prazosin[no description available]medium30aromatic ether;
furans;
monocarboxylic acid amide;
piperazines;
quinazolines		alpha-adrenergic antagonist;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
primidone[no description available]medium10pyrimidoneanticonvulsant;
environmental contaminant;
xenobiotic
probenecid[no description available]medium30benzoic acids;
sulfonamide		uricosuric drug
procainamide[no description available]medium30benzamidesanti-arrhythmia drug;
platelet aggregation inhibitor;
sodium channel blocker
procarbazine[no description available]medium10benzamides;
hydrazines		antineoplastic agent
propafenone[no description available]medium20aromatic ketone;
secondary alcohol;
secondary amino compound		anti-arrhythmia drug
propofol[no description available]medium20phenolsanticonvulsant;
antiemetic;
intravenous anaesthetic;
radical scavenger;
sedative
sch 16134[no description available]medium10benzodiazepine
ranitidine[no description available]medium30aralkylamine
riluzole[no description available]medium10benzothiazoles
rimantadine[no description available]medium10alkylamine
risperidone[no description available]medium301,2-benzoxazoles;
heteroarylpiperidine;
organofluorine compound;
pyridopyrimidine		alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
psychotropic drug;
second generation antipsychotic;
serotonergic antagonist
salmeterol xinafoate[no description available]medium10ether;
phenols;
primary alcohol;
secondary alcohol;
secondary amino compound
sevoflurane[no description available]medium10ether;
organofluorine compound		central nervous system depressant;
inhalation anaesthetic;
platelet aggregation inhibitor
sulfadiazine[no description available]medium30pyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antiinfective agent;
antimicrobial agent;
antiprotozoal drug;
coccidiostat;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic
sotalol[no description available]medium30ethanolamines;
secondary alcohol;
secondary amino compound;
sulfonamide		anti-arrhythmia drug;
beta-adrenergic antagonist;
environmental contaminant;
xenobiotic
sulconazole[no description available]medium10dichlorobenzene;
imidazoles;
monochlorobenzenes;
organic sulfide
sulfasalazine[no description available]medium10
sumatriptan[no description available]medium30sulfonamide;
tryptamines		serotonergic agonist;
vasoconstrictor agent
suprofen[no description available]medium30aromatic ketone;
monocarboxylic acid;
thiophenes		antirheumatic drug;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
tazarotene[no description available]medium10acetylenic compound;
ethyl ester;
pyridines;
retinoid;
thiochromane		keratolytic drug;
prodrug;
teratogenic agent
temazepam[no description available]medium10benzodiazepine
terazosin[no description available]medium30furans;
piperazines;
primary amino compound;
quinazolines		alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent
terfenadine[no description available]medium10diarylmethane
thioridazine[no description available]medium10phenothiazines;
piperidines		alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
thiotepa[no description available]medium30aziridines
ticlopidine[no description available]medium10monochlorobenzenes;
thienopyridine		anticoagulant;
fibrin modulating drug;
hematologic agent;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
tioconazole[no description available]medium10dichlorobenzene;
ether;
imidazoles;
thiophenes
tiopronin[no description available]medium10N-acyl-amino acid
tizanidine[no description available]medium30benzothiadiazole;
imidazoles		alpha-adrenergic agonist;
muscle relaxant
ultram[no description available]medium30aromatic ether;
tertiary alcohol;
tertiary amino compound
trazodone[no description available]medium20monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazolopyridine		adrenergic antagonist;
antidepressant;
anxiolytic drug;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
triazolam[no description available]medium30triazolobenzodiazepinesedative
trientine[no description available]medium10polyazaalkane;
tetramine		copper chelator
trifluoperazine[no description available]medium10N-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines		antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
trimethadione[no description available]medium10oxazolidinoneanticonvulsant;
geroprotector
trimetrexate[no description available]medium30
trimipramine[no description available]medium20dibenzoazepine;
tertiary amino compound		antidepressant;
environmental contaminant;
xenobiotic
venlafaxine[no description available]medium30cyclohexanols;
monomethoxybenzene;
tertiary alcohol;
tertiary amino compound		adrenergic uptake inhibitor;
analgesic;
antidepressant;
dopamine uptake inhibitor;
environmental contaminant;
serotonin uptake inhibitor;
xenobiotic
ici 204,219[no description available]medium10carbamate ester;
indoles;
N-sulfonylcarboxamide		anti-asthmatic agent;
leukotriene antagonist
zolpidem[no description available]medium30imidazopyridinecentral nervous system depressant;
GABA agonist;
sedative
zomepirac[no description available]medium10aromatic ketone;
monocarboxylic acid;
monochlorobenzenes;
pyrroles		cardiovascular drug;
non-steroidal anti-inflammatory drug
floxuridine[no description available]medium10nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
antiviral drug;
radiosensitizing agent
spironolactone[no description available]medium103-oxo-Delta(4) steroid;
oxaspiro compound;
steroid lactone;
thioester		aldosterone antagonist;
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
penicillamine[no description available]medium10non-proteinogenic alpha-amino acid;
penicillamine		antirheumatic drug;
chelator;
copper chelator;
drug allergen
prednisone[no description available]medium4011-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
pilocarpine[no description available]medium10pilocarpineantiglaucoma drug
vincristine[no description available]medium20acetate ester;
formamides;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid		antineoplastic agent;
drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
testosterone propionate[no description available]medium10steroid ester
bretylium tosylate[no description available]medium10organosulfonate salt;
quaternary ammonium salt		adrenergic antagonist;
anti-arrhythmia drug;
antihypertensive agent
cytarabine[no description available]medium10beta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside		antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
trifluridine[no description available]medium10nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
antiviral drug;
EC 2.1.1.45 (thymidylate synthase) inhibitor
medroxyprogesterone acetate[no description available]medium1020-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
corticosteroid;
steroid ester		adjuvant;
androgen;
antineoplastic agent;
antioxidant;
female contraceptive drug;
inhibitor;
progestin;
synthetic oral contraceptive
mestranol[no description available]medium1017beta-hydroxy steroid;
aromatic ether;
terminal acetylenic compound		prodrug;
xenoestrogen
methylprednisolone[no description available]medium306-methylprednisolone;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antiemetic;
environmental contaminant;
neuroprotective agent;
xenobiotic
estradiol dipropionate[no description available]medium10steroid ester
nafcillin[no description available]medium30penicillin allergen;
penicillin		antibacterial drug
methohexital[no description available]medium20acetylenic compound;
barbiturates		drug allergen;
intravenous anaesthetic
estradiol 17 beta-cypionate[no description available]medium10steroid ester
testosterone enanthate[no description available]medium10heptanoate ester;
sterol ester		androgen
betamethasone[no description available]medium3011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		anti-asthmatic agent;
anti-inflammatory drug;
immunosuppressive agent
chenodeoxycholic acid[no description available]medium10bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid		human metabolite;
mouse metabolite
podophyllotoxin[no description available]medium10furonaphthodioxole;
lignan;
organic heterotetracyclic compound		antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
levocarnitine[no description available]medium10carnitineantilipemic drug;
nootropic agent;
nutraceutical;
Saccharomyces cerevisiae metabolite;
water-soluble vitamin (role)
megestrol acetate[no description available]medium1020-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
steroid ester		antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
acetylcysteine[no description available]medium140acetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid		antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
acetylcysteine[no description available]medium148acetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid		antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
erythromycin[no description available]medium40cyclic ketone;
erythromycin
levonorgestrel[no description available]medium2017beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound		contraceptive drug;
female contraceptive drug;
progestin;
synthetic oral contraceptive
estradiol valerate[no description available]medium10steroid ester
ethambutol[no description available]medium30ethanolamines;
ethylenediamine derivative		antitubercular agent;
environmental contaminant;
xenobiotic
dronabinol[no description available]medium20benzochromene;
diterpenoid;
phytocannabinoid;
polyketide		cannabinoid receptor agonist;
epitope;
hallucinogen;
metabolite;
non-narcotic analgesic
pimozide[no description available]medium10benzimidazoles;
heteroarylpiperidine;
organofluorine compound		antidyskinesia agent;
dopaminergic antagonist;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
betamethasone valerate[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
primary alpha-hydroxy ketone;
steroid ester		anti-inflammatory drug
methylprednisolone hemisuccinate[no description available]medium10corticosteroid hormone;
hemisuccinate
stavudine[no description available]medium30dihydrofuran;
nucleoside analogue;
organic molecular entity		antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
cyclacillin[no description available]medium10penicillinantibacterial drug
tranylcypromine[no description available]medium102-phenylcyclopropan-1-amine
cladribine[no description available]medium30organochlorine compound;
purine 2'-deoxyribonucleoside		antineoplastic agent;
immunosuppressive agent
beclomethasone[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
corticosteroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		anti-asthmatic drug;
anti-inflammatory drug
estradiol enanthate[no description available]medium10steroid ester
betamethasone-17,21-dipropionate[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
propanoate ester;
steroid ester		antipsoriatic
olsalazine[no description available]medium20azobenzenes;
dicarboxylic acid		non-steroidal anti-inflammatory drug;
prodrug
zalcitabine[no description available]medium20pyrimidine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
selegiline[no description available]medium30selegiline;
terminal acetylenic compound		geroprotector
levamisole[no description available]medium106-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazoleantinematodal drug;
antirheumatic drug;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
immunological adjuvant;
immunomodulator
cephalexin[no description available]medium30beta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative		antibacterial drug
isosorbide-5-mononitrate[no description available]medium30glucitol derivative;
nitrate ester		nitric oxide donor;
vasodilator agent
danazol[no description available]medium1017beta-hydroxy steroid;
terminal acetylenic compound		anti-estrogen;
estrogen antagonist;
geroprotector
daunorubicin[no description available]medium10aminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones		antineoplastic agent;
bacterial metabolite
cephapirin[no description available]medium20cephalosporinantibacterial drug
bromocriptine[no description available]medium10indole alkaloidantidyskinesia agent;
antiparkinson drug;
dopamine agonist;
hormone antagonist
ursodeoxycholic acid[no description available]medium10bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid		human metabolite;
mouse metabolite
metipranolol[no description available]medium10acetate ester;
aromatic ether;
propanolamine;
secondary amino compound		anti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
halazepam[no description available]medium10organic molecular entity
du-21220[no description available]medium20benzyl alcohols;
polyphenol;
secondary alcohol;
secondary amino compound
cefazolin[no description available]medium30beta-lactam antibiotic allergen;
cephalosporin;
tetrazoles;
thiadiazoles		antibacterial drug
amoxicillin[no description available]medium30penicillin allergen;
penicillin		antibacterial drug
timolol[no description available]medium30timololanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
moricizine[no description available]medium10carbamate ester;
morpholines;
phenothiazines		anti-arrhythmia drug
bitolterol[no description available]medium10carboxylic ester;
diester;
ethanolamines;
secondary alcohol;
secondary amino compound		anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
prodrug
zidovudine[no description available]medium30azide;
pyrimidine 2',3'-dideoxyribonucleoside		antimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
tobramycin[no description available]medium30amino cyclitol glycosideantibacterial agent;
antimicrobial agent;
toxin
paclitaxel[no description available]medium220taxane diterpenoid;
tetracyclic diterpenoid		antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
paclitaxel[no description available]medium223taxane diterpenoid;
tetracyclic diterpenoid		antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
etoposide[no description available]medium20beta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound		antineoplastic agent;
DNA synthesis inhibitor
dobutamine[no description available]medium10catecholamine;
secondary amine		beta-adrenergic agonist;
cardiotonic drug;
sympathomimetic agent
penbutolol[no description available]medium10ethanolamines
ribavirin[no description available]medium301-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide		anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
guanadrel[no description available]medium10guanidines;
spiroketal		adrenergic antagonist;
antihypertensive agent
methyldopa[no description available]medium30L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		alpha-adrenergic agonist;
antihypertensive agent;
hapten;
peripheral nervous system drug;
sympatholytic agent
tocainide[no description available]medium30monocarboxylic acid amideanti-arrhythmia drug;
local anaesthetic;
sodium channel blocker
sq-11725[no description available]medium30
diltiazem[no description available]medium505-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetateantihypertensive agent;
calcium channel blocker;
vasodilator agent
levobunolol[no description available]medium10aromatic ether;
cyclic ketone;
propanolamine		antiglaucoma drug;
beta-adrenergic antagonist
vecuronium bromide[no description available]medium20organic bromide salt;
quaternary ammonium salt		muscle relaxant;
neuromuscular agent;
nicotinic antagonist
permethrin[no description available]medium10cyclopropanecarboxylate ester;
cyclopropanes		agrochemical;
ectoparasiticide;
pyrethroid ester acaricide;
pyrethroid ester insecticide;
scabicide
sufentanil[no description available]medium30anilide;
ether;
piperidines;
thiophenes		anaesthesia adjuvant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
torsemide[no description available]medium30aminopyridine;
N-sulfonylurea;
secondary amino compound		antihypertensive agent;
loop diuretic
cefmetazole[no description available]medium20cephalosporinantibacterial drug
desflurane[no description available]medium10organofluorine compoundinhalation anaesthetic
idarubicin[no description available]medium30anthracycline antibiotic;
deoxy hexoside;
monosaccharide derivative
cefonicid[no description available]medium10cephalosporinantibacterial drug
piperacillin[no description available]medium30penicillin allergen;
penicillin		antibacterial drug
paroxetine[no description available]medium30aromatic ether;
benzodioxoles;
organofluorine compound;
piperidines		antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
captopril[no description available]medium30alkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
cefoperazone[no description available]medium20cephalosporinantibacterial drug
lodoxamide[no description available]medium10organonitrogen compound;
organooxygen compound
atracurium[no description available]medium20diester;
quaternary ammonium ion		muscle relaxant;
nicotinic antagonist
butoconazole[no description available]medium10aryl sulfide;
conazole antifungal drug;
dichlorobenzene;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes
naftifine[no description available]medium10allylamine antifungal drug;
naphthalenes;
tertiary amine		EC 1.14.13.132 (squalene monooxygenase) inhibitor;
sterol biosynthesis inhibitor
pergolide[no description available]medium10diamine;
methyl sulfide;
organic heterotetracyclic compound		antiparkinson drug;
dopamine agonist
cefadroxil anhydrous[no description available]medium30cephalosporinantibacterial drug
encainide[no description available]medium30benzamides;
piperidines		anti-arrhythmia drug;
sodium channel blocker
nedocromil[no description available]medium10dicarboxylic acid;
organic heterotricyclic compound		anti-allergic agent;
anti-asthmatic drug;
non-steroidal anti-inflammatory drug
cefaclor anhydrous[no description available]medium10cephalosporinantibacterial drug;
drug allergen
alfentanil[no description available]medium30monocarboxylic acid amide;
piperidines		central nervous system depressant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
peripheral nervous system drug
cefotetan[no description available]medium20
lovastatin[no description available]medium30delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)		anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug
levocabastine[no description available]medium10piperidines
simvastatin[no description available]medium20delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic)		EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug
pravastatin[no description available]medium303-hydroxy carboxylic acid;
carbobicyclic compound;
carboxylic ester;
hydroxy monocarboxylic acid;
secondary alcohol;
statin (semi-synthetic)		anticholesteremic drug;
environmental contaminant;
metabolite;
xenobiotic
cabergoline[no description available]medium10N-acylureaantineoplastic agent;
antiparkinson drug;
dopamine agonist
quinapril[no description available]medium10dicarboxylic acid monoester;
ethyl ester;
isoquinolines;
tertiary carboxamide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
fosphenytoin[no description available]medium10imidazolidine-2,4-dione
finasteride[no description available]medium303-oxo steroid;
aza-steroid;
delta-lactam		androgen antagonist;
antihyperplasia drug;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor
esmolol[no description available]medium20aromatic ether;
ethanolamines;
methyl ester;
secondary alcohol;
secondary amino compound
adapalene[no description available]medium10adamantanes;
monocarboxylic acid;
naphthoic acid		dermatologic drug;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
non-steroidal anti-inflammatory drug
sparfloxacin[no description available]medium30fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
zileuton[no description available]medium101-benzothiophenes;
ureas		anti-asthmatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor;
leukotriene antagonist;
non-steroidal anti-inflammatory drug
cidofovir anhydrous[no description available]medium30phosphonic acids;
pyrimidone		anti-HIV agent;
antineoplastic agent;
antiviral drug;
photosensitizing agent
topotecan[no description available]medium30pyranoindolizinoquinolineantineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
gemcitabine[no description available]medium30organofluorine compound;
pyrimidine 2'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
ibutilide[no description available]medium30benzenes;
organic amino compound
remifentanil[no description available]medium30alpha-amino acid ester;
anilide;
monocarboxylic acid amide;
piperidinecarboxylate ester		intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
sedative
atorvastatin[no description available]medium20aromatic amide;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrroles;
statin (synthetic)		environmental contaminant;
xenobiotic
lamivudine[no description available]medium30monothioacetal;
nucleoside analogue;
oxacycle;
primary alcohol		allergen;
anti-HBV agent;
antiviral drug;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor;
HIV-1 reverse transcriptase inhibitor;
prodrug
irinotecan[no description available]medium30carbamate ester;
delta-lactone;
N-acylpiperidine;
pyranoindolizinoquinoline;
ring assembly;
tertiary alcohol;
tertiary amino compound		antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
valsartan[no description available]medium30biphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid		angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
adenosine[no description available]medium100adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
adenosine[no description available]medium101adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
cefprozil[no description available]medium20cephalosporin;
semisynthetic derivative		antibacterial drug
methylprednisolone aceponate[no description available]medium10corticosteroid hormone
dexamethasone 17-valerate[no description available]medium1021-hydroxy steroid
dexamethasone dipropionate[no description available]medium10corticosteroid hormone
iopamidol[no description available]high1530benzenedicarboxamide;
organoiodine compound;
pentol		environmental contaminant;
radioopaque medium;
xenobiotic
iopamidol[no description available]high15333benzenedicarboxamide;
organoiodine compound;
pentol		environmental contaminant;
radioopaque medium;
xenobiotic
dexfenfluramine[no description available]medium20fenfluramineappetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
sertraline[no description available]medium10dichlorobenzene;
secondary amino compound;
tetralins		antidepressant;
serotonin uptake inhibitor
erythromycin propionate[no description available]medium10erythromycin derivative
dexrazoxane[no description available]medium30razoxaneantineoplastic agent;
cardiovascular drug;
chelator;
immunosuppressive agent
antebate[no description available]medium10corticosteroid hormone
atovaquone[no description available]medium30hydroxy-1,2-naphthoquinone
flunisolide[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic ketal;
fluorinated steroid;
primary alpha-hydroxy ketone		anti-asthmatic drug;
anti-inflammatory drug;
immunosuppressive agent
clarithromycin[no description available]medium20macrolide antibioticantibacterial drug;
environmental contaminant;
protein synthesis inhibitor;
xenobiotic
nicotine[no description available]medium403-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
moexipril[no description available]medium10peptide
methotrexate[no description available]medium30dicarboxylic acid;
monocarboxylic acid amide;
pteridines		abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
docetaxel[no description available]medium30hydrate;
secondary alpha-hydroxy ketone		antineoplastic agent
levofloxacin[no description available]medium309-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
fluoroquinolone antibiotic;
quinolone antibiotic		antibacterial drug;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
naproxen[no description available]medium10methoxynaphthalene;
monocarboxylic acid		antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
ropivacaine[no description available]medium30piperidinecarboxamide;
ropivacaine		local anaesthetic
ropivacaine[no description available]medium31piperidinecarboxamide;
ropivacaine		local anaesthetic
estradiol 3-benzoate[no description available]medium1017beta-hydroxy steroid;
benzoate ester		estrogen receptor agonist;
xenoestrogen
estramustine[no description available]medium1017beta-hydroxy steroid;
carbamate ester;
organochlorine compound		alkylating agent;
antineoplastic agent;
radiation protective agent
ritonavir[no description available]medium101,3-thiazoles;
carbamate ester;
carboxamide;
L-valine derivative;
ureas		antiviral drug;
environmental contaminant;
HIV protease inhibitor;
xenobiotic
pentostatin[no description available]medium10coformycinsantimetabolite;
antineoplastic agent;
Aspergillus metabolite;
bacterial metabolite;
EC 3.5.4.4 (adenosine deaminase) inhibitor
quinidine[no description available]medium30cinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
meropenem[no description available]medium30alpha,beta-unsaturated monocarboxylic acid;
carbapenemcarboxylic acid;
organic sulfide;
pyrrolidinecarboxamide		antibacterial agent;
antibacterial drug;
drug allergen
griseofulvin[no description available]medium101-benzofurans;
antibiotic antifungal drug;
benzofuran antifungal drug;
organochlorine compound;
oxaspiro compound		antibacterial agent;
Penicillium metabolite
cefoxitin[no description available]medium20beta-lactam antibiotic allergen;
cephalosporin;
cephamycin;
semisynthetic derivative		antibacterial drug
saquinavir[no description available]medium20L-asparagine derivative;
quinolines		antiviral drug;
HIV protease inhibitor
netilmicin[no description available]medium30
metyrosine[no description available]medium10L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		antihypertensive agent;
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor
rocuronium bromide[no description available]medium10organic bromide salt;
quaternary ammonium salt		muscle relaxant;
neuromuscular agent
terconazole[no description available]medium101-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-isopropylpiperazine
bacampicillin[no description available]medium10penicillanic acid esterprodrug
erythromycin ethylsuccinate[no description available]medium10cyclic ketone;
erythromycin derivative;
ethyl ester;
succinate ester
amcinonide[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
acetate ester;
corticosteroid;
fluorinated steroid;
spiroketal		anti-inflammatory drug
betamethasone acetate[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
acetate ester;
fluorinated steroid;
steroid ester;
tertiary alpha-hydroxy ketone
acarbose[no description available]medium20amino cyclitol;
glycoside
tretinoin[no description available]medium10retinoic acid;
vitamin A		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
mycophenolic acid[no description available]medium102-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols		anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic
mupirocin[no description available]medium10alpha,beta-unsaturated carboxylic ester;
epoxide;
monocarboxylic acid;
oxanes;
secondary alcohol;
triol		antibacterial drug;
bacterial metabolite;
protein synthesis inhibitor
fosfomycin[no description available]medium30epoxide;
phosphonic acids		antimicrobial agent;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor
zithromax[no description available]medium30macrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
teniposide[no description available]medium30aromatic ether;
beta-D-glucoside;
cyclic acetal;
furonaphthodioxole;
gamma-lactone;
monosaccharide derivative;
phenols;
thiophenes		antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
cefamandole[no description available]medium30cephalosporin;
semisynthetic derivative		antibacterial drug
dactinomycin[no description available]medium10actinomycinmutagen
melphalan[no description available]medium30L-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound		alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
sch 22219[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
glucocorticoid;
propanoate ester;
steroid ester		anti-inflammatory drug
mezlocillin[no description available]medium30penicillin allergen;
penicillin		antibacterial drug
cholinophyllin[no description available]medium10
fludarabine[no description available]medium20purine nucleoside
propylthiouracil[no description available]medium30pyrimidinethioneantidote to paracetamol poisoning;
antimetabolite;
antioxidant;
antithyroid drug;
carcinogenic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
hormone antagonist
ipratropium bromide anhydrous[no description available]medium10
etomidate[no description available]medium20ethyl ester;
imidazoles		intravenous anaesthetic;
sedative
mercaptopurine[no description available]medium30aryl thiol;
purines;
thiocarbonyl compound		anticoronaviral agent;
antimetabolite;
antineoplastic agent
thiothixene[no description available]medium10N-methylpiperazineanticoronaviral agent
benztropine[no description available]medium10diarylmethane
sulindac[no description available]medium10monocarboxylic acid;
organofluorine compound;
sulfoxide		analgesic;
antineoplastic agent;
antipyretic;
apoptosis inducer;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug;
tocolytic agent
enclomiphene[no description available]medium10
terbinafine[no description available]medium10acetylenic compound;
allylamine antifungal drug;
enyne;
naphthalenes;
tertiary amine		EC 1.14.13.132 (squalene monooxygenase) inhibitor;
P450 inhibitor;
sterol biosynthesis inhibitor
thioguanine anhydrous[no description available]medium102-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
succimer[no description available]medium10dicarboxylic acid;
dithiol;
sulfur-containing carboxylic acid		chelator
streptozocin[no description available]medium10
tamoxifen[no description available]medium10stilbenoid;
tertiary amino compound		angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
ethionamide[no description available]medium10pyridines;
thiocarboxamide		antilipemic drug;
antitubercular agent;
fatty acid synthesis inhibitor;
leprostatic drug;
prodrug
dezocine[no description available]medium10phenols;
primary amino compound		opioid analgesic
dapiprazole[no description available]medium10N-alkylpiperazine;
N-arylpiperazine;
pyridines		alpha-adrenergic antagonist;
antipsychotic agent;
miotic;
ophthalmology drug
flosequinan[no description available]medium10quinolines
calcitriol[no description available]medium10D3 vitamins;
hydroxycalciol;
triol		antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
alprostadil[no description available]medium20prostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
amphotericin b[no description available]medium10antibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic		antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
pulmicort[no description available]medium3011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone		anti-inflammatory drug;
bronchodilator agent;
drug allergen
olopatadine[no description available]medium10
bw b1090u[no description available]medium10isoquinolines
7432 s[no description available]medium10cephalosporin;
dicarboxylic acid		antibacterial drug
etretinate[no description available]medium10enoate ester;
ethyl ester;
retinoid		keratolytic drug
isotretinoin[no description available]medium10retinoic acidantineoplastic agent;
keratolytic drug;
teratogenic agent
misoprostol[no description available]medium10
epoprostenol[no description available]medium10prostaglandins Imouse metabolite
betamethasone benzoate[no description available]medium1021-hydroxy steroid
dorzolamide[no description available]medium10sulfonamide;
thiophenes		antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
hydromorphone[no description available]medium20morphinane alkaloid;
organic heteropentacyclic compound		mu-opioid receptor agonist;
opioid analgesic
ly 163892[no description available]medium10carbacephem;
zwitterion		antibacterial drug;
antimicrobial agent
nalmefene[no description available]medium30morphinane alkaloid
topiramate[no description available]medium10cyclic ketal;
ketohexose derivative;
sulfamate ester		anticonvulsant;
sodium channel blocker
calcipotriene[no description available]medium10cyclopropanes;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol;
triol		antipsoriatic;
drug allergen
clobetasol[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
fluorinated steroid;
glucocorticoid;
tertiary alpha-hydroxy ketone		anti-inflammatory drug;
SMO receptor agonist
fluticasone[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
3-oxo-Delta(4) steroid;
corticosteroid;
fluorinated steroid;
thioester		anti-allergic agent;
anti-asthmatic drug
halobetasol[no description available]medium10corticosteroid hormone
latanoprost[no description available]medium10isopropyl ester;
prostaglandins Falpha;
triol		antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor;
prodrug
nalbuphine[no description available]medium30organic heteropentacyclic compoundmu-opioid receptor antagonist;
opioid analgesic
rimexolone[no description available]medium1020-oxo steroid
vinorelbine[no description available]medium30acetate ester;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
ring assembly;
vinca alkaloid		antineoplastic agent;
photosensitizing agent
fluvoxamine[no description available]medium10(trifluoromethyl)benzenes;
5-methoxyvalerophenone O-(2-aminoethyl)oxime		antidepressant;
anxiolytic drug;
serotonin uptake inhibitor
(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid[no description available]medium20dihydroxy monocarboxylic acid;
indoles;
organofluorine compound
oxiconazole[no description available]medium10conazole antifungal drug;
dichlorobenzene;
imidazole antifungal drug;
imidazoles;
oxime O-ether		antiinfective agent
naltrexone[no description available]medium20cyclopropanes;
morphinane-like compound;
organic heteropentacyclic compound		antidote to opioid poisoning;
central nervous system depressant;
environmental contaminant;
mu-opioid receptor antagonist;
xenobiotic
butorphanol[no description available]medium30morphinane alkaloidantitussive;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
cefixime[no description available]medium30cephalosporinantibacterial drug;
drug allergen
lisinopril[no description available]medium30dipeptideEC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
benazepril[no description available]medium10benzazepine;
dicarboxylic acid monoester;
ethyl ester;
lactam		EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
ramipril[no description available]medium10azabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid monoester;
dipeptide;
ethyl ester		bradykinin receptor B2 agonist;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor;
prodrug
indinavir sulfate[no description available]medium30dicarboxylic acid diamide;
N-(2-hydroxyethyl)piperazine;
piperazinecarboxamide		HIV protease inhibitor
enalapril[no description available]medium10dicarboxylic acid monoester;
dipeptide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug
cefuroxime[no description available]medium303-(carbamoyloxymethyl)cephalosporin;
furans;
oxime O-ether		drug allergen
ceftriaxone[no description available]medium301,2,4-triazines;
1,3-thiazoles;
cephalosporin;
oxime O-ether		antibacterial drug;
drug allergen;
EC 3.5.2.6 (beta-lactamase) inhibitor
cefepime[no description available]medium30cephalosporin;
oxime O-ether		antibacterial drug
ceftazidime[no description available]medium30cephalosporin;
oxime O-ether		antibacterial drug;
drug allergen;
EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor
trandolapril[no description available]medium10dicarboxylic acid monoester;
dipeptide;
ethyl ester;
organic heterobicyclic compound;
secondary amino compound;
tertiary carboxamide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
guanabenz[no description available]medium10dichlorobenzene
famotidine[no description available]medium301,3-thiazoles;
guanidines;
sulfonamide		anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
cefotaxime[no description available]medium301,3-thiazoles;
cephalosporin;
oxime O-ether		antibacterial drug;
drug allergen
aztreonam[no description available]medium30beta-lactam antibiotic allergen;
monobactam		antibacterial drug;
drug allergen;
EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor
cci 15641[no description available]medium10cephalosporin
cefpodoxime[no description available]medium10carboxylic acid;
cephalosporin		antibacterial drug
dirithromycin[no description available]medium10macrolide antibioticprodrug
cefpodoxime proxetil[no description available]medium10carboxylic acid;
carboxylic ester;
cephalosporin		antibacterial drug;
prodrug
ceftizoxime[no description available]medium30cephalosporinantibacterial drug
nitrofurantoin[no description available]medium30imidazolidine-2,4-dione;
nitrofuran antibiotic;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic		antibacterial drug;
antiinfective agent;
hepatotoxic agent
dantrolene[no description available]medium20
fosinopril[no description available]medium10
nystatin a1[no description available]medium10nystatins
mesna[no description available]medium10organosulfonic acid
cefamandole nafate[no description available]medium10organic sodium saltantibacterial drug;
prodrug
tetracycline[no description available]medium30
minocycline[no description available]medium20
piroxicam[no description available]medium10benzothiazine;
monocarboxylic acid amide;
pyridines		analgesic;
antirheumatic drug;
cyclooxygenase 1 inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
meclocycline[no description available]medium10
warfarin[no description available]medium40benzenes;
hydroxycoumarin;
methyl ketone
acyclovir[no description available]medium302-aminopurines;
oxopurine		antimetabolite;
antiviral drug
rifampin[no description available]medium30cyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion		angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
clozapine[no description available]medium30benzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound		adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic
didanosine[no description available]medium30purine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor;
geroprotector;
HIV-1 reverse transcriptase inhibitor
ganciclovir[no description available]medium302-aminopurines;
oxopurine		antiinfective agent;
antiviral drug
valacyclovir[no description available]medium10L-valyl esterantiviral drug
olanzapine[no description available]medium10benzodiazepine;
N-arylpiperazine;
N-methylpiperazine		antiemetic;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
serotonin uptake inhibitor
penciclovir[no description available]medium302-aminopurines;
propane-1,3-diols		antiviral drug
allopurinol[no description available]medium30nucleobase analogue;
organic heterobicyclic compound		antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
rifabutin[no description available]medium30
quinacrine[no description available]medium10acridines;
aromatic ether;
organochlorine compound;
tertiary amino compound		antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
1-(3-chlorophenyl)piperazine[no description available]medium10monochlorobenzenes;
N-arylpiperazine		drug metabolite;
environmental contaminant;
serotonergic agonist;
xenobiotic
enprofylline[no description available]medium20oxopurineanti-arrhythmia drug;
anti-asthmatic drug;
bronchodilator agent;
non-steroidal anti-inflammatory drug
acetazolamide[no description available]medium30monocarboxylic acid amide;
sulfonamide;
thiadiazoles		anticonvulsant;
diuretic;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
alfuzosin[no description available]medium10monocarboxylic acid amide;
quinazolines;
tetrahydrofuranol		alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent
alosetron[no description available]medium10imidazoles;
pyridoindole		antiemetic;
gastrointestinal drug;
serotonergic antagonist
alprenolol[no description available]medium20secondary alcohol;
secondary amino compound		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
diatrizoic acid[no description available]high530acetamides;
benzoic acids;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
diatrizoic acid[no description available]high5310acetamides;
benzoic acids;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
amsacrine[no description available]medium10acridines;
aromatic ether;
sulfonamide		antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
antipyrine[no description available]medium20pyrazoloneantipyretic;
cyclooxygenase 3 inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
bevantolol[no description available]medium20propanolamineanti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
calcium channel blocker
biperiden[no description available]medium10piperidines;
tertiary alcohol;
tertiary amino compound		antidote to sarin poisoning;
antidyskinesia agent;
antiparkinson drug;
muscarinic antagonist;
parasympatholytic
bromazepam[no description available]medium20organic molecular entity
bromopride[no description available]medium20benzamides
brotizolam[no description available]medium10organic molecular entity
buflomedil[no description available]medium20aromatic ketone
bunazosin[no description available]medium10quinazolines
bupivacaine[no description available]medium20aromatic amide;
piperidinecarboxamide;
tertiary amino compound
caffeine[no description available]medium30purine alkaloid;
trimethylxanthine		adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
metrizoate[no description available]medium30monocarboxylic acidradioopaque medium
chlorambucil[no description available]medium20aromatic amine;
monocarboxylic acid;
nitrogen mustard;
organochlorine compound;
tertiary amino compound		alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
chlordiazepoxide[no description available]medium20benzodiazepine
chloroquine[no description available]medium20aminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
chlorpheniramine[no description available]medium20monochlorobenzenes;
pyridines;
tertiary amino compound		anti-allergic agent;
antidepressant;
antipruritic drug;
H1-receptor antagonist;
histamine antagonist;
serotonin uptake inhibitor
chlorpromazine[no description available]medium20organochlorine compound;
phenothiazines;
tertiary amine		anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
chlorpropamide[no description available]medium20monochlorobenzenes;
N-sulfonylurea		hypoglycemic agent;
insulin secretagogue
chlorthalidone[no description available]medium20isoindoles;
monochlorobenzenes;
sulfonamide
cifenline[no description available]medium20diarylmethane
cimetidine[no description available]medium20aliphatic sulfide;
guanidines;
imidazoles;
nitrile		adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
citalopram[no description available]medium202-benzofurans;
cyclic ether;
nitrile;
organofluorine compound;
tertiary amino compound
clonazepam[no description available]medium201,4-benzodiazepinone;
monochlorobenzenes		anticonvulsant;
anxiolytic drug;
GABA modulator
dapsone[no description available]medium20substituted aniline;
sulfone		anti-inflammatory drug;
antiinfective agent;
antimalarial;
leprostatic drug
desipramine[no description available]medium20dibenzoazepine;
secondary amino compound		adrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
cholinergic antagonist;
drug allergen;
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
serotonin uptake inhibitor
nordazepam[no description available]medium101,4-benzodiazepinone;
organochlorine compound		anticonvulsant;
anxiolytic drug;
GABA modulator;
human metabolite;
sedative
amphetamine[no description available]medium10primary amine
diazoxide[no description available]medium20benzothiadiazine;
organochlorine compound;
sulfone		antihypertensive agent;
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
diuretic;
K-ATP channel agonist;
sodium channel blocker;
sympathomimetic agent;
vasodilator agent
diphenhydramine[no description available]medium40ether;
tertiary amino compound		anti-allergic agent;
antidyskinesia agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
antitussive;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
oneirogen;
sedative
domperidone[no description available]medium20benzimidazoles;
heteroarylpiperidine		antiemetic;
dopaminergic antagonist
doxapram[no description available]medium10morpholines;
pyrrolidin-2-ones		central nervous system stimulant
dyphylline[no description available]medium10oxopurine;
propane-1,2-diols		bronchodilator agent;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
muscle relaxant;
vasodilator agent
ethacrynic acid[no description available]medium10aromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid		EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic
etilefrine[no description available]medium20phenols
berotek[no description available]medium10resorcinols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
sympathomimetic agent;
tocolytic agent
fenspiride[no description available]medium10azaspiro compound
fleroxacin[no description available]medium20difluorobenzene;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-alkylpiperazine;
quinolines		antibacterial drug;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
flunitrazepam[no description available]medium101,4-benzodiazepinone;
C-nitro compound;
monofluorobenzenes		anxiolytic drug;
GABAA receptor agonist;
sedative
fluorescite[no description available]medium10benzoic acids;
cyclic ketone;
hydroxy monocarboxylic acid;
organic heterotricyclic compound;
phenols;
xanthene dye		fluorescent dye;
radioopaque medium
hexobarbital[no description available]medium20barbiturates
hydralazine[no description available]medium20azaarene;
hydrazines;
ortho-fused heteroarene;
phthalazines		antihypertensive agent;
vasodilator agent
hydroflumethiazide[no description available]medium10benzothiadiazine;
thiazide		antihypertensive agent;
diuretic
hydroxychloroquine[no description available]medium10aminoquinoline;
organochlorine compound;
primary alcohol;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antimalarial;
antirheumatic drug;
dermatologic drug
hypericin[no description available]medium10
lidocaine[no description available]medium30benzenes;
monocarboxylic acid amide;
tertiary amino compound		anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
imipramine[no description available]medium20dibenzoazepineadrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
iothalamic acid[no description available]medium230organic molecular entity
iothalamic acid[no description available]medium233organic molecular entity
avapro[no description available]medium10azaspiro compound;
biphenylyltetrazole		angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
isoproterenol[no description available]medium10catechols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
ketamine[no description available]medium10cyclohexanones;
monochlorobenzenes;
secondary amino compound		analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic
ketanserin[no description available]medium20aromatic ketone;
organofluorine compound;
piperidines;
quinazolines		alpha-adrenergic antagonist;
antihypertensive agent;
cardiovascular drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist
letrozole[no description available]medium20nitrile;
triazoles		antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
lorazepam[no description available]medium20benzodiazepine
meperidine[no description available]medium20ethyl ester;
piperidinecarboxylate ester;
tertiary amino compound		antispasmodic drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
mepivacaine[no description available]medium20piperidinecarboxamidedrug allergen;
local anaesthetic
mepivacaine[no description available]medium21piperidinecarboxamidedrug allergen;
local anaesthetic
meprobamate[no description available]medium10organic molecular entity
methadone[no description available]medium20benzenes;
diarylmethane;
ketone;
tertiary amino compound
methapyrilene[no description available]medium10ethylenediamine derivativeanti-allergic agent;
carcinogenic agent;
H1-receptor antagonist;
sedative
methylphenidate[no description available]medium20beta-amino acid ester;
methyl ester;
piperidines
metolazone[no description available]medium20organochlorine compound;
quinazolines;
sulfonamide		antihypertensive agent;
diuretic;
ion transport inhibitor
milrinone[no description available]medium20bipyridines;
nitrile;
pyridone		cardiotonic drug;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
moclobemide[no description available]medium20benzamides;
monochlorobenzenes;
morpholines		antidepressant;
environmental contaminant;
xenobiotic
acecainide[no description available]medium20acetamides;
benzamides		anti-arrhythmia drug
naratriptan[no description available]medium20heteroarylpiperidine;
sulfonamide;
tryptamines		serotonergic agonist;
vasoconstrictor agent
nefopam[no description available]medium10benzoxazocine;
tertiary amino compound
nitrazepam[no description available]medium201,4-benzodiazepinone;
C-nitro compound		anticonvulsant;
antispasmodic drug;
drug metabolite;
GABA modulator;
sedative
nitrendipine[no description available]medium30C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
ethyl ester;
methyl ester		antihypertensive agent;
calcium channel blocker;
geroprotector;
vasodilator agent
nitrendipine[no description available]medium31C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
ethyl ester;
methyl ester		antihypertensive agent;
calcium channel blocker;
geroprotector;
vasodilator agent
nomifensine[no description available]medium20isoquinolinesdopamine uptake inhibitor
oxazepam[no description available]medium201,4-benzodiazepinone;
organochlorine compound		anxiolytic drug;
environmental contaminant;
xenobiotic
oxiracetam[no description available]medium10organonitrogen compound;
organooxygen compound
oxybutynin[no description available]medium10acetylenic compound;
carboxylic ester;
racemate;
tertiary alcohol;
tertiary amino compound		antispasmodic drug;
calcium channel blocker;
local anaesthetic;
muscarinic antagonist;
muscle relaxant;
parasympatholytic
pantoprazole[no description available]medium20aromatic ether;
benzimidazoles;
organofluorine compound;
pyridines;
sulfoxide		anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
environmental contaminant;
xenobiotic
papaverine[no description available]medium40benzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines		antispasmodic drug;
vasodilator agent
papaverine[no description available]medium41benzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines		antispasmodic drug;
vasodilator agent
pentobarbital[no description available]medium10barbituratesGABAA receptor agonist
phenacetin[no description available]medium10acetamides;
aromatic ether		cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug
phenobarbital[no description available]medium20barbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
moxonidine[no description available]medium20organohalogen compound;
pyrimidines
pimobendan[no description available]medium10benzimidazoles;
pyridazinone		cardiotonic drug;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
piretanide[no description available]medium20aromatic ether
prilocaine[no description available]medium10amino acid amide;
monocarboxylic acid amide		anticonvulsant;
local anaesthetic
primaquine[no description available]medium10aminoquinoline;
aromatic ether;
N-substituted diamine		antimalarial
prochlorperazine[no description available]medium10N-alkylpiperazine;
N-methylpiperazine;
organochlorine compound;
phenothiazines		alpha-adrenergic antagonist;
antiemetic;
cholinergic antagonist;
dopamine receptor D2 antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic
procyclidine[no description available]medium10pyrrolidines;
tertiary alcohol		antidyskinesia agent;
antiparkinson drug;
muscarinic antagonist
promazine[no description available]medium10phenothiazines;
tertiary amine		antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
muscarinic antagonist;
phenothiazine antipsychotic drug;
serotonergic antagonist
promethazine[no description available]medium20phenothiazines;
tertiary amine		anti-allergic agent;
anticoronaviral agent;
antiemetic;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
sedative
propranolol[no description available]medium30naphthalenes;
propanolamine;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
pyridostigmine[no description available]medium20pyridinium ion
pyrimethamine[no description available]medium10aminopyrimidine;
monochlorobenzenes		antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
rabeprazole[no description available]medium20benzimidazoles;
pyridines;
sulfoxide		anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
rizatriptan[no description available]medium20tryptaminesanti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
risedronic acid[no description available]medium20pyridines
imatinib[no description available]medium20aromatic amine;
benzamides;
N-methylpiperazine;
pyridines;
pyrimidines		antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
vorinostat[no description available]medium10dicarboxylic acid diamide;
hydroxamic acid		antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
sulfamethoxazole[no description available]medium40isoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic
sulfinpyrazone[no description available]medium20pyrazolidines;
sulfoxide		uricosuric drug
sulfisoxazole[no description available]medium20isoxazoles;
sulfonamide antibiotic;
sulfonamide		antibacterial drug;
drug allergen
suramin[no description available]medium20naphthalenesulfonic acid;
phenylureas;
secondary carboxamide		angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
gatifloxacin[no description available]medium20N-arylpiperazine;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antiinfective agent;
antimicrobial agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
temozolomide[no description available]medium10imidazotetrazine;
monocarboxylic acid amide;
triazene derivative		alkylating agent;
antineoplastic agent;
prodrug
terbutaline[no description available]medium20phenylethanolamines;
resorcinols		anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hypoglycemic agent;
sympathomimetic agent;
tocolytic agent
thalidomide[no description available]medium10phthalimides;
piperidones
tinidazole[no description available]medium20imidazolesantiamoebic agent;
antibacterial drug;
antiparasitic agent;
antiprotozoal drug
tolbutamide[no description available]medium20N-sulfonylureahuman metabolite;
hypoglycemic agent;
insulin secretagogue;
potassium channel blocker
tranexamic acid[no description available]medium10amino acid
triamterene[no description available]medium20pteridinesdiuretic;
sodium channel blocker
trimethoprim[no description available]medium60aminopyrimidine;
methoxybenzenes		antibacterial drug;
diuretic;
drug allergen;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
environmental contaminant;
xenobiotic
urapidil[no description available]medium10piperazines
viloxazine[no description available]medium10aromatic ether
zaleplon[no description available]medium20nitrile;
pyrazolopyrimidine		anticonvulsant;
anxiolytic drug;
central nervous system depressant;
sedative
zopiclone[no description available]medium20monochloropyridine;
pyrrolopyrazine		central nervous system depressant;
sedative
prednisolone[no description available]medium2011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
cephaloridine[no description available]medium10beta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative		antibacterial drug
penicillin g[no description available]medium20penicillin allergen;
penicillin		antibacterial drug;
drug allergen;
epitope
chloramphenicol[no description available]medium20C-nitro compound;
carboxamide;
diol;
organochlorine compound		antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
ethinyl estradiol[no description available]medium3017-hydroxy steroid;
3-hydroxy steroid;
terminal acetylenic compound		xenoestrogen
apomorphine[no description available]medium10aporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug
cephalothin[no description available]medium10azabicycloalkene;
beta-lactam antibiotic allergen;
carboxylic acid;
cephalosporin;
semisynthetic derivative;
thiophenes		antibacterial drug;
antimicrobial agent
kanamycin a[no description available]medium10kanamycinsbacterial metabolite
levodopa[no description available]medium20amino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug
methicillin[no description available]medium20penicillin allergen;
penicillin		antibacterial drug
colchicine[no description available]medium10alkaloid;
colchicine		anti-inflammatory agent;
gout suppressant;
mutagen
oxacillin[no description available]medium20penicillinantibacterial agent;
antibacterial drug
ampicillin[no description available]medium20beta-lactam antibiotic;
penicillin allergen;
penicillin		antibacterial drug
triamcinolone acetonide[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone		anti-allergic agent;
anti-inflammatory drug
phencyclidine[no description available]medium20benzenes;
piperidines		anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
dichloroacetic acid[no description available]medium10monocarboxylic acid;
organochlorine compound		astringent;
marine metabolite
penicillin v[no description available]medium20penicillin allergen;
penicillin
isosorbide dinitrate[no description available]medium10glucitol derivative;
nitrate ester		nitric oxide donor;
vasodilator agent
ergotamine[no description available]medium10peptide ergot alkaloidalpha-adrenergic agonist;
mycotoxin;
non-narcotic analgesic;
oxytocic;
serotonergic agonist;
vasoconstrictor agent
neostigmine bromide[no description available]medium10bromide salt
pirinitramide[no description available]medium20nitrile
edrophonium bromide[no description available]medium10
azacitidine[no description available]medium10N-glycosyl-1,3,5-triazine;
nucleoside analogue		antineoplastic agent
galantamine[no description available]medium20benzazepine alkaloid fundamental parent;
benzazepine alkaloid;
organic heterotetracyclic compound;
tertiary amino compound		antidote to curare poisoning;
cholinergic drug;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
plant metabolite
dextropropoxyphene[no description available]medium101-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoatemu-opioid receptor agonist;
opioid analgesic
ketobemidone[no description available]medium10piperidines
chlormethiazole[no description available]medium20thiazoles
methamphetamine[no description available]medium10amphetamines;
secondary amine		central nervous system stimulant;
environmental contaminant;
neurotoxin;
psychotropic drug;
xenobiotic
lithium carbonate[no description available]medium10carbonate salt;
lithium salt		antimanic drug
lormetazepam[no description available]medium201,4-benzodiazepinone;
organochlorine compound		sedative
vinblastine[no description available]medium20
vancomycin[no description available]medium20glycopeptideantibacterial drug;
antimicrobial agent;
bacterial metabolite
metylperon[no description available]medium10aromatic ketone
spectinomycin[no description available]medium10cyclic acetal;
cyclic hemiketal;
cyclic ketone;
pyranobenzodioxin;
secondary alcohol;
secondary amino compound		antibacterial drug;
antimicrobial agent;
bacterial metabolite
benperidol[no description available]medium10aromatic ketone
chlordesmethyldiazepam[no description available]medium10benzodiazepine
doxifluridine[no description available]medium20organofluorine compound;
pyrimidine 5'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
prodrug
dicloxacillin[no description available]medium20dichlorobenzene;
penicillin		antibacterial drug
streptomycin[no description available]medium10antibiotic antifungal drug;
antibiotic fungicide;
streptomycins		antibacterial drug;
antifungal agrochemical;
antimicrobial agent;
antimicrobial drug;
bacterial metabolite;
protein synthesis inhibitor
carbenicillin[no description available]medium20penicillin allergen;
penicillin		antibacterial drug
floxacillin[no description available]medium20penicillin allergen;
penicillin		antibacterial drug
beclomethasone dipropionate[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
corticosteroid;
enone;
glucocorticoid;
propanoate ester;
steroid ester		anti-arrhythmia drug;
anti-asthmatic drug;
anti-inflammatory drug;
prodrug
terodiline[no description available]medium20diarylmethane
1-(4-carboxyphenyl)-3,3-dimethyltriazene[no description available]medium10
metocurine iodide[no description available]medium20aromatic ether
apazone[no description available]medium10benzotriazinesnon-steroidal anti-inflammatory drug;
uricosuric drug
pregnanolone[no description available]medium103-hydroxy-5beta-pregnan-20-one;
3alpha-hydroxy steroid		human metabolite;
intravenous anaesthetic;
sedative
ribostamycin[no description available]medium10amino cyclitol glycoside;
aminoglycoside antibiotic		antibacterial drug;
antimicrobial agent;
metabolite
indoramin[no description available]medium10tryptamines
toloxatone[no description available]medium20oxazolidinone;
primary alcohol;
toluenes
sisomicin[no description available]medium20amino cyclitol glycoside;
aminoglycoside antibiotic;
beta-L-arabinoside;
monosaccharide derivative
amdinocillin[no description available]medium10penicillinantibacterial drug;
antiinfective agent
ticarcillin[no description available]medium20penicillin allergen;
penicillin		antibacterial drug
trimazosin[no description available]medium10N-arylpiperazine
adinazolam[no description available]medium20triazolobenzodiazepineanticonvulsant;
antidepressant;
anxiolytic drug;
sedative
amikacin[no description available]medium10alpha-D-glucoside;
amino cyclitol glycoside;
aminoglycoside;
carboxamide		antibacterial drug;
antimicrobial agent;
nephrotoxin
tolamolol[no description available]medium10
cephradine[no description available]medium20beta-lactam antibiotic allergen;
cephalosporin		antibacterial drug
sulbenicillin[no description available]medium20penicillin
meptazinol[no description available]medium20azepanes
medroxalol[no description available]medium10salicylamides
epirubicin[no description available]medium40aminoglycoside;
anthracycline antibiotic;
anthracycline;
deoxy hexoside;
monosaccharide derivative;
p-quinones;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		antimicrobial agent;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
lorcainide[no description available]medium20acetamides
ceforanide[no description available]medium10cephalosporinantibacterial drug
moxalactam[no description available]medium20cephalosporin;
oxacephem		antibacterial drug
endralazine[no description available]medium10benzamides
pefloxacin[no description available]medium20fluoroquinolone antibiotic;
monocarboxylic acid;
N-alkylpiperazine;
N-arylpiperazine;
quinolone antibiotic;
quinolone		antibacterial drug;
antiinfective agent;
DNA synthesis inhibitor
recainam[no description available]medium20
flupirtine[no description available]medium20aminopyridine
enoximone[no description available]medium20aromatic ketone
idazoxan[no description available]medium10benzodioxine;
imidazolines		alpha-adrenergic antagonist
remoxipride[no description available]medium20dimethoxybenzene
bambuterol[no description available]medium10carbamate ester;
phenylethanolamines		anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
prodrug;
sympathomimetic agent;
tocolytic agent
atomoxetine[no description available]medium20aromatic ether;
secondary amino compound;
toluenes		adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
xenobiotic
trospectomycin[no description available]medium10dioxanes
sematilide[no description available]medium20
clinafloxacin[no description available]medium20quinolines
adefovir[no description available]medium206-aminopurines;
ether;
phosphonic acids		antiviral drug;
DNA synthesis inhibitor;
drug metabolite;
HIV-1 reverse transcriptase inhibitor;
nephrotoxic agent
loxiglumide[no description available]medium10organic molecular entity
tiagabine[no description available]medium20beta-amino acid;
piperidinemonocarboxylic acid;
tertiary amino compound;
thiophenes		anticonvulsant;
GABA reuptake inhibitor
mibefradil[no description available]medium10tetralinsT-type calcium channel blocker
bromfenac[no description available]medium20aromatic amino acid;
benzophenones;
organobromine compound;
substituted aniline		non-narcotic analgesic;
non-steroidal anti-inflammatory drug
aripiprazole[no description available]medium10aromatic ether;
delta-lactam;
dichlorobenzene;
N-alkylpiperazine;
N-arylpiperazine;
quinolone		drug metabolite;
H1-receptor antagonist;
second generation antipsychotic;
serotonergic agonist
ibandronic acid[no description available]medium10
ziprasidone[no description available]medium201,2-benzisothiazole;
indolones;
organochlorine compound;
piperazines		antipsychotic agent;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
psychotropic drug;
serotonergic antagonist
zanamivir[no description available]medium20guanidinesantiviral agent;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor
zolmitriptan[no description available]medium20oxazolidinone;
tryptamines		anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
tirofiban[no description available]medium20L-tyrosine derivative;
piperidines;
sulfonamide		anticoagulant;
fibrin modulating drug;
platelet glycoprotein-IIb/IIIa receptor antagonist
cisatracurium[no description available]medium10diester;
quaternary ammonium ion		muscle relaxant;
nicotinic antagonist
fosinoprilat[no description available]medium10L-proline derivative;
phosphinic acids		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
trovafloxacin[no description available]medium20
imipramine n-oxide[no description available]medium10dibenzooxazepine
dexloxiglumide[no description available]medium20glutamic acid derivative
intoplicine[no description available]medium10pyridoindole
repaglinide[no description available]medium20piperidines
telmisartan[no description available]medium20benzimidazoles;
biphenyls;
carboxybiphenyl		angiotensin receptor antagonist;
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
environmental contaminant;
xenobiotic
ethinyl estradiol-17-sulfate[no description available]medium10
ethinylestradiol-3-sulfate[no description available]medium1017beta-hydroxy steroid;
steroid sulfate		antineoplastic agent;
estrogen
cefcanel[no description available]medium10
zoledronic acid[no description available]medium201,1-bis(phosphonic acid);
imidazoles		bone density conservation agent
epristeride[no description available]medium20steroid acid
talinolol[no description available]medium20ureas
denaverine[no description available]medium10diarylmethane
diprafenone[no description available]medium20aromatic compound
nebivolol[no description available]medium10chromanes;
diol;
organofluorine compound;
secondary alcohol;
secondary amino compound
uk 68798[no description available]medium20aromatic ether;
sulfonamide;
tertiary amino compound		anti-arrhythmia drug;
potassium channel blocker
ljc 10627[no description available]medium20carbapenems;
organic sulfide;
pyrazolotriazole		antibacterial drug
voriconazole[no description available]medium20conazole antifungal drug;
difluorobenzene;
pyrimidines;
tertiary alcohol;
triazole antifungal drug		P450 inhibitor
betamipron[no description available]medium10organonitrogen compound;
organooxygen compound
bufuralol[no description available]medium20benzofurans
panipenem[no description available]medium10organic molecular entity
perindoprilat[no description available]medium10dicarboxylic acid;
dipeptide;
L-alanine derivative;
organic heterobicyclic compound		antihypertensive agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
7-hydroxystaurosporine[no description available]medium10
methotrimeprazine[no description available]medium10phenothiazines;
tertiary amine		anticoronaviral agent;
cholinergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
non-narcotic analgesic;
phenothiazine antipsychotic drug;
serotonergic antagonist
9-aminocamptothecin[no description available]medium10pyranoindolizinoquinoline
sch 34343[no description available]medium20
squalamine[no description available]medium10bile acid
rivastigmine[no description available]medium20carbamate ester;
tertiary amino compound		cholinergic drug;
EC 3.1.1.8 (cholinesterase) inhibitor;
neuroprotective agent
frovatriptan[no description available]medium20carbazoles
eletriptan[no description available]medium10indoles;
N-alkylpyrrolidine;
sulfone		non-steroidal anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
rosiglitazone[no description available]medium20aminopyridine;
thiazolidinediones		EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
insulin-sensitizing drug
mci 9038[no description available]medium10peptide
imipenem, anhydrous[no description available]medium10beta-lactam antibiotic allergen;
carbapenems;
zwitterion		antibacterial drug
bosentan anhydrous[no description available]medium10primary alcohol;
pyrimidines;
sulfonamide		antihypertensive agent;
endothelin receptor antagonist
asulacrine[no description available]medium10acridines
hydroxycotinine[no description available]medium10N-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid
quinaprilat[no description available]medium20dicarboxylic acid;
isoquinolines;
tertiary carboxamide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
vasodilator agent
2-hydroxyimipramine[no description available]medium20dibenzoazepine
ecteinascidin 743[no description available]medium10acetate ester;
azaspiro compound;
bridged compound;
hemiaminal;
isoquinoline alkaloid;
lactone;
organic heteropolycyclic compound;
organic sulfide;
oxaspiro compound;
polyphenol;
tertiary amino compound		alkylating agent;
angiogenesis modulating agent;
anti-inflammatory agent;
antineoplastic agent;
marine metabolite
almotriptan[no description available]medium20indoles;
sulfonamide;
tertiary amine		non-steroidal anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
mk 0663[no description available]medium10bipyridines;
organochlorine compound;
sulfone		cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
gefitinib[no description available]medium10aromatic ether;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
quinazolines;
secondary amino compound;
tertiary amino compound		antineoplastic agent;
epidermal growth factor receptor antagonist
tamsulosin[no description available]medium205-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamidealpha-adrenergic antagonist;
antineoplastic agent
sulbactam[no description available]medium20penicillanic acids
dilevalol[no description available]medium102-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide
irofulven[no description available]medium10cyclohexenones
ym 872[no description available]medium10
ertapenem[no description available]medium10carbapenemcarboxylic acid;
pyrrolidinecarboxamide		antibacterial drug
dx 8951[no description available]medium10pyranoindolizinoquinoline
cilomilast[no description available]medium20methoxybenzenes
conivaptan[no description available]medium10benzazepineaquaretic;
vasopressin receptor antagonist
tezosentan[no description available]medium10
sabarubicin[no description available]medium10
moxifloxacin[no description available]medium20aromatic ether;
cyclopropanes;
fluoroquinolone antibiotic;
pyrrolidinopiperidine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antibacterial drug
clevidipine[no description available]medium10dihydropyridine
solifenacin[no description available]medium20isoquinolines
xamoterol[no description available]medium20morpholines
abanoquil[no description available]medium10
anidulafungin[no description available]medium10antibiotic antifungal drug;
azamacrocycle;
echinocandin;
heterodetic cyclic peptide;
semisynthetic derivative
atropine[no description available]medium20
melagatran[no description available]medium20azetidines;
carboxamidine;
dicarboxylic acid monoamide;
non-proteinogenic alpha-amino acid;
secondary amino compound		anticoagulant;
EC 3.4.21.5 (thrombin) inhibitor;
serine protease inhibitor
tesaglitazar[no description available]medium20
bms204352[no description available]medium10
fosfluconazole[no description available]medium10conazole antifungal drug;
triazole antifungal drug;
triazoles		prodrug
cp 101,606[no description available]medium20
nsc-89199[no description available]medium10carbamate ester;
organochlorine compound;
steroid phosphate
phenethicillin[no description available]medium10penicillin allergen;
penicillin
acivicin[no description available]medium10isoxazoles;
non-proteinogenic L-alpha-amino acid;
organochlorine compound		antileishmanial agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor;
glutamine antagonist;
metabolite
bortezomib[no description available]medium10amino acid amide;
L-phenylalanine derivative;
pyrazines		antineoplastic agent;
antiprotozoal drug;
protease inhibitor;
proteasome inhibitor
digitoxin[no description available]medium10cardenolide glycosideEC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
pancuronium[no description available]medium10acetate ester;
steroid ester		cholinergic antagonist;
muscle relaxant;
nicotinic antagonist
rocuronium[no description available]medium103alpha-hydroxy steroid;
acetate ester;
androstane;
morpholines;
quaternary ammonium ion;
tertiary amino compound		drug allergen;
muscle relaxant;
neuromuscular agent
abacavir[no description available]medium202,6-diaminopurinesantiviral drug;
drug allergen;
HIV-1 reverse transcriptase inhibitor
miglitol[no description available]medium20piperidines
linezolid[no description available]medium20acetamides;
morpholines;
organofluorine compound;
oxazolidinone		antibacterial drug;
protein synthesis inhibitor
tolterodine[no description available]medium20tertiary amineantispasmodic drug;
muscarinic antagonist;
muscle relaxant
darifenacin[no description available]medium101-benzofurans;
monocarboxylic acid amide;
pyrrolidines		antispasmodic drug;
muscarinic antagonist
fluticasone propionate[no description available]medium1011beta-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
corticosteroid;
fluorinated steroid;
propanoate ester;
steroid ester;
thioester		adrenergic agent;
anti-allergic agent;
anti-asthmatic drug;
anti-inflammatory drug;
bronchodilator agent;
dermatologic drug
tacrolimus[no description available]medium20macrolide lactambacterial metabolite;
immunosuppressive agent
cerivastatin[no description available]medium20dihydroxy monocarboxylic acid;
pyridines;
statin (synthetic)
rosuvastatin[no description available]medium20dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrimidines;
statin (synthetic);
sulfonamide		anti-inflammatory agent;
antilipemic drug;
cardioprotective agent;
CETP inhibitor;
environmental contaminant;
xenobiotic
cocaine[no description available]medium30benzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid		adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
clindamycin[no description available]medium20
bms 214662[no description available]medium10benzenes;
benzodiazepine;
imidazoles;
nitrile;
sulfonamide;
thiophenes		antineoplastic agent;
apoptosis inducer;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
eptifibatide[no description available]medium10homodetic cyclic peptide;
macrocycle;
organic disulfide		anticoagulant;
platelet aggregation inhibitor
gs 4071[no description available]medium20acetate ester;
amino acid;
cyclohexenecarboxylic acid;
primary amino compound		antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
marine xenobiotic metabolite
decitabine[no description available]medium202'-deoxyribonucleoside
sm 8668[no description available]medium10
troxacitabine[no description available]medium10carbohydrate derivative;
nucleobase-containing molecular entity
tiazofurin[no description available]medium101,3-thiazoles;
C-glycosyl compound;
monocarboxylic acid amide		antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
prodrug
sitafloxacin[no description available]medium20fluoroquinolone antibiotic;
quinolines;
quinolone antibiotic
tenofovir[no description available]medium20nucleoside analogue;
phosphonic acids		antiviral drug;
drug metabolite;
HIV-1 reverse transcriptase inhibitor
dibekacin[no description available]medium10kanamycinsantibacterial agent;
protein synthesis inhibitor
micafungin[no description available]medium10antibiotic antifungal drug;
echinocandin		antiinfective agent
tropisetron[no description available]medium10indolyl carboxylic acid
leuprolide[no description available]medium10oligopeptideanti-estrogen;
antineoplastic agent;
gonadotropin releasing hormone agonist
cotinine[no description available]medium20N-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid		antidepressant;
biomarker;
human xenobiotic metabolite;
plant metabolite
methimazole[no description available]medium101,3-dihydroimidazole-2-thionesantithyroid drug
drotaverin[no description available]medium20isoquinolines
digoxin[no description available]medium20cardenolide glycoside;
steroid saponin		anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
cancidas[no description available]medium10
lincomycin[no description available]medium10carbohydrate-containing antibiotic;
L-proline derivative;
monocarboxylic acid amide;
pyrrolidinecarboxamide;
S-glycosyl compound		antimicrobial agent;
bacterial metabolite
thiopental[no description available]medium20barbituratesanticonvulsant;
drug allergen;
environmental contaminant;
intravenous anaesthetic;
sedative;
xenobiotic
hmr 3647[no description available]medium20
nelarabine[no description available]medium10beta-D-arabinoside;
monosaccharide derivative;
purine nucleoside		antineoplastic agent;
DNA synthesis inhibitor;
prodrug
2-[(2-ethoxyphenoxy)-phenylmethyl]morpholine[no description available]medium20aromatic ether
dolasetron[no description available]medium10indolyl carboxylic acid
or 1259[no description available]medium10hydrazone;
nitrile;
pyridazinone		anti-arrhythmia drug;
cardiotonic drug;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
vasodilator agent
gestodene[no description available]medium10steroidestrogen
quinine[no description available]medium20cinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
isepamicin[no description available]medium10
ifetroban[no description available]medium10benzenes;
monocarboxylic acid
lamifiban[no description available]medium10N-acylglycine
telavancin[no description available]medium10glycopeptideantibacterial drug;
antimicrobial agent
sitagliptin[no description available]medium20triazolopyrazine;
trifluorobenzene		EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
environmental contaminant;
hypoglycemic agent;
serine proteinase inhibitor;
xenobiotic
tolcapone[no description available]medium202-nitrophenols;
benzophenones;
catechols		antiparkinson drug;
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
quercetin[no description available]medium107-hydroxyflavonol;
pentahydroxyflavone		antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
clavulanic acid[no description available]medium20oxapenamantibacterial drug;
anxiolytic drug;
bacterial metabolite;
EC 3.5.2.6 (beta-lactamase) inhibitor
eprosartan[no description available]medium20dicarboxylic acid;
imidazoles;
thiophenes		angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
montelukast[no description available]medium20aliphatic sulfide;
monocarboxylic acid;
quinolines		anti-arrhythmia drug;
anti-asthmatic drug;
leukotriene antagonist
mivacurium[no description available]medium10isoquinolines
entacapone[no description available]medium202-nitrophenols;
catechols;
monocarboxylic acid amide;
nitrile		antidyskinesia agent;
antiparkinson drug;
central nervous system drug;
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
paricalcitol[no description available]medium20hydroxy seco-steroid;
seco-cholestane		antiparathyroid drug
sdz psc 833[no description available]medium10homodetic cyclic peptide
indocyanine green[no description available]medium101,1-diunsubstituted alkanesulfonate;
benzoindole;
cyanine dye
codeine[no description available]medium20morphinane alkaloid;
organic heteropentacyclic compound		antitussive;
drug allergen;
environmental contaminant;
opioid analgesic;
opioid receptor agonist;
prodrug;
xenobiotic
cyclosporine[no description available]medium20homodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite
naloxone[no description available]medium20morphinane alkaloid;
organic heteropentacyclic compound;
tertiary alcohol		antidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist
oxycodone[no description available]medium20organic heteropentacyclic compound;
semisynthetic derivative		antitussive;
mu-opioid receptor agonist;
opioid analgesic
alvocidib[no description available]medium10dihydroxyflavone;
hydroxypiperidine;
monochlorobenzenes;
tertiary amino compound		antineoplastic agent;
antirheumatic drug;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
morphine[no description available]medium20morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
cicaprost[no description available]medium10monoterpenoid
dexmedetomidine[no description available]medium10medetomidinealpha-adrenergic agonist;
analgesic;
non-narcotic analgesic;
sedative
iloprost[no description available]medium30carbobicyclic compound;
monocarboxylic acid;
secondary alcohol		platelet aggregation inhibitor;
vasodilator agent
iloprost[no description available]medium31carbobicyclic compound;
monocarboxylic acid;
secondary alcohol		platelet aggregation inhibitor;
vasodilator agent
nateglinide[no description available]medium20phenylalanine derivative
romidepsin[no description available]medium10cyclodepsipeptide;
heterocyclic antibiotic;
organic disulfide		antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
morphine-6-glucuronide[no description available]medium10morphinane alkaloid
cefodizime[no description available]medium101,3-thiazoles;
cephalosporin;
oxime O-ether		antibacterial drug;
EC 1.14.18.1 (tyrosinase) inhibitor
methylnaltrexone[no description available]medium10phenanthrenes
enalaprilat anhydrous[no description available]medium20dicarboxylic acid;
dipeptide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
hr 810[no description available]medium10cephalosporin;
cyclopentapyridine
cefetamet[no description available]medium20cephalosporin
ginkgolide b[no description available]medium10
palonosetron[no description available]medium10azabicycloalkane;
delta-lactam;
organic heterotricyclic compound		antiemetic;
serotonergic antagonist
cefatrizine[no description available]medium20amino acid amide;
carboxylic acid;
cephalosporin;
phenols;
semisynthetic derivative;
triazoles		antibacterial drug;
EC 2.7.11.20 (elongation factor 2 kinase) inhibitor
eniporide[no description available]medium10
cilastatin[no description available]medium20carboxamide;
L-cysteine derivative;
non-proteinogenic L-alpha-amino acid;
organic sulfide		EC 3.4.13.19 (membrane dipeptidase) inhibitor;
environmental contaminant;
protease inhibitor;
xenobiotic
ixabepilone[no description available]medium101,3-thiazoles;
beta-hydroxy ketone;
epoxide;
lactam;
macrocycle		antineoplastic agent;
microtubule-destabilising agent
azlocillin[no description available]medium20penicillin allergen;
penicillin;
semisynthetic derivative		antibacterial drug
verlukast[no description available]medium10
carumonam[no description available]medium10monobactamantibacterial drug
eritoran[no description available]medium10lipid As
artesunate[no description available]medium10artemisinin derivative;
cyclic acetal;
dicarboxylic acid monoester;
hemisuccinate;
semisynthetic derivative;
sesquiterpenoid		antimalarial;
antineoplastic agent;
ferroptosis inducer
dexniguldipine[no description available]medium10diarylmethane
napsagatran[no description available]medium10
temsirolimus[no description available]medium10macrolide lactam
bms188797[no description available]medium10
azimilide[no description available]medium10imidazolidine-2,4-dione
tomopenem[no description available]medium20
bb-83698[no description available]medium10
zotarolimus[no description available]medium10lactam;
macrolide
gentamicin sulfate[no description available]medium20
bn 52020[no description available]medium10
vindesine[no description available]medium10
scopolamine hydrobromide[no description available]medium20
scopolamine hydrobromide[no description available]medium21
bisaramil[no description available]medium10
teicoplanin[no description available]medium20
ly-146032[no description available]medium20heterodetic cyclic peptide;
lipopeptide antibiotic;
lipopeptide;
macrocycle;
macrolide		antibacterial drug;
bacterial metabolite;
calcium-dependent antibiotics
dalbavancin[no description available]medium10carbohydrate acid derivative;
glycopeptide;
monosaccharide derivative;
semisynthetic derivative		antibacterial drug;
antimicrobial agent
cetrorelix[no description available]medium10oligopeptideantineoplastic agent;
GnRH antagonist
chlortetracycline[no description available]medium10
oxytetracycline, anhydrous[no description available]medium20
roquinimex[no description available]medium10aromatic amide
mobic[no description available]medium201,3-thiazoles;
benzothiazine;
monocarboxylic acid amide		analgesic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
mobiflex[no description available]medium20heteroaryl hydroxy compound;
monocarboxylic acid amide;
pyridines;
thienothiazine		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
isoxicam[no description available]medium20benzothiazine;
isoxazoles;
monocarboxylic acid amide		antirheumatic drug;
non-steroidal anti-inflammatory drug
demeclocycline[no description available]medium10
rolitetracycline[no description available]medium10
tigecycline[no description available]medium20
dacarbazine[no description available]medium10dacarbazine
sildenafil[no description available]medium20piperazines;
pyrazolopyrimidine;
sulfonamide		EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
vardenafil[no description available]medium20imidazotriazine;
N-alkylpiperazine;
N-sulfonylpiperazine		EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
leucovorin[no description available]medium20formyltetrahydrofolic acidEscherichia coli metabolite;
mouse metabolite
tegaserod[no description available]medium20carboxamidine;
guanidines;
hydrazines;
indoles		gastrointestinal drug;
serotonergic agonist
tirapazamine[no description available]medium10aromatic amine;
benzotriazines;
N-oxide		antibacterial agent;
antineoplastic agent;
apoptosis inducer
aprepitant[no description available]medium10(trifluoromethyl)benzenes;
cyclic acetal;
morpholines;
triazoles		antidepressant;
antiemetic;
neurokinin-1 receptor antagonist;
peripheral nervous system drug;
substance P receptor antagonist
ceftobiprole[no description available]medium10cephalosporin;
thiadiazoles		antimicrobial agent
dan 2163[no description available]medium10aromatic amide;
aromatic amine;
benzamides;
pyrrolidines;
sulfone		environmental contaminant;
second generation antipsychotic;
xenobiotic
practolol[no description available]medium10acetamides;
ethanolamines;
propanolamine;
secondary alcohol;
secondary amino compound		anti-arrhythmia drug;
beta-adrenergic antagonist
sulpiride[no description available]medium10benzamides;
N-alkylpyrrolidine;
sulfonamide		antidepressant;
antiemetic;
antipsychotic agent;
dopaminergic antagonist
chlorine[no description available]medium20diatomic chlorine;
gas molecular entity		bleaching agent
chlorine[no description available]medium10halide anion;
monoatomic chlorine		cofactor;
Escherichia coli metabolite;
human metabolite
iomeprol[no description available]high660benzenedicarboxamide;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
iomeprol[no description available]high6610benzenedicarboxamide;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
cardiovascular agents[no description available]medium72
mannitol[no description available]medium90mannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
iobitridol[no description available]high220benzenedicarboxamide;
hexol;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
iobitridol[no description available]high226benzenedicarboxamide;
hexol;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
ioxitalamic acid[no description available]high100acetamides;
benzoic acids;
dicarboxylic acid monoamide;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
n,n-dimethylarginine[no description available]medium10dimethylarginine;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor
arginine[no description available]medium10arginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
n(g),n(g')-dimethyl-l-arginine[no description available]medium10alpha-amino acid
piperidines[no description available]medium20
amikacin[no description available]medium10
iodine[no description available]medium3910diatomic iodinenutrient
meglumine[no description available]medium121hexosamine;
secondary amino compound
gadolinium dtpa[no description available]medium704gadolinium coordination entityMRI contrast agent
urea[no description available]medium10isourea;
monocarboxylic acid amide;
one-carbon compound		Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
bilirubin[no description available]medium20biladienes;
dicarboxylic acid		antioxidant;
human metabolite;
mouse metabolite
gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate[no description available]medium30
gadoxetic acid disodium[no description available]medium70
butyryl-n-trihexylcitrate[no description available]medium20
acetosulfame[no description available]medium10organic heteromonocyclic compound;
organonitrogen heterocyclic compound;
oxacycle;
sulfamate ester		environmental contaminant;
sweetening agent;
xenobiotic
sodium pertechnetate tc 99m[no description available]medium41
bismuth[no description available]medium10metal atom;
pnictogen
singlet oxygen[no description available]medium10chalcogen;
monoatomic oxygen;
nonmetal atom		macronutrient
carbon-11 methionine[no description available]medium10
methionine[no description available]medium10aspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid		antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
gadolinium[no description available]medium170f-block element atom;
lanthanoid atom
regorafenib[no description available]medium10(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
monofluorobenzenes;
phenylureas;
pyridinecarboxamide		antineoplastic agent;
hepatotoxic agent;
tyrosine kinase inhibitor
yttrium radioisotopes[no description available]medium30
3-iodobenzylguanidine[no description available]medium10organoiodine compound
fluorodeoxyglucose f18[no description available]medium3152-deoxy-2-((18)F)fluoro-D-glucose;
2-deoxy-2-fluoro-aldehydo-D-glucose
sulfur hexafluoride[no description available]medium90sulfur coordination entitygreenhouse gas;
NMR chemical shift reference compound;
ultrasound contrast agent
nitinol[no description available]medium50
hydrogen carbonate[no description available]medium30carbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pyrroles[no description available]medium20pyrrole;
secondary amine
malondialdehyde[no description available]medium10dialdehydebiomarker
erlotinib hydrochloride[no description available]medium22hydrochloride;
terminal acetylenic compound		antineoplastic agent;
protein kinase inhibitor
quinazolines[no description available]medium22azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinazolines
diatrizoate meglumine[no description available]medium420monocarboxylic acid anionradioopaque medium
diatrizoate meglumine[no description available]medium427monocarboxylic acid anionradioopaque medium
titanium[no description available]medium30titanium group element atom
titanium dioxide[no description available]medium30titanium oxidesfood colouring
brine[no description available]medium10
iotrolan[no description available]medium428organic molecular entity
fluorescein-5-isothiocyanate[no description available]medium10fluorescein isothiocyanate
choline[no description available]medium10cholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
histamine[no description available]medium41aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter
sirolimus[no description available]medium30antibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol		antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
cremophor el[no description available]medium10
glycerol[no description available]medium20alditol;
triol		algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
acrylic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acidmetabolite
iodine[no description available]medium20halide anion;
monoatomic iodine		human metabolite
polidocanol[no description available]medium10hydroxypolyetherhepatotoxic agent;
nonionic surfactant;
sclerotherapy agent
n-vinyl-2-pyrrolidinone[no description available]medium10pyrrolidin-2-ones
losartan potassium[no description available]medium11
estrone[no description available]medium1017-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols		antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite
ammonium chloride[no description available]medium10ammonium salt;
inorganic chloride		ferroptosis inhibitor
salicylic acid[no description available]medium10monohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
nicorandil[no description available]medium11nitrate ester;
pyridinecarboxamide		potassium channel opener;
vasodilator agent
hydroxyl radical[no description available]medium20oxygen hydride;
oxygen radical;
reactive oxygen species
boron[no description available]medium10boron group element atom;
metalloid atom;
nonmetal atom		micronutrient
nitrates[no description available]medium10monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
ioxilan[no description available]medium71amidobenzoic acid
barium sulfate[no description available]medium100barium salt;
inorganic barium salt;
metal sulfate		radioopaque medium
barium sulfate[no description available]medium102barium salt;
inorganic barium salt;
metal sulfate		radioopaque medium
taurocholic acid[no description available]medium20amino sulfonic acid;
bile acid taurine conjugate		human metabolite
technetium[no description available]medium20manganese group element atom
iridium[no description available]medium10cobalt group element atom;
platinum group metal atom
clofibric acid[no description available]medium30aromatic ether;
monocarboxylic acid;
monochlorobenzenes		anticholesteremic drug;
antilipemic drug;
antineoplastic agent;
herbicide;
marine xenobiotic metabolite;
PPARalpha agonist
iridium oxide[no description available]medium10
sodium bicarbonate[no description available]medium20one-carbon compound;
organic sodium salt		antacid;
food anticaking agent
ioxaglate[no description available]high500benzenedicarboxamide;
benzoic acids;
organoiodine compound		radioopaque medium
ioxaglate[no description available]high5017benzenedicarboxamide;
benzoic acids;
organoiodine compound		radioopaque medium
angiotensin ii[no description available]medium20amino acid zwitterion;
angiotensin II		human metabolite
su 11248[no description available]medium10monocarboxylic acid amide;
pyrroles		angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
immunomodulator;
neuroprotective agent;
vascular endothelial growth factor receptor antagonist
sorafenib[no description available]medium31(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
phenylureas;
pyridinecarboxamide		angiogenesis inhibitor;
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
ferroptosis inducer;
tyrosine kinase inhibitor
niacinamide[no description available]medium31pyridine alkaloid;
pyridinecarboxamide;
vitamin B3		anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
dihydroxyphenylalanine[no description available]medium10hydroxyphenylalanine;
non-proteinogenic alpha-amino acid;
tyrosine derivative		human metabolite
fluorodopa f 18[no description available]medium10(18)F radiopharmaceutical;
6-fluoro-L-dopa
ammonium hydroxide[no description available]medium10azane;
gas molecular entity;
mononuclear parent hydride		EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
l 743,872[no description available]medium10
triazoles[no description available]medium101,2,3-triazole
endothelin-1[no description available]medium20
iosmin[no description available]medium20amidobenzoic acid
ozone[no description available]medium30elemental molecule;
gas molecular entity;
reactive oxygen species;
triatomic oxygen		antiseptic drug;
disinfectant;
electrophilic reagent;
greenhouse gas;
mutagen;
oxidising agent;
tracer
benzoylecgonine[no description available]medium10benzoate ester;
tropane alkaloid		epitope;
human xenobiotic metabolite;
marine xenobiotic metabolite;
plant metabolite
thiazolyl blue[no description available]medium10organic bromide saltcolorimetric reagent;
dye
trypan blue[no description available]medium10
thiazoles[no description available]medium101,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
probucol[no description available]medium10dithioketal;
polyphenol		anti-inflammatory drug;
anticholesteremic drug;
antilipemic drug;
antioxidant;
cardiovascular drug
ascorbic acid[no description available]medium10ascorbic acid;
vitamin C		coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
mitomycin[no description available]medium10mitomycinalkylating agent;
antineoplastic agent
acetyl triethyl citrate[no description available]medium10
everolimus[no description available]medium10cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
primary alcohol;
secondary alcohol		anticoronaviral agent;
antineoplastic agent;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
technetium tc 99m pentetate[no description available]medium10
thyroxine[no description available]medium402-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine		antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
d-alpha tocopherol[no description available]medium21alpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
sulfites[no description available]medium10divalent inorganic anion;
sulfur oxide;
sulfur oxoanion
sodium citrate, anhydrous[no description available]medium10organic sodium saltanticoagulant;
flavouring agent
gadofosveset trisodium[no description available]medium10
beta carotene[no description available]medium10carotenoid beta-end derivative;
cyclic carotene		antioxidant;
biological pigment;
cofactor;
ferroptosis inhibitor;
human metabolite;
mouse metabolite;
plant metabolite;
provitamin A
2-aminoethoxydiphenyl borate[no description available]medium10organoboron compound;
primary amino compound		calcium channel blocker;
IP3 receptor antagonist;
potassium channel opener
mocetinostat[no description available]medium10aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline		antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
iopentol[no description available]medium133amidobenzoic acid
methylcellulose[no description available]medium30
gadolinium oxide[no description available]medium10
rolipram[no description available]medium11pyrrolidin-2-onesantidepressant;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
mesopram[no description available]medium11
oxazoles[no description available]medium111,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
bq 123[no description available]medium20cyclic peptide
gold[no description available]medium10copper group element atom;
elemental gold
psyllium[no description available]medium10very long-chain fatty acid
1,3-dipropyl-8-cyclopentylxanthine[no description available]medium10oxopurineadenosine A1 receptor antagonist;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
chromozym th[no description available]medium10
h-d-phe-pip-arg-pna[no description available]medium10
imatinib mesylate[no description available]medium10methanesulfonate saltanticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
sodium perchlorate[no description available]medium10inorganic sodium salt
triiodothyronine[no description available]medium302-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine		human metabolite;
mouse metabolite;
thyroid hormone
cysteine[no description available]medium10cysteiniumfundamental metabolite
creatine[no description available]medium10glycine derivative;
guanidines;
zwitterion		geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent;
nutraceutical
fibrinogen[no description available]medium30iditolfungal metabolite
cesium[no description available]medium10alkali metal atom
cesium iodide[no description available]medium10
silicon[no description available]medium10carbon group element atom;
metalloid atom;
nonmetal atom
phenprocoumon[no description available]medium10hydroxycoumarinanticoagulant;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor
trimetazidine[no description available]medium11aromatic amine
povidone-iodine[no description available]medium20
methylene blue[no description available]medium10organic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
potassium iodide[no description available]medium10potassium saltexpectorant;
radical scavenger
palladium[no description available]medium10metal allergen;
nickel group element atom;
platinum group metal atom
aluminum oxide[no description available]medium10
nickel[no description available]medium10metal allergen;
nickel group element atom		epitope;
micronutrient
hydrogen[no description available]medium10elemental hydrogen;
elemental molecule;
gas molecular entity		antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
nitroglycerin[no description available]medium20nitroglycerolexplosive;
muscle relaxant;
nitric oxide donor;
prodrug;
tocolytic agent;
vasodilator agent;
xenobiotic
5-amino-2,4,6-triiodoisophthalic acid[no description available]medium10
tartaric acid[no description available]medium10tartaric acidEscherichia coli metabolite
meglumine ioglicinate[no description available]medium30
muramidase[no description available]medium20
metrizamide[no description available]medium50amino sugar
ioglicic acid[no description available]medium22amidobenzoic acid
acetrizoic acid[no description available]medium10aminobenzoic acid
iodamide[no description available]high20benzoic acids;
organoiodine compound		radioopaque medium
iothalamate meglumine[no description available]medium100amidobenzoic acid
pentetic acid[no description available]medium130pentacarboxylic acidcopper chelator
cortisone[no description available]medium1011-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		human metabolite;
mouse metabolite
gentamicin[no description available]medium10
aldosterone[no description available]medium2111beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde		human metabolite;
mouse metabolite
cyclic gmp[no description available]medium103',5'-cyclic purine nucleotide;
guanyl ribonucleotide		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
atrial natriuretic factor[no description available]medium10polypeptide
pituitrin[no description available]medium10
arabinose[no description available]medium10L-arabinoseEscherichia coli metabolite;
mouse metabolite
urografin 76[no description available]medium21
fibrin[no description available]medium11peptide
edetic acid[no description available]medium11ethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid		anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector
cellulose[no description available]medium20glycoside
dipyridamole[no description available]medium20piperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol		adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
technetium tc 99m mertiatide[no description available]medium20
technetium tc 99m dimercaptosuccinic acid[no description available]medium10
triiodothyronine, reverse[no description available]medium103,3',5'-triiodothyronine;
amino acid zwitterion
ng-nitroarginine methyl ester[no description available]medium10alpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor
chromium[no description available]medium10chromium group element atom;
metal allergen		micronutrient
meglumine ioxithalamate[no description available]medium20
iosimide[no description available]medium42
americium[no description available]medium10actinoid atom;
f-block element atom
arginine vasopressin[no description available]medium11vasopressincardiovascular drug;
hematologic agent;
mitogen
evans blue[no description available]medium20organic sodium saltfluorochrome;
histological dye;
sodium channel blocker;
teratogenic agent
diethylnitrosamine[no description available]medium10nitrosaminecarcinogenic agent;
hepatotoxic agent;
mutagen
iodecol[no description available]medium10
iodipamide[no description available]medium00benzoic acids;
organoiodine compound;
secondary carboxamide		radioopaque medium
perflexane[no description available]low00fluoroalkane;
fluorocarbon;
volatile organic compound		non-polar solvent;
radioopaque medium
perflubron[no description available]low00haloalkane;
organobromine compound;
perfluorinated compound		blood substitute;
radioopaque medium
perfluoropentane[no description available]low00fluoroalkane;
fluorocarbon		radioopaque medium;
ultrasound contrast agent
fluorescein[no description available]low002-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye		fluorescent dye;
radioopaque medium
perfluorophenanthrene[no description available]low00fluorocarbonradioopaque medium
meglumine iodipamide[no description available]low00organoammonium saltradioopaque medium
amidotrizoic acid dihydrate[no description available]low00hydrateradioopaque medium
sodium diatrizoate[no description available]medium00organic sodium salt;
organoiodine compound		radioopaque medium
methoxyflurane[no description available]low00ether;
organochlorine compound;
organofluorine compound		hepatotoxic agent;
inhalation anaesthetic;
nephrotoxic agent;
non-narcotic analgesic
nitrilotriacetic acid[no description available]low00NTA;
tricarboxylic acid		carcinogenic agent;
nephrotoxic agent
2,3,4-trimethylpentane[no description available]low00alkane;
volatile organic compound		mammalian metabolite;
nephrotoxic agent
tetrachloroethylene[no description available]low00chlorocarbon;
chloroethenes		nephrotoxic agent
adefovir dipivoxil[no description available]low006-aminopurines;
carbonate ester;
ether;
organic phosphonate		antiviral drug;
DNA synthesis inhibitor;
HIV-1 reverse transcriptase inhibitor;
nephrotoxic agent;
prodrug
2,8-dihydroxyadenine[no description available]low006-aminopurines;
diol;
heteroaryl hydroxy compound;
oxopurine		human urinary metabolite;
mammalian metabolite;
mouse metabolite;
nephrotoxic agent
2-(s-glutathionyl)hydroquinone[no description available]low00aryl sulfide;
glutathione conjugate;
hydroquinones		human xenobiotic metabolite;
nephrotoxic agent
sgx 523[no description available]low00aryl sulfide;
biaryl;
pyrazoles;
quinolines;
triazolopyridazine		c-Met tyrosine kinase inhibitor;
nephrotoxic agent
octane[no description available]low00alkanexenobiotic
2-nitropropane[no description available]low00secondary nitroalkanecarcinogenic agent;
hepatotoxic agent;
polar aprotic solvent;
xenobiotic
dibenzofuran[no description available]low00dibenzofurans;
mancude organic heterotricyclic parent;
polycyclic heteroarene		xenobiotic
acetochlor[no description available]low00aromatic amide;
monocarboxylic acid amide;
organochlorine compound		environmental contaminant;
herbicide;
xenobiotic
alachlor[no description available]low00aromatic amide;
monocarboxylic acid amide;
organochlorine compound		environmental contaminant;
herbicide;
xenobiotic
antazoline[no description available]low00aromatic amine;
imidazolines;
tertiary amino compound		cholinergic antagonist;
H1-receptor antagonist;
xenobiotic
atrazine[no description available]low00chloro-1,3,5-triazine;
diamino-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
bentazone[no description available]low00benzothiadiazineenvironmental contaminant;
herbicide;
xenobiotic
candesartan[no description available]low00benzimidazolecarboxylic acid;
biphenylyltetrazole		angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
chloral hydrate[no description available]low00aldehyde hydrate;
ethanediol;
organochlorine compound		general anaesthetic;
mouse metabolite;
sedative;
xenobiotic
chlorpyrifos[no description available]low00chloropyridine;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
clotrimazole[no description available]low00conazole antifungal drug;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes		antiinfective agent;
environmental contaminant;
xenobiotic
diazinon[no description available]low00organic thiophosphate;
pyrimidines		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
nematicide;
xenobiotic
dicamba[no description available]low00dichlorobenzene;
methoxybenzoic acid		agrochemical;
environmental contaminant;
herbicide;
synthetic auxin;
xenobiotic
dichlobanil[no description available]low00dichlorobenzene;
nitrile		agrochemical;
cellulose synthesis inhibitor;
environmental contaminant;
herbicide;
xenobiotic
dimethoate[no description available]low00monocarboxylic acid amide;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
diuron[no description available]low003-(3,4-substituted-phenyl)-1,1-dimethylurea;
dichlorobenzene		environmental contaminant;
mitochondrial respiratory-chain inhibitor;
photosystem-II inhibitor;
urea herbicide;
xenobiotic
fenofibrate[no description available]low00aromatic ether;
chlorobenzophenone;
isopropyl ester;
monochlorobenzenes		antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
tetramisole[no description available]low00imidazothiazoleenvironmental contaminant;
xenobiotic
methomyl[no description available]low00aliphatic sulfide;
carbamate ester		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
nematicide;
xenobiotic
deet[no description available]low00benzamides;
monocarboxylic acid amide		environmental contaminant;
insect repellent;
xenobiotic
1-(3-trifluoromethylphenyl)piperazine[no description available]low00(trifluoromethyl)benzenes;
N-arylpiperazine		environmental contaminant;
psychotropic drug;
serotonergic agonist;
xenobiotic
oxybenzone[no description available]low00hydroxybenzophenone;
monomethoxybenzene		dermatologic drug;
environmental contaminant;
protective agent;
ultraviolet filter;
xenobiotic
pioglitazone[no description available]low00aromatic ether;
pyridines;
thiazolidinediones		antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
prometone[no description available]low00diamino-1,3,5-triazine;
methoxy-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
prometryne[no description available]low00diamino-1,3,5-triazine;
methylthio-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
propachlor[no description available]low00anilide;
monocarboxylic acid amide;
organochlorine compound		environmental contaminant;
herbicide;
xenobiotic
propazine[no description available]low00chloro-1,3,5-triazine;
diamino-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
saccharin[no description available]low001,2-benzisothiazole;
N-sulfonylcarboxamide		environmental contaminant;
sweetening agent;
xenobiotic
simazine[no description available]low00chloro-1,3,5-triazine;
diamino-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
sulfadimethoxine[no description available]low00aromatic ether;
pyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antiinfective agent;
antimicrobial agent;
drug allergen;
environmental contaminant;
xenobiotic
sulfamethazine[no description available]low00pyrimidines;
sulfonamide antibiotic;
sulfonamide		antibacterial drug;
antiinfective agent;
antimicrobial agent;
carcinogenic agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
ligand;
xenobiotic
sulfapyridine[no description available]low00pyridines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antiinfective agent;
dermatologic drug;
drug allergen;
environmental contaminant;
xenobiotic
sulfathiazole[no description available]low001,3-thiazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antiinfective agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic
triclosan[no description available]low00aromatic ether;
dichlorobenzene;
monochlorobenzenes;
phenols		antibacterial agent;
antimalarial;
drug allergen;
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
fungicide;
persistent organic pollutant;
xenobiotic
trifluralin[no description available]low00(trifluoromethyl)benzenes;
C-nitro compound;
substituted aniline		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
reserpine[no description available]low00alkaloid ester;
methyl ester;
yohimban alkaloid		adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
aminopyrine[no description available]low00pyrazolone;
tertiary amino compound		antipyretic;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
barbituric acid[no description available]low00barbituratesallergen;
xenobiotic
bisphenol a[no description available]low00bisphenolendocrine disruptor;
environmental contaminant;
xenobiotic;
xenoestrogen
pseudoephedrine[no description available]low00phenylethanolamines;
secondary alcohol;
secondary amino compound		anti-asthmatic drug;
bronchodilator agent;
central nervous system drug;
nasal decongestant;
plant metabolite;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
2-methyl-4-chlorophenoxy gamma-butyric acid[no description available]low00aromatic ether;
monocarboxylic acid;
monochlorobenzenes		environmental contaminant;
phenoxy herbicide;
xenobiotic
benzotriazole[no description available]low00benzotriazolesenvironmental contaminant;
xenobiotic
benzothiazole[no description available]low00benzothiazolesenvironmental contaminant;
plant metabolite;
xenobiotic
3,4-dichloroaniline[no description available]low00dichloroanilineepitope;
xenobiotic
acetophenone[no description available]low00acetophenonesanimal metabolite;
photosensitizing agent;
xenobiotic
phenylhydrazine[no description available]low00phenylhydrazinesxenobiotic
triclocarban[no description available]low00dichlorobenzene;
monochlorobenzenes;
phenylureas		antimicrobial agent;
antiseptic drug;
disinfectant;
environmental contaminant;
xenobiotic
fenuron[no description available]low003-(3,4-substituted-phenyl)-1,1-dimethylureaagrochemical;
environmental contaminant;
herbicide;
photosystem-II inhibitor;
xenobiotic
cyanuric acid[no description available]low001,3,5-triazinanes;
1,3,5-triazines;
heteroaryl hydroxy compound		xenobiotic
diglyme[no description available]low00polyetherenvironmental contaminant;
solvent;
xenobiotic
propylene[no description available]low00alkene;
gas molecular entity		refrigerant;
xenobiotic
2-naphthalenesulfonic acid[no description available]low00naphthalenesulfonic acidenvironmental contaminant;
xenobiotic
4-sulfanilic acid[no description available]low00aminobenzenesulfonic acidallergen;
environmental contaminant;
xenobiotic metabolite;
xenobiotic
5-tolyltriazole[no description available]low00benzotriazolesenvironmental contaminant;
xenobiotic
monuron[no description available]low003-(3,4-substituted-phenyl)-1,1-dimethylurea;
monochlorobenzenes		environmental contaminant;
herbicide;
xenobiotic
ephedrine[no description available]low00phenethylamine alkaloid;
phenylethanolamines		bacterial metabolite;
environmental contaminant;
nasal decongestant;
plant metabolite;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
linuron[no description available]low00dichlorobenzene;
phenylureas		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
perfluorooctanoic acid[no description available]low00fluoroalkanoic acidcarcinogenic agent;
endocrine disruptor;
environmental contaminant;
surfactant;
xenobiotic
perfluorodecanoic acid[no description available]low00fluoroalkanoic acidenvironmental contaminant;
xenobiotic
perfluorobutyric acid[no description available]low00fluoroalkanoic acidchromatographic reagent;
environmental contaminant;
xenobiotic
triphenylmethane[no description available]low00triarylmethaneenvironmental contaminant;
xenobiotic
3-methylquinoline[no description available]low00methylquinolinexenobiotic
terbutryne[no description available]low00diamino-1,3,5-triazine;
methylthio-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
metformin hydrochloride[no description available]low00hydrochlorideenvironmental contaminant;
hypoglycemic agent;
xenobiotic
ioxynil[no description available]low00iodophenol;
nitrile		environmental contaminant;
herbicide;
xenobiotic
bromoxynil[no description available]low00dibromobenzene;
hydroxynitrile;
phenols		environmental contaminant;
herbicide;
xenobiotic
pyrazon[no description available]low00benzenes;
organochlorine compound;
primary amino compound;
pyridazinone		environmental contaminant;
herbicide;
xenobiotic
methiocarb[no description available]low00aryl sulfide;
carbamate ester;
methyl sulfide		acaricide;
agrochemical;
avicide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
molluscicide;
xenobiotic
lenacil[no description available]low00cyclopentapyrimidineagrochemical;
environmental contaminant;
herbicide;
xenobiotic
fluometuron[no description available]low00(trifluoromethyl)benzenes;
3-(3,4-substituted-phenyl)-1,1-dimethylurea		agrochemical;
environmental contaminant;
herbicide;
photosystem-II inhibitor;
xenobiotic
1,2-benzisothiazoline-3-one[no description available]low00organic heterobicyclic compound;
organonitrogen heterocyclic compound		disinfectant;
drug allergen;
environmental contaminant;
platelet aggregation inhibitor;
sensitiser;
xenobiotic
asulam[no description available]low00carbamate ester;
primary amino compound;
substituted aniline;
sulfonamide		agrochemical;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
herbicide;
xenobiotic
chlorpyrifos-methyl[no description available]low00chloropyridine;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
terbutylazine[no description available]low00chloro-1,3,5-triazine;
diamino-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
1-indanol[no description available]low00aromatic alcohol;
indanes;
secondary alcohol		xenobiotic
desmedipham[no description available]low00carbamate esteragrochemical;
environmental contaminant;
herbicide;
xenobiotic
phenmedipham[no description available]low00carbamate esterenvironmental contaminant;
herbicide;
xenobiotic
chlortoluron[no description available]low00monochlorobenzenes;
phenylureas		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
methoxuron[no description available]low003-(3,4-substituted-phenyl)-1,1-dimethylurea;
monochlorobenzenes;
monomethoxybenzene		agrochemical;
environmental contaminant;
herbicide;
photosystem-II inhibitor;
plant growth regulator;
xenobiotic
neohesperidin dihydrochalcone[no description available]low00dihydrochalcones;
disaccharide derivative;
neohesperidoside		environmental contaminant;
plant metabolite;
sweetening agent;
xenobiotic
metribuzin[no description available]low001,2,4-triazines;
cyclic ketone;
organic sulfide		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
cyanazine[no description available]low001,3,5-triazinylamino nitrile;
chloro-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
pirimicarb[no description available]low00aminopyrimidine;
carbamate ester;
tertiary amino compound		agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
butachlor[no description available]low00aromatic amide;
organochlorine compound;
tertiary carboxamide		environmental contaminant;
herbicide;
xenobiotic
propamocarb[no description available]low00carbamate ester;
carbamate fungicide;
tertiary amino compound		antifungal agrochemical;
environmental contaminant;
xenobiotic
5-chloro-2-methyl-4-isothiazolin-3-one[no description available]low001,2-thiazoles;
organochlorine compound		antimicrobial agent;
environmental contaminant;
xenobiotic
2-n-octyl-4-isothiazolin-3-one[no description available]low001,2-thiazolesantibacterial agent;
antifungal agrochemical;
environmental contaminant;
xenobiotic
amitraz[no description available]low00formamidines;
tertiary amino compound		acaricide;
environmental contaminant;
insecticide;
xenobiotic
isoproturon[no description available]low003-(3,4-substituted-phenyl)-1,1-dimethylureaagrochemical;
environmental contaminant;
herbicide;
xenobiotic
metamitron[no description available]low001,2,4-triazinesenvironmental contaminant;
herbicide;
xenobiotic
bezafibrate[no description available]low00aromatic ether;
monocarboxylic acid amide;
monocarboxylic acid;
monochlorobenzenes		antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
triclopyr[no description available]low00aromatic ether;
chloropyridine;
monocarboxylic acid		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
propiconazole[no description available]low00conazole fungicide;
cyclic ketal;
dichlorobenzene;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
metazachlor[no description available]low00aromatic amide;
organochlorine compound;
pyrazoles		environmental contaminant;
herbicide;
xenobiotic
4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acid[no description available]low00aminopyridine;
aromatic ether;
monocarboxylic acid;
organochlorine compound;
organofluorine compound		environmental contaminant;
herbicide;
xenobiotic
fenoxycarb[no description available]low00aromatic ether;
carbamate ester		environmental contaminant;
insecticide;
juvenile hormone mimic;
xenobiotic
metsulfuron methyl[no description available]low001,3,5-triazines;
benzoate ester;
N-sulfonylurea		environmental contaminant;
herbicide;
xenobiotic
clomazone[no description available]low00isoxazolidinone;
monochlorobenzenes		agrochemical;
carotenoid biosynthesis inhibitor;
environmental contaminant;
herbicide;
xenobiotic
aromasil[no description available]low0017-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid		antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor;
environmental contaminant;
xenobiotic
prosulfocarb[no description available]low00benzenes;
monothiocarbamic ester		environmental contaminant;
herbicide;
xenobiotic
3-iodo-2-propynylbutylcarbamate[no description available]medium00acetylenic compound;
carbamate ester;
carbamate fungicide;
organoiodine compound		antifungal agrochemical;
environmental contaminant;
xenobiotic
oseltamivir[no description available]low00acetamides;
amino acid ester;
cyclohexenecarboxylate ester;
primary amino compound		antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
environmental contaminant;
prodrug;
xenobiotic
perfluorohexanoic acid[no description available]low00fluoroalkanoic acidenvironmental contaminant;
xenobiotic
perfluoro-n-heptanoic acid[no description available]low00fluoroalkanoic acidenvironmental contaminant;
xenobiotic
perfluoro-n-nonanoic acid[no description available]low00fluoroalkanoic acidpersistent organic pollutant;
surfactant;
xenobiotic
acamprosate[no description available]low00acetamides;
organosulfonic acid		environmental contaminant;
neurotransmitter agent;
xenobiotic
trichlorosucrose[no description available]low00disaccharide derivative;
organochlorine compound		environmental contaminant;
sweetening agent;
xenobiotic
nicosulfuron[no description available]low00N-sulfonylurea;
pyridines;
pyrimidines		environmental contaminant;
herbicide;
xenobiotic
prochloraz[no description available]low00amide fungicide;
aromatic ether;
conazole fungicide;
imidazole fungicide;
imidazoles;
trichlorobenzene;
ureas		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
thifensulfuron methyl[no description available]low001,3,5-triazines;
methyl ester;
N-sulfonylurea;
thiophenes		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
flusilazole[no description available]low00conazole fungicide;
monofluorobenzenes;
organosilicon compound;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
perfluoropentanoic acid[no description available]low00fluoroalkanoic acidenvironmental contaminant;
xenobiotic
1-benzylpiperazine[no description available]low00N-alkylpiperazineenvironmental contaminant;
psychotropic drug;
serotonergic agonist;
xenobiotic
perfluoroundecanoic acid[no description available]low00fluoroalkanoic acidenvironmental contaminant;
xenobiotic
sulfluramid[no description available]low00sulfonamideacaricide;
environmental contaminant;
insecticide;
xenobiotic
spiroxamine[no description available]low00dioxolane;
spiroketal;
tertiary amino compound		antifungal agrochemical;
environmental contaminant;
sterol biosynthesis inhibitor;
xenobiotic
difenoconazole[no description available]low00aromatic ether;
conazole fungicide;
cyclic ketal;
dioxolane;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
dimethomorph[no description available]low00mixture;
morpholine fungicide		antifungal agrochemical;
environmental contaminant;
xenobiotic
cyprodinil[no description available]low00aminopyrimidine;
anilinopyrimidine fungicide;
cyclopropanes;
secondary amino compound		antifungal agrochemical;
aryl hydrocarbon receptor agonist;
environmental contaminant;
xenobiotic
imidacloprid[no description available]low00imidacloprid;
imidazolidines;
monochloropyridine		environmental contaminant;
genotoxin;
neonicotinoid insectide;
nicotinic acetylcholine receptor agonist;
xenobiotic
foe 5043[no description available]low00aromatic amide;
monofluorobenzenes;
thiadiazoles		environmental contaminant;
herbicide;
xenobiotic
irgarol 1051[no description available]low00aryl sulfide;
cyclopropanes;
diamino-1,3,5-triazine		antifouling biocide;
environmental contaminant;
xenobiotic
pyrimethanil[no description available]low00aminopyrimidine;
anilinopyrimidine fungicide;
secondary amino compound		antifungal agrochemical;
aryl hydrocarbon receptor agonist;
environmental contaminant;
xenobiotic
kathon 930[no description available]low001,2-thiazoles;
organochlorine compound		environmental contaminant;
fungicide;
xenobiotic
fluazinam[no description available]low00(trifluoromethyl)benzenes;
aminopyridine;
C-nitro compound;
chloropyridine;
monochlorobenzenes;
secondary amino compound		allergen;
antifungal agrochemical;
apoptosis inducer;
environmental contaminant;
xenobiotic
teflubenzuron[no description available]low00dichlorobenzene;
difluorobenzene;
N-acylurea		environmental contaminant;
insecticide;
xenobiotic
diflufenican[no description available]low00(trifluoromethyl)benzenes;
aromatic ether;
pyridinecarboxamide		carotenoid biosynthesis inhibitor;
environmental contaminant;
herbicide;
xenobiotic
sulcotrione[no description available]low00aromatic ketone;
beta-triketone;
cyclohexanones;
sulfone		carotenoid biosynthesis inhibitor;
environmental contaminant;
herbicide;
xenobiotic
tebufenozide[no description available]low00carbohydrazideecdysone agonist;
environmental contaminant;
xenobiotic
dpx e9636[no description available]low00aromatic ether;
N-sulfonylurea;
pyridines;
pyrimidines;
sulfone		environmental contaminant;
herbicide;
xenobiotic
arsenocholine[no description available]low00arsonium ion;
organoarsenic compound		human urinary metabolite;
marine metabolite;
xenobiotic
methoxyfenozide[no description available]low00carbohydrazide;
monomethoxybenzene		environmental contaminant;
insecticide;
xenobiotic
thiamethoxam[no description available]low001,3-thiazoles;
2-nitroguanidine derivative;
organochlorine compound;
oxadiazane		antifeedant;
carcinogenic agent;
environmental contaminant;
neonicotinoid insectide;
xenobiotic
thiacloprid[no description available]low00monochloropyridine;
nitrile;
thiazolidines		environmental contaminant;
neonicotinoid insectide;
xenobiotic
aspartame[no description available]low00carboxylic acid;
dipeptide zwitterion;
dipeptide;
methyl ester		apoptosis inhibitor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
environmental contaminant;
micronutrient;
nutraceutical;
sweetening agent;
xenobiotic
2-ethyl-5-carboxypentyl phthalate[no description available]low00phthalic acid monoesterxenobiotic
carpropamid[no description available]low00amide fungicide;
cyclopropylcarboxamide;
monochlorobenzenes		antifungal agrochemical;
EC 4.2.1.94 (scytalone dehydratase) inhibitor;
melanin synthesis inhibitor;
xenobiotic
mesotrione[no description available]low00aromatic ketone;
beta-triketone;
C-nitro compound;
sulfone		carotenoid biosynthesis inhibitor;
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor;
environmental contaminant;
herbicide;
xenobiotic
troleandomycin[no description available]low00acetate ester;
epoxide;
macrolide antibiotic;
monosaccharide derivative;
polyketide;
semisynthetic derivative		EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor;
xenobiotic
dronedarone[no description available]low001-benzofurans;
aromatic ether;
aromatic ketone;
sulfonamide;
tertiary amino compound		anti-arrhythmia drug;
environmental contaminant;
xenobiotic
pinoxaden[no description available]low00pivalate ester;
pyrazolooxadiazepine		agrochemical;
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor;
environmental contaminant;
proherbicide;
xenobiotic
2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide[no description available]low00anilide fungicide;
biphenyls;
monochlorobenzenes;
pyridinecarboxamide		antifungal agrochemical;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor;
environmental contaminant;
xenobiotic
prizes[no description available]low00carboxamidine;
monochloropyridine;
nitrile		environmental contaminant;
neonicotinoid insectide;
xenobiotic
lenticin[no description available]low00amino-acid betaine;
indole alkaloid;
L-tryptophan derivative		fungal metabolite;
plant metabolite;
xenobiotic
cyanoginosin lr[no description available]low00microcystinbacterial metabolite;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
environmental contaminant;
xenobiotic
dieldrin[no description available]low00epoxide;
organochlorine compound;
organochlorine insecticide		carcinogenic agent;
xenobiotic
ranitidine[no description available]low00C-nitro compound;
furans;
organic sulfide;
tertiary amino compound		anti-ulcer drug;
drug allergen;
environmental contaminant;
H2-receptor antagonist;
xenobiotic
azoxystrobin[no description available]low00aryloxypyrimidine;
enoate ester;
enol ether;
methoxyacrylate strobilurin antifungal agent;
methyl ester;
nitrile		antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
quinone outside inhibitor;
xenobiotic
tylosin[no description available]low00aldehyde;
disaccharide derivative;
enone;
leucomycin;
macrolide antibiotic;
monosaccharide derivative		allergen;
bacterial metabolite;
environmental contaminant;
xenobiotic
levetiracetam[no description available]low00pyrrolidin-2-onesanticonvulsant;
environmental contaminant;
xenobiotic
dextromethorphan[no description available]low006-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthreneantitussive;
environmental contaminant;
neurotoxin;
NMDA receptor antagonist;
oneirogen;
prodrug;
xenobiotic
kresoxim-methyl[no description available]low00aromatic ether;
methoxyiminoacetate strobilurin antifungal agent;
methyl ester;
oxime O-ether		antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
xenobiotic
pyrachlostrobin[no description available]low00aromatic ether;
carbamate ester;
carbanilate fungicide;
methoxycarbanilate strobilurin antifungal agent;
monochlorobenzenes;
pyrazoles		antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
xenobiotic
microcystin rr[no description available]low00microcystin;
organic molecular entity		bacterial metabolite;
environmental contaminant;
xenobiotic
roxithromycin[no description available]low00roxithromycinenvironmental contaminant;
xenobiotic
yunaconitine[no description available]low00acetate ester;
aromatic ether;
benzoate ester;
bridged compound;
diterpene alkaloid;
organic heteropolycyclic compound;
polyether;
secondary alcohol;
tertiary alcohol;
tertiary amino compound		antifeedant;
human urinary metabolite;
phytotoxin;
plant metabolite;
xenobiotic
pymetrozine[no description available]low001,2,4-triazines;
pyridines		antifeedant;
environmental contaminant;
TRPV channel modulator;
xenobiotic
neotame[no description available]low00dipeptideenvironmental contaminant;
sweetening agent;
xenobiotic
flonicamid[no description available]low00nitrile;
organofluorine compound;
pyridinecarboxamide		environmental contaminant;
insecticide;
xenobiotic
microcystin-lf[no description available]low00microcystinbacterial metabolite;
environmental contaminant;
xenobiotic
decarbamylsaxitoxin[no description available]low00alkaloid;
guanidines;
ketone hydrate;
paralytic shellfish toxin;
primary alcohol;
pyrrolopurine		bacterial metabolite;
marine metabolite;
neurotoxin;
toxin;
xenobiotic
mephedrone[no description available]low00amphetamines;
aromatic ketone;
secondary amino compound		environmental contaminant;
xenobiotic
clothianidin[no description available]low001,3-thiazoles;
2-nitroguanidine derivative;
clothianidin;
organochlorine compound		environmental contaminant;
neonicotinoid insectide;
nicotinic acetylcholine receptor agonist;
xenobiotic
benzene[no description available]low00aromatic annulene;
benzenes;
volatile organic compound		carcinogenic agent;
environmental contaminant;
non-polar solvent
formaldehyde[no description available]low00aldehyde;
one-carbon compound		allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
naphthalene[no description available]low00naphthalenes;
ortho-fused bicyclic arene		apoptosis inhibitor;
carcinogenic agent;
environmental contaminant;
mouse metabolite;
plant metabolite;
volatile oil component
phenanthrene[no description available]low00ortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon;
phenanthrenes		environmental contaminant;
mouse metabolite
pyridine[no description available]low00azaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines		environmental contaminant;
NMR chemical shift reference compound
2,4,6-tribromophenol[no description available]low00bromophenolenvironmental contaminant;
fungicide;
marine metabolite
2,4-dichlorophenoxyacetic acid[no description available]low00chlorophenoxyacetic acid;
dichlorobenzene		agrochemical;
defoliant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
environmental contaminant;
phenoxy herbicide;
synthetic auxin
4-nonylphenol[no description available]low00phenolsenvironmental contaminant
dibutyl phthalate[no description available]low00diester;
phthalate ester		EC 3.2.1.20 (alpha-glucosidase) inhibitor;
environmental contaminant;
metabolite;
plasticiser;
teratogenic agent
ethion[no description available]low00organic thiophosphateacaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide
methyl parathion[no description available]low00C-nitro compound;
organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
genotoxin
bromodichloromethane[no description available]low00halomethaneenvironmental contaminant;
reagent
trichlorofluoromethane[no description available]low00chlorofluorocarbon;
halomethane		environmental contaminant;
NMR chemical shift reference compound;
NMR solvent;
refrigerant
tris(2-butoxyethyl) phosphate[no description available]low00trialkyl phosphateenvironmental contaminant;
flame retardant
cumene hydroperoxide[no description available]low00peroxolenvironmental contaminant;
Mycoplasma genitalium metabolite;
oxidising agent
1-nitronaphthalene[no description available]low00mononitronaphthaleneenvironmental contaminant;
mouse metabolite
2-nitrotoluene[no description available]low00mononitrotoluenecarcinogenic agent;
environmental contaminant
2-methyl-4-chlorophenoxyacetic acid[no description available]low00chlorophenoxyacetic acid;
monochlorobenzenes		environmental contaminant;
phenoxy herbicide;
synthetic auxin
benzotrifluoride[no description available]low00(trifluoromethyl)benzenes;
fluorohydrocarbon		environmental contaminant;
NMR chemical shift reference compound;
solvent
n-nitrosopiperidine[no description available]low00nitrosamine;
piperidine		apoptosis inducer;
carcinogenic agent;
environmental contaminant;
mutagen
cyclamic acid[no description available]low00sulfamic acidsenvironmental contaminant;
human xenobiotic metabolite
1,3-dichloropropane[no description available]low00chloroalkane;
chlorohydrocarbon		environmental contaminant;
nematicide
malachite green[no description available]low00organic chloride saltantibacterial agent;
antifungal drug;
carcinogenic agent;
environmental contaminant;
fluorochrome;
histological dye;
teratogenic agent
2,6-dimethylnaphthalene[no description available]low00dimethylnaphthaleneenvironmental contaminant
brilliant green[no description available]low00organic hydrogensulfate saltantibacterial agent;
antiseptic drug;
environmental contaminant;
fluorochrome;
histological dye;
poison
ametryne[no description available]low00diamino-1,3,5-triazine;
methylthio-1,3,5-triazine		environmental contaminant;
herbicide
3-methylfuran[no description available]low00furans;
volatile organic compound		Aspergillus metabolite;
environmental contaminant;
fungal metabolite;
Penicillium metabolite;
plant metabolite
bpmc[no description available]low00carbamate esteragrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
herbicide;
insecticide
pirimiphos methyl[no description available]low00aminopyrimidine;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide
pendimethalin[no description available]low00C-nitro compound;
secondary amino compound;
substituted aniline		agrochemical;
environmental contaminant;
herbicide
isoprothiolane[no description available]low00dithiolanes;
isopropyl ester;
malonate ester		antifungal agrochemical;
environmental contaminant;
insecticide;
phospholipid biosynthesis inhibitor
perfluorododecanoic acid[no description available]low00fluoroalkanoic acidenvironmental contaminant
t-2 toxin[no description available]low00acetate ester;
organic heterotetracyclic compound;
trichothecene		apoptosis inducer;
cardiotoxic agent;
DNA synthesis inhibitor;
environmental contaminant;
fungal metabolite;
mycotoxin;
neurotoxin
4-iodo-2,5-dimethoxyphenylisopropylamine[no description available]low00amphetamines;
dimethoxybenzene;
organoiodine compound
5-iodo-2-(oxaloamino)benzoic acid[no description available]low00organoiodine compound
am 251[no description available]low00amidopiperidine;
carbohydrazide;
dichlorobenzene;
organoiodine compound;
pyrazoles		antidepressant;
antineoplastic agent;
apoptosis inducer;
CB1 receptor antagonist
clioquinol[no description available]low00monohydroxyquinoline;
organochlorine compound;
organoiodine compound		antibacterial agent;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
antiprotozoal drug;
chelator;
copper chelator
iodoquinol[no description available]low00monohydroxyquinoline;
organoiodine compound		antiamoebic agent;
antibacterial agent;
antiprotozoal drug;
antiseptic drug
ml 7[no description available]low00N-sulfonyldiazepane;
organoiodine compound		EC 2.7.11.18 (myosin-light-chain kinase) inhibitor
iodoacetic acid[no description available]low00haloacetic acid;
organoiodine compound		alkylating agent
idoxuridine[no description available]low00organoiodine compound;
pyrimidine 2'-deoxyribonucleoside		antiviral drug;
DNA synthesis inhibitor
2,3,5-triiodobenzoic acid[no description available]low00benzoic acids;
organoiodine compound		antiauxins
iodohippuric acid[no description available]low00benzamides;
N-acylglycine;
organoiodine compound
nitrohydroxyiodophenylacetate[no description available]low002-nitrophenols;
organoiodine compound;
phenylacetic acids		antigen
closantel[no description available]low00aromatic amide;
monocarboxylic acid amide;
monochlorobenzenes;
nitrile;
organoiodine compound;
phenols
2-iodosobenzoic acid[no description available]low00benzoic acids;
organoiodine compound		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor
5-iodouracil[no description available]low00organoiodine compoundantimetabolite
4-iodopyrazole[no description available]low00organoiodine compound;
pyrazoles
5-iodotubercidin[no description available]low00organoiodine compound
4'-deoxy-4'-iododoxorubicin[no description available]low00organoiodine compound;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine[no description available]low00adenosines;
monocarboxylic acid amide;
organoiodine compound		adenosine A3 receptor agonist
3,5-diiodothyropropionic acid[no description available]low00aromatic ether;
monocarboxylic acid;
organoiodine compound;
phenols
3-(2-iodoacetamido)-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl[no description available]low00aminoxyls;
organoiodine compound;
pyrrolidinecarboxamide
4-iodo-6-phenylpyrimidine[no description available]low00biaryl;
organoiodine compound;
pyrimidines		antineoplastic agent;
apoptosis inducer;
macrophage migration inhibitory factor inhibitor
n-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl)iodoacetamide[no description available]low00aminoxyls;
organoiodine compound;
piperidinecarboxamide;
secondary carboxamide		radical scavenger;
spin label
triptorelin[no description available]low00organoiodine compound
7-hydroxy-2-(n-n-propyl-n-(3-iodo-2'-propenyl)-amino)tetralin[no description available]low00organoiodine compound;
phenols;
tertiary amino compound;
tetralins		dopamine agonist
pd 0325901[no description available]low00difluorobenzene;
hydroxamic acid ester;
monofluorobenzenes;
organoiodine compound;
propane-1,2-diols;
secondary amino compound		antineoplastic agent;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
pd 150606[no description available]low00cinnamic acids;
organoiodine compound;
thioenol		apoptosis inhibitor;
calpain inhibitor
am 694[no description available]low00aromatic ketone;
indoles;
organofluorine compound;
organoiodine compound;
synthetic cannabinoid		cannabinoid receptor agonist
3-iodo-4-aminobenzyl-5'-N-methylcarboxamidoadenosine[no description available]low00adenosines;
monocarboxylic acid amide;
organoiodine compound
trametinib[no description available]low00acetamides;
aromatic amine;
cyclopropanes;
organofluorine compound;
organoiodine compound;
pyridopyrimidine;
ring assembly		anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
gdc-0973[no description available]low00aromatic amine;
difluorobenzene;
N-acylazetidine;
organoiodine compound;
piperidines;
secondary amino compound;
tertiary alcohol		antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
GDC-0623[no description available]low00hydroxamic acid ester;
imidazopyridine;
monofluorobenzenes;
organoiodine compound;
primary alcohol;
secondary amino compound;
substituted aniline		antineoplastic agent;
apoptosis inducer;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
calicheamicin gamma(1)i[no description available]low00calicheamicin;
enediyne antibiotic;
organoiodine compound		antineoplastic agent;
metabolite
malonamide[no description available]low00dicarboxylic acid diamide
oxamide[no description available]low00dicarboxylic acid diamide
lopinavir[no description available]low00amphetamines;
dicarboxylic acid diamide		anticoronaviral agent;
antiviral drug;
HIV protease inhibitor
bml 210[no description available]low00dicarboxylic acid diamideantineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
scio-469[no description available]low00aromatic amide;
aromatic ketone;
chloroindole;
dicarboxylic acid diamide;
indolecarboxamide;
monofluorobenzenes;
N-acylpiperazine;
N-alkylpiperazine		antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide[no description available]low00benzamides;
biphenyls;
cyclopropanes;
dicarboxylic acid diamide		EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
cabozantinib[no description available]low00aromatic ether;
dicarboxylic acid diamide;
organofluorine compound;
quinolines		antineoplastic agent;
tyrosine kinase inhibitor
hordatine a[no description available]low00aromatic ether;
benzofurans;
dicarboxylic acid diamide;
guanidines;
phenols		adrenergic antagonist;
metabolite
ro 4929097[no description available]low00dibenzoazepine;
dicarboxylic acid diamide;
lactam;
organofluorine compound		EC 3.4.23.46 (memapsin 2) inhibitor
ConditionIndicatedRelationship StrengthStudiesTrials
(pPNET) Peripheral Primitive Neuroectodermal Tumors0low20
Abdomen, Acute0low20
Abdominal Abscess0low10
Abdominal Aortic Aneurysm0low160
Abdominal Injuries0low30
Abdominal Migraine0low10
Abdominal Neoplasms0low20
Abdominal Pain0low60
Aberrant Tissue0low10
Abnormalities, Multiple0low10
Abnormality, Heart0medium102
Abnormality, Torsion0low10
Abscess0low20
Abscess, Abdominal0low10
Abscess, Hepatic0low20
Abscess, Intra-Abdominal0low10
Achalasia0low10
Achalasia, Esophageal0low10
Ache0medium21
Acidosis0low10
Active Hyperemia0low10
Acute Confusional Migraine0low10
Acute Coronary Syndrome0low20
Acute Disease0low300
Acute Edematous Pancreatitis0medium91
Acute Generalised Exanthematous Pustulosis0low20
Acute Generalized Exanthematous Pustulosis0low20
Acute Ischemic Stroke0low10
Acute Kidney Failure0medium4312
Acute Kidney Injury0medium4312
Acute Kidney Insufficiency0medium4312
Acute Liver Injury, Drug-Induced0low30
Acute Localized Exanthematous Pustulosis0low20
Acute Lymphoid Leukemia0low10
Acute Myelogenous Leukemia0low20
Acute Myeloid Leukemia0low20
Acute Myeloid Leukemia with Maturation0low20
Acute Myeloid Leukemia without Maturation0low20
Acute Necrotizing Pancreatitis0low40
Acute Pancreatitis0medium91
Acute Post-operative Pain0low10
Acute Postoperative Pain0low10
Acute Renal Failure0medium4312
Acute Renal Injury0medium4312
Acute Renal Insufficiency0medium4312
Acute Respiratory Distress Syndrome0low10
Addison Disease0low20
Addison's Disease0low20
Adenitis, Salivary Gland0low30
Adenocarcinoma0medium171
Adenocarcinoma Of Kidney0medium211
Adenocarcinoma, Alveolar0low10
Adenocarcinoma, Basal Cell0medium171
Adenocarcinoma, Bronchiolo-Alveolar0low10
Adenocarcinoma, Clear Cell0low10
Adenocarcinoma, Granular Cell0medium171
Adenocarcinoma, Mucinous0low20
Adenocarcinoma, Oxyphilic0medium171
Adenocarcinoma, Renal0medium211
Adenocarcinoma, Renal Cell0medium211
Adenocarcinoma, Tubular0medium171
Adenolymphoma0low20
Adenoma0low80
Adenoma Sebaceum0low10
Adenoma, Adrenal Cortical0low50
Adenoma, Adrenocortical0low50
Adenoma, Basal Cell0low80
Adenoma, Follicular0low80
Adenoma, Hepatocellular0low10
Adenoma, Liver Cell0low10
Adenoma, Malignant0medium171
Adenoma, Microcystic0low80
Adenoma, Monomorphic0low80
Adenoma, Oxyphilic0low30
Adenoma, Papillary0low80
Adenoma, Pleomorphic0low20
Adenoma, Trabecular0low80
Adnexitis0low10
Adrenal Cancer0low140
Adrenal Cortex Cancer0low10
Adrenal Cortex Neoplasms0low10
Adrenal Gland Cancer0low140
Adrenal Gland Diseases0low10
Adrenal Gland Neoplasms0low140
Adrenal Neoplasm0low140
Adrenocortical Adenoma0low50
Adrenocortical Cancer0low10
Adrenocortical Carcinoma0low10
Adult Respiratory Distress Syndrome0low10
Adverse Drug Event0medium61
Adverse Drug Reaction0medium61
Aganglionic Megacolon0low10
Aganglionosis, Colonic0low10
Aganglionosis, Rectosigmoid Colon0low10
Aganglionosis, Total Colonic0low10
AIDS-Related Opportunistic Infections0low10
Air Embolism0low10
Airway Obstruction0low20
Albuminuria0medium21
ALL, Childhood0low10
Allergic Acute Coronary Syndrome0low10
Allergic Angina Syndrome0low10
Allergic Contact Dermatitis0low10
Allergic Myocardial Infarction0low10
Allergic Reaction0medium51
Allergy0medium51
Allergy, Drug0medium222
Alloxan Diabetes0low40
Alogia0low10
Alveolar Cell Carcinoma0low10
Alveolar Echinococcosis, Hepatic0low20
Amaurosis0low10
Anaphylactic Reaction0low80
Anaphylactoid Reaction0low80
Anaphylactoid Shock0low80
Anaphylaxis0low80
Anasarca0low30
Anemia, Fanconi0low10
Anemia, Sickle Cell0low10
Anepia0low10
Aneuploid0low10
Aneuploid Cell0low10
Aneuploidy0low10
Aneurysm0low40
Aneurysm, Abdominal Aortic0low160
Aneurysm, Anterior Cerebral Artery0medium241
Aneurysm, Anterior Communicating Artery0medium241
Aneurysm, Aortic0low50
Aneurysm, Arteriovenous0low30
Aneurysm, Bacterial0low10
Aneurysm, Basilar Artery0medium241
Aneurysm, Cerebral0medium241
Aneurysm, False0low60
Aneurysm, Iliac0low20
Aneurysm, Infected0low10
Aneurysm, Intracranial0medium241
Aneurysm, Middle Cerebral Artery0medium241
Aneurysm, Mycotic0low10
Aneurysm, Posterior Cerebral Artery0medium241
Aneurysm, Posterior Communicating Artery0medium241
Aneurysm, Ruptured0low20
Aneurysm, Thoracic Aortic0low50
Angina at Rest0low30
Angina Pectoris0low70
Angina Pectoris, Unstable0low30
Angina, Preinfarction0low30
Angina, Unstable0low30
Angio-Osteohypertrophy Syndrome0low10
Angiodysplasia0low10
Angioedema0low10
Angiofollicular Lymph Hyperplasia0low10
Angiofollicular Lymph Node Hyperplasia0low10
Angiofollicular Lymphoid Hyperplasia0low10
Angiogenesis, Pathologic0low110
Angiogenesis, Pathological0low110
Angiolymphoid Hyperplasia with Eosinophilia0low10
Angioma0low50
Angioma, Sclerosing0low10
Angiomatosis Retinae0low10
Angiomyolipoma0medium61
Angioneurotic Edema0low10
Angioosteohypertrophy Syndrome0low10
Angiosarcoma0low10
Angiospasm, Intracranial0low10
Angor Pectoris0low70
Anisakiasis0low10
Anisakis Infection0low10
ANLL0low20
Anomalous Pulmonary Venous Return0low10
Anorectal Diseases0low10
Anorectal Disorders0low10
Anoxemia0low40
Anoxia0low40
Anterior Cerebral Artery Aneurysm0medium241
Anterior Choroidal Artery Infarction0low30
Anterior Circulation Transient Ischemic Attack0low10
Anterior Communicating Artery Aneurysm0medium241
Anterior Fascicular Block0low10
Anti-MuSK Myasthenia Gravis0low30
Anton Syndrome0low20
Anton-Babinski Syndrome0low20
Anton's Syndrome0low20
Anuria0low10
Aortic Aneurysm0low50
Aortic Aneurysm, Abdominal0low160
Aortic Aneurysm, Ruptured0low20
Aortic Aneurysm, Thoracic0low50
Aortic Aneurysm, Thoracoabdominal0low50
Aortic Coarctation0low10
Aortic Diseases0medium111
Aortic Dissection0low100
Aortic Rupture0low20
Aortic Stenosis0low50
Aortic Valve Disease 10low10
Aortic Valve Stenosis0low50
Aortic Valve, Bicuspid0low10
Aphasia0low10
Aphasia, Acquired0low10
Aphasia, Ageusic0low10
Aphasia, Auditory Discriminatory0low10
Aphasia, Commisural0low10
Aphasia, Functional0low10
Aphasia, Global0low10
Aphasia, Graphomotor0low10
Aphasia, Intellectual0low10
Aphasia, Mixed0low10
Aphasia, Post-Ictal0low10
Aphasia, Post-Traumatic0low10
Aphasia, Progressive0low10
Aphasia, Semantic0low10
Aphasia, Syntactical0low10
Apolipoprotein B-100, Familial Defective0low20
Apolipoprotein B-100, Familial Ligand-Defective0low20
Apoplexy0medium51
Appendicitis0low50
ARDS, Human0low10
Arrhythmia0medium21
Arrhythmias, Cardiac0medium21
Arrythmia0medium21
Arterial Diseases, Carotid0medium42
Arterial Diseases, Cerebral0low10
Arterial Diseases, Common Carotid0medium42
Arterial Diseases, External Carotid0medium42
Arterial Diseases, Internal Carotid0medium42
Arterial Hyperemia0low10
Arterial Obstructive Diseases0medium112
Arterial Occlusive Diseases0medium112
Arteriosclerosis0medium32
Arteriosclerosis Obliterans0low10
Arteriosclerosis, Coronary0medium6016
Arteriovenous Aneurysm0low30
Arteriovenous Fistula0low30
Arteriovenous Fistulas0low30
Arteriovenous Malformations0low20
Arteriovenous Malformations, Cerebral0medium51
Arthralgia0low20
Arthritis, Rheumatoid0low10
Aseptic Necrosis of Bone0low10
Aspergilloses, Bronchopulmonary0low20
Aspergillosis0low10
Aspergillosis, Bronchopulmonary0low20
Aspergillus Infection0low10
Aspiration, Respiratory0low10
Asthma0low10
Asthma, Bronchial0low10
Asthmatic Crisis0low10
Asthmatic Shock0low10
Astrocytoma, Grade IV0low10
Asystole0low10
Atelectasis0low10
Atelectasis, Congestive0low10
Atherogenesis0medium31
Atheroma0low90
Atheromatous Plaque0low90
Atheromatous Plaques0low90
Atherosclerosis0medium31
Atherosclerosis, Coronary0medium6016
Atherosclerotic Disease, Carotid0medium42
Atherosclerotic Plaque0low90
Atherosclerotic Plaques0low90
Athletic Injuries0low10
Atopic Hypersensitivity0low20
Atresia, Pulmonary0low20
Atresia, Pulmonary Valve0low20
Atresias, Pulmonary0low20
Atresias, Pulmonary Valve0low20
Atrial Fibrillation0low70
Atrial Septal Defect0low10
Atrial Septal Defect Ostium Primum0low10
Atrial Septal Defects0low10
Atrophy0low10
Atypical Ductal Hyperplasia0medium11
Aura0low10
Auricular Fibrillation0low70
Autoimmune Disease0low10
Autoimmune Diseases0low10
Avascular Necrosis of Bone0low10
AVM (Arteriovenous Malformation) Intracranial0medium51
Awakening Epilepsy0low10
Bacterial Aneurysm0low10
Bacterial Aneurysms0low10
Basedow Disease0low10
Basedow's Disease0low10
Basilar Artery Aneurysm0medium241
Basilar Artery Insufficiency0medium21
Basilar Artery Ischemia0medium21
Basilar Artery Stenosis0medium21
Basilar Insufficiency0medium21
Basilar Steal Syndrome0low10
Benign Fibrous Histiocytoma0low10
Benign Neoplasms0medium124
Benign Neoplasms, Brain0low40
Berry Aneurysm0medium241
Bicuspid Aortic Valve0low10
Bicuspid Aortic Valve Disease0low10
Bilateral Blindness0low10
Bilateral Nasal Obstruction0low10
Bile Duct Cancer0low60
Bile Duct Cysts0low10
Bile Duct Diseases0medium21
Bile Duct Neoplasms0low60
Bile Duct Obstruction0low10
Bile Duct Obstruction, Extrahepatic0low10
Biliary Calculi0low20
Biliary Calculi, Common Bile Duct0low20
Biliary Stasis0low10
Biliary Stasis, Extrahepatic0low10
Biliary Tract Cancer0low10
Biliary Tract Diseases0low10
Biliary Tract Neoplasms0low10
Bladder Cancer0low30
Bladder Disorder, Neurogenic0low10
Bladder Neoplasms0low30
Bladder Neurogenesis0low10
Bladder Tumors0low30
Bladder, Neurogenic0low10
Bladder, Overactive0low10
Bleeding0low40
Blindness0low10
Blindness, Acquired0low10
Blindness, Bilateral0low10
Blindness, Complete0low10
Blindness, Cortical0low20
Blindness, Cortical, Post-Ictal0low20
Blindness, Cortical, Transient0low20
Blindness, Hysterical0low10
Blindness, Legal0low10
Blindness, Monocular0low10
Blindness, Transient0low10
Blindness, Unilateral0low10
Blood Clot0medium91
Blood Loss, Postoperative0low10
Blood Poisoning0low10
Blood Pressure, High0medium42
Blood Pressure, Low0medium11
Blood Vessel Dissection0low100
Bloodstream Infection0low10
Blunt Injuries0low20
Body Weight0medium126
Bone Cancer0low20
Bone Fractures0low10
Bone Inflammation0low10
Bone Marrow Diseases0low10
Bone Marrow Neoplasms0low10
Bone Necrosis0low10
Bone Neoplasms0low20
Bourneville Disease0low10
Bourneville Phakomatosis0low10
Bourneville Syndrome0low10
Bourneville-Pringle Disease0low10
Bourneville-Pringle's Disease0low10
Bourneville's Disease0low10
Bourneville's Syndrome0low10
Bowel Diseases, Inflammatory0low10
Brachial-Basilar Insufficiency Syndrome0low10
Brain Aneurysm0medium241
Brain Cancer0low40
Brain Diseases0low40
Brain Disorders0low40
Brain Edema0low30
Brain Hemorrhage0low10
Brain Hemorrhage, Cerebral0low30
Brain Ischemia0low70
Brain Metastases0low40
Brain Neoplasm, Primary0low40
Brain Neoplasms0low40
Brain Neoplasms, Benign0low40
Brain Neoplasms, Malignant0low40
Brain Neoplasms, Malignant, Primary0low40
Brain Neoplasms, Primary Malignant0low40
Brain Stem Ischemia, Transient0low10
Brain Stem Transient Ischemic Attack0low10
Brain Swelling0low30
Brain TIA0low10
Brain Tumor, Primary0low40
Brain Tumor, Recurrent0low40
Brain Tumors0low40
Brain Vascular Disorders0low70
Brainstem Ischemia, Transient0low10
Brainstem Transient Ischemic Attack0low10
Breast Cancer0medium121
Breast Carcinoma0medium121
Breast Diseases0medium21
Breast Neoplasms0medium121
Breast Tumors0medium121
Breathing Sounds0low10
Breathlessness0low40
Brill-Symmers Disease0low20
Broken Bones0low10
Bronchial Asthma0low10
Bronchial Diseases0low30
Bronchial Fistula0low10
Bronchopulmonary Aspergilloses0low20
Bronchopulmonary Aspergillosis0low20
Bronchopulmonary Sequestration0low20
Bronchopulmonary Sequestrations0low20
Budd-Chiari Syndrome0medium31
Bundle Branch Block0low10
Bundle-Branch Block0low10
Burns, Chemical0low10
Cadaver0low70
Calcification, Pathologic0medium241
Calcinosis0medium241
Calcinosis, Tumoral0medium241
Cancer0medium124
Cancer of Adrenal Cortex0low10
Cancer of Bile Duct0low60
Cancer of Biliary Tract0low10
Cancer of Bladder0low30
Cancer of Bone0low20
Cancer of Brain0low40
Cancer of Breast0medium121
Cancer of Colon0low30
Cancer of Duodenum0low20
Cancer of Esophagus0low40
Cancer of Gallbladder0low10
Cancer of Gastrointestinal Tract0low50
Cancer of Head0medium122
Cancer of Head and Neck0medium122
Cancer of Intestines0low20
Cancer of Kidney0medium291
Cancer of Larynx0medium21
Cancer of Liver0medium766
Cancer of Lung0medium273
Cancer of Mediastinum0medium21
Cancer of Mouth0low10
Cancer of Nasopharynx0medium41
Cancer of Neck0medium122
Cancer of Nose0low10
Cancer of Ovary0low20
Cancer of Pancreas0medium252
Cancer of Paranasal Sinus0low10
Cancer of Parathyroid0low10
Cancer of Parotid0low20
Cancer of Pelvis0low20
Cancer of Pharynx0low10
Cancer of Prostate0low40
Cancer of Rectum0low60
Cancer of Salivary Gland0low10
Cancer of Stomach0low110
Cancer of the Adrenal Cortex0low10
Cancer of the Adrenal Gland0low140
Cancer of the Bile Duct0low60
Cancer of the Biliary Tract0low10
Cancer of the Bladder0low30
Cancer of the Bone0low20
Cancer of the Brain0low40
Cancer of the Breast0medium121
Cancer of the Colon0low30
Cancer of the Duodenum0low20
Cancer of the Esophagus0low40
Cancer of the Gallbladder0low10
Cancer of the Gastrointestinal Tract0low50
Cancer of the Head0medium122
Cancer of the Head and Neck0medium122
Cancer of the Intestines0low20
Cancer of the Kidney0medium291
Cancer of the Larynx0medium21
Cancer of the Liver0medium766
Cancer of the Lung0medium273
Cancer of the Mediastinum0medium21
Cancer of the Mouth0low10
Cancer of the Nasopharynx0medium41
Cancer of the Neck0medium122
Cancer of the Nose0low10
Cancer of the Ovary0low20
Cancer of the Pancreas0medium252
Cancer of the Parathyroid0low10
Cancer of the Parotid0low20
Cancer of the Pelvis0low20
Cancer of the Pharynx0low10
Cancer of the Prostate0low40
Cancer of the Rectum0low60
Cancer of the Salivary Gland0low10
Cancer of the Stomach0low110
Cancer of the Thymus0low40
Cancer of the Thyroid0medium21
Cancer of the Tongue0low10
Cancer of the Tonsil0low10
Cancer of the Urinary Tract0low10
Cancer of the Uterus0medium11
Cancer of Thymus0low40
Cancer of Thyroid0medium21
Cancer of Tongue0low10
Cancer of Tonsil0low10
Cancer of Urinary Tract0low10
Cancer of Uterus0medium11
Cancer, Embryonal0low10
Cancer, Embryonal and Mixed0low10
Cancer, Hepatocellular0medium766
Cancer, Radiation-Induced0low10
Cancer, Second Primary0low10
Canine Diseases0low10
Capillary Telangiectasia, Brain0low30
Carcinoma0low50
Carcinoma, Adrenal Cortical0low10
Carcinoma, Adrenocortical0low10
Carcinoma, Alveolar0low10
Carcinoma, Anaplastic0low50
Carcinoma, Bronchiolar0low10
Carcinoma, Bronchiolo-Alveolar0low10
Carcinoma, Bronchioloalveolar0low10
Carcinoma, Colloid0low20
Carcinoma, Cribriform0medium171
Carcinoma, Ductal, Breast0medium11
Carcinoma, Ductal, Pancreatic0low40
Carcinoma, Epidermoid0low120
Carcinoma, Granular Cell0medium171
Carcinoma, Hepatocellular0medium413
Carcinoma, Hypernephroid0medium211
Carcinoma, Infiltrating Duct0medium11
Carcinoma, Intraductal0medium11
Carcinoma, Intraductal, Noninfiltrating0medium11
Carcinoma, Invasive Ductal, Breast0medium11
Carcinoma, Lobular0medium21
Carcinoma, Mammary Ductal0medium11
Carcinoma, Mucinous0low20
Carcinoma, Neuroendocrine0low30
Carcinoma, Non-Small Cell Lung0medium73
Carcinoma, Non-Small-Cell Lung0medium73
Carcinoma, Pancreatic Ductal0low40
Carcinoma, Papillary0low40
Carcinoma, Planocellular0low120
Carcinoma, Renal Cell0medium211
Carcinoma, Spindle-Cell0low50
Carcinoma, Squamous0low120
Carcinoma, Squamous Cell0low120
Carcinoma, Squamous Cell of Head and Neck0low10
Carcinoma, Thymic0low20
Carcinoma, Transitional Cell0low10
Carcinoma, Tubular0medium171
Carcinoma, Undifferentiated0low50
Carcinomatosis0low50
Cardiac Aneurysm0low10
Cardiac Arrest0low10
Cardiac Arrhythmia0medium21
Cardiac Arrhythmias0medium21
Cardiac Cancer0low20
Cardiac Carcinoma0low20
Cardiac Complex, Premature0low10
Cardiac Complexes, Premature0low10
Cardiac Diseases0medium42
Cardiac Disorders0medium42
Cardiac Dysrhythmia0medium21
Cardiac Edema0low10
Cardiac Failure0medium41
Cardiac Neoplasms0low20
Cardiac Rupture, Traumatic0low10
Cardiac Tumor0low20
Cardiac Tumors0low20
Cardiomyopathies0low20
Cardiomyopathies, Primary0low20
Cardiomyopathies, Secondary0low20
Cardiomyopathy, Hypertrophic0low30
Cardiomyopathy, Hypertrophic Obstructive0low30
Cardiopulmonary Arrest0low10
Cardiospasm0low10
Cardiovascular Diseases0medium43
Cardiovascular Stroke0medium224
Carotid Artery Diseases0medium42
Carotid Artery Disorders0medium42
Carotid Artery Narrowing0low110
Carotid Artery Plaque0low110
Carotid Artery Stenosis0low110
Carotid Artery Ulcerating Plaque0low110
Carotid Atherosclerosis0medium42
Carotid Atherosclerotic Disease0medium42
Carotid Circulation Transient Ischemic Attack0low10
Carotid Stenosis0low110
Carotid Ulcer0low110
Castleman Disease0low10
Castleman's Disease0low10
Castleman's Tumor0low10
Castlemans Disease0low10
Celiac Disease0low10
Celiac Sprue0low10
Central Nervous System Congenital Vascular Malformations0low30
Central Nervous System Disease0low10
Central Nervous System Diseases0low10
Central Nervous System Disorder0low10
Central Nervous System Disorders0low10
Central Nervous System Disorders, Intracranial0low40
Central Nervous System Intracranial Disorders0low40
Central Nervous System Vascular Anomalies0low30
Central Nervous System Vascular Malformations0low30
Centrala nervsystemets sjukdomar@sv0low10
Centriacinar Emphysema0low20
Centrilobular Emphysema0low20
Cerebellar Diseases0low10
Cerebellar Disorders0low10
Cerebellar Dysfunction0low10
Cerebellar Syndromes0low10
Cerebelloretinal Angiomatosis, Familial0low10
Cerebellum Diseases0low10
Cerebral Aneurysm0medium241
Cerebral Angiospasm0low10
Cerebral Arterial Diseases0low10
Cerebral Arteriovenous Malformations0medium51
Cerebral Artery Diseases0low10
Cerebral Artery Spasm0low10
Cerebral Edema0low30
Cerebral Edema, Cytotoxic0low30
Cerebral Edema, Vasogenic0low30
Cerebral Embryonic Artery, Persistent0low30
Cerebral Hemorrhage0low30
Cerebral Infarct0low30
Cerebral Infarction0low30
Cerebral Infarction, Left Hemisphere0low30
Cerebral Infarction, Right Hemisphere0low30
Cerebral Ischemia0low70
Cerebral Ischemia, Transient0low10
Cerebral Parenchymal Hemorrhage0low30
Cerebral Primitive Neuroectodermal Tumor0low10
Cerebral Sclerosis0low10
Cerebral Stroke0medium51
Cerebral Vasospasm0low10
Cerebral, Left Hemisphere, Infarction0low30
Cerebral, Right Hemisphere, Infarction0low30
Cerebrovascular Accident0medium51
Cerebrovascular Accident, Acute0medium51
Cerebrovascular Apoplexy0medium51
Cerebrovascular Diseases0low70
Cerebrovascular Disorders0low70
Cerebrovascular Insufficiency0low70
Cerebrovascular Moyamoya Disease0low10
Cerebrovascular Occlusion0low70
Cerebrovascular Spasm0low10
Cerebrovascular Stroke0medium51
Cervical Migraine Syndrome0low10
Chemical and Drug Induced Liver Injury0low30
Chemical Burns0low10
Chemically-Induced Liver Toxicity0low30
Chest Injuries0low10
Chest Pain0low80
Chiari's Syndrome0medium31
Chloroma0low10
Choking0low20
Cholangiocarcinoma0low50
Cholangiocellular Carcinoma0low50
Cholangitis0low10
Choledochal Cyst0low10
Choledochal Cyst, Diverticulum0low10
Choledochal Cyst, Type I0low10
Choledochal Cyst, Type II0low10
Choledochal Cyst, Type III0low10
Choledochal Cyst, Type IV0low10
Choledochal Cyst, Type V0low10
Choledochal Diverticulum0low10
Choledochocele0low10
Choledocholithiasis0low10
Cholelithiasis0low10
Cholelithiasis, Common Bile Duct0low10
Cholera Infantum0low20
Cholestasis0low10
Cholestasis, Extrahepatic0low10
Chorangioma0low50
Chorioangioma0low50
Choristoma0low10
Choroby OUN@pl0low10
Chromophil Renal Cell Carcinoma0medium211
Chromophobe Renal Cell Carcinoma0medium211
Chromosomal Translocation0low10
Chronic Disease0low90
Chronic Hepatitis B0low10
Chronic Hepatitis B Virus Infection0low10
Chronic Illness0low90
Chronic Kidney Diseases0medium62
Chronic Kidney Failure0medium174
Chronic Kidney Insufficiency0medium62
Chronic Post-operative Pain0low10
Chronic Post-surgical Pain0low10
Chronic Postoperative Pain0low10
Chronic Postsurgical Pain0low10
Chronic Renal Diseases0medium62
Chronic Renal Insufficiency0medium62
Chronic Sialadenitis0low30
Chronically Ill0low90
Chylopericardium0low30
Cicatrix0low20
Cicatrization0low20
Cirrhosis0low40
Cirrhosis, Liver0low50
Clear Cell Renal Carcinoma0medium211
Clear Cell Renal Cell Carcinoma0medium211
CNS Disease0low10
CNS Diseases0low10
CNS Disorders, Intracranial0low40
CNS Vascular Malformations0low30
Coarctation of Aorta0low10
Coarctation of Aorta Dominant0low10
Coarctation of the Aorta0low10
Coin Lesion, Pulmonary0low50
Coin Lesions, Pulmonary0low50
Cold Fingers, Hereditary0low10
Colicky Pain0low60
Colitis0low10
Colitis, Granulomatous0low50
Collecting Duct Carcinoma0medium211
Collecting Duct Carcinoma (Kidney)0medium211
Collecting Duct Carcinoma of the Kidney0medium211
Colon Cancer0low30
Colon Neoplasms0low30
Colonic Aganglionosis0low10
Colonic Cancer0low30
Colonic Diverticulitis0low10
Colonic Neoplasms0low30
Colonic Polyps0low20
Colorectal Cancer0medium141
Colorectal Carcinoma0medium141
Colorectal Neoplasms0medium141
Colorectal Tumors0medium141
Common Bile Duct Calculi0low20
Common Bile Duct Cyst0low10
Common Bile Duct Diseases0low10
Common Bile Duct Gall Stone0low20
Common Bile Duct Gall Stones0low20
Common Bile Duct Gallstone0low20
Common Bile Duct Gallstones0low20
Common Carotid Artery Diseases0medium42
Common Carotid Artery Stenosis0low110
Complication, Intraoperative0low30
Complication, Peroperative0low30
Complication, Postoperative0low200
Complications of Diabetes Mellitus0medium22
Compression Atelectasis0low10
Compression Pulmonary Atelectasis0low10
Congenital Biliary Dilatation0low10
Congenital Choledochal Cyst0low10
Congenital Cystic Adenomatoid Malformation0low10
Congenital Cystic Adenomatoid Malformation of Lung0low10
Congenital Cystic Adenomatoid Malformation, Type 10low10
Congenital Cystic Adenomatoid Malformation, Type 20low10
Congenital Cystic Adenomatoid Malformation, Type 30low10
Congenital Cystic Adenomatoid Malformation, Type I0low10
Congenital Cystic Adenomatoid Malformation, Type II0low10
Congenital Cystic Adenomatoid Malformation, Type III0low10
Congenital Dysplastic Angiopathy0low10
Congenital Heart Defect0medium102
Congenital Heart Defects0medium102
Congenital Heart Disease0medium102
Congenital Intestinal Aganglionosis0low10
Congenital Intracranial Arteriovenous Malformations0medium51
Congenital Megacolon0low10
Congenital Myotonic Dystrophy0low10
Congenital Vascular Malformations, Central Nervous System0low30
Congenital Zika Syndrome0low10
Congenital Zika Virus Infection0low10
Congestive Atelectasis0low10
Congestive Heart Failure0medium41
Congestive Pulmonary Atelectasis0low10
Conn Adenoma0low50
Conn Disease0low50
Conn's Disease0low50
Consciousness, Loss of0low10
Constitutional Liver Dysfunction0low10
Constriction, Pathologic0low90
Constriction, Pathological0low90
Contact Dermatitis0low10
Contraction Pulmonary Atelectasis0low10
Convulsive Generalized Seizure Disorder0low10
Convulsive Seizure Disorder, Generalized0low10
Coronary Arteriosclerosis0medium6016
Coronary Artery Disease0medium6016
Coronary Artery Stenosis0medium292
Coronary Artery Vasospasm0low10
Coronary Atherosclerosis0medium6016
Coronary Disease0medium358
Coronary Heart Disease0medium358
Coronary Occlusion0low20
Coronary Restenosis0medium92
Coronary Stenoses0medium292
Coronary Stenosis0medium292
Coronary Thrombosis0low30
Coronary Vasospasm0low10
Coronary Vessel Anomalies0low40
Corpse0low70
Coxarthrosis0low10
Crackles0low10
Crescendo Transient Ischemic Attacks0low10
Crohn Disease0low50
Crohn's Disease0low50
Crohn's Enteritis0low50
Cruveilhier-Baumgarten Syndrome0low50
Cryptogenic Embolism Stroke0low10
Cryptogenic Ischemic Stroke0low10
Cryptogenic Stroke0low10
Cushing Syndrome0low10
Cushing's Syndrome0low10
CVA (Cerebrovascular Accident)0medium51
Cyst0low20
Cyst, Common Bile Duct0low10
Cystadenocarcinoma0low10
Cystadenoma Lymphomatosum, Papillary0low20
Cystic Adenomatoid Malformation of Lung0low10
Cystic Adenomatoid Malformation of Lung, Congenital0low10
Cystic Echinococcosis0low10
Cystic Kidney Diseases0low30
Cystic Renal Diseases0low30
Cystitis0low10
Cysts0low20
Cysts, Common Bile Duct0low10
Cysts, Hydatid0low10
Cytomegalic Inclusion Disease0low10
Cytomegalovirus Infections0low10
Cytotoxic Brain Edema0low30
Cytotoxic Cerebral Edema0low30
DCIS0medium11
Deep Vein Thrombosis0low50
Deep Venous Thrombosis0low50
Deep-Vein Thrombosis0low50
Deep-Venous Thrombosis0low50
Defects, Congenital Heart0medium102
Deficiency, Oxygen0low40
Degenerative Disc Disease0low10
Degenerative Intervertebral Discs0low10
Degenerative Intervertebral Disks0low10
Deglutition Disorders0medium21
Dehiscence, Surgical Wound0low10
Dejerine-Lichtheim Phenomenon0low10
Delayed Hypersensitivity0medium11
Delayed Postpartum Hemorrhage0low10
Dental Tissue Neoplasms0low10
Dermatitis Medicamentosa0low50
Dermatitis Venenata0low10
Dermatitis, Adverse Drug Reaction0low50
Dermatitis, Allergic Contact0low10
Dermatitis, Allergic Eczematous0low10
Dermatitis, Contact0low10
Dermatitis, Contact, Allergic0low10
Dermatofibroma0low10
Dermatoses0low20
Dermatosis0low20
Diabetes Complications0medium22
Diabetes Mellitus0medium31
Diabetes Mellitus, Adult-Onset0low20
Diabetes Mellitus, Experimental0low40
Diabetes Mellitus, Ketosis-Resistant0low20
Diabetes Mellitus, Maturity-Onset0low20
Diabetes Mellitus, Non Insulin Dependent0low20
Diabetes Mellitus, Non-Insulin-Dependent0low20
Diabetes Mellitus, Noninsulin Dependent0low20
Diabetes Mellitus, Noninsulin-Dependent0low20
Diabetes Mellitus, Slow-Onset0low20
Diabetes Mellitus, Stable0low20
Diabetes Mellitus, Type 20low20
Diabetes Mellitus, Type II0low20
Diabetes-Related Complications0medium22
Diabetic Angiopathies0low10
Diabetic Complications0medium22
Diabetic Glomerulosclerosis0medium22
Diabetic Kidney Disease0medium22
Diabetic Nephropathies0medium22
Diabetic Nephropathy0medium22
Diabetic Vascular Complications0low10
Diabetic Vascular Diseases0low10
Diaphragmatic Hernia0low10
Diffuse Large B-Cell Lymphoma0low10
Diffuse Large-Cell Lymphoma0low10
Diffuse Lymphocytic Lymphoma, Poorly-Differentiated0low10
Diffuse Mixed Small and Large Cell Lymphoma0low20
Diffuse Mixed-Cell Lymphoma0low20
Diffuse Parenchymal Lung Disease0low10
Diffuse Parenchymal Lung Diseases0low10
Diffuse Small Cleaved-Cell Lymphoma0low20
Diffuse Undifferentiated Lymphoma0low20
Diffuse, Large B-Cell, Lymphoma0low10
Dilatation, Pathologic0low30
Dilatation, Pathological0low30
Dilatations, Pathologic0low30
Dilatations, Pathological0low30
Disc Degeneration0low10
Disc Degradation0low10
Disease Exacerbation0low180
Disease Models, Animal0low240
Disease Progression0low180
Disease, Pulmonary0low50
Diseases, Peripheral Vascular0low40
Diseases, Pulmonary0low50
Disk Degeneration0low10
Disk Degradation0low10
Dissecting Aneurysm0low100
Dissection, Blood Vessel0low100
Diverticula0low20
Diverticulitis0low10
Diverticulitis, Colonic0low10
Diverticulosis0low20
Diverticulum0low20
Diverticulum, Meckel0low20
Doenu00E7as do Sistema Nervoso Central@pt0low10
Dog Diseases0low10
Dropsy0low30
Drug Allergy0medium222
Drug Eruptions0low50
Drug Hypersensitivity0medium222
Drug Side Effects0medium61
Drug Toxicity0medium61
Drug-Induced Acute Liver Injury0low30
Drug-Induced Liver Disease0low30
Drug-Induced Liver Injury0low30
Drug-Related Side Effects and Adverse Reactions0medium61
Duct-Cell Carcinoma of the Pancreas0low40
Duct-Cell Carcinoma, Pancreas0low40
Ductal Carcinoma In Situ0medium11
Ductal Carcinoma of the Pancreas0low40
Duodenal Cancer0low20
Duodenal Neoplasms0low20
Dural Arteriovenous Fistula0low30
Dysesthesia0low10
Dysgeusia0low10
Dysphagia0medium21
Dysphasia0low10
Dysphasia, Global0low10
Dyspnea0low40
Dystrophia Myotonica0low10
Dystrophia Myotonica 10low10
Dystrophia Myotonica 20low10
Echinococcosis0low10
Echinococcosis, Hepatic0low20
Echinococcosis, Hepatic Alveolar0low20
Echinococcus Granulosus Infection0low10
Echinococcus Infection0low10
Ectasia0low30
Ectopic Heartbeats0low10
Ectopic Tissue0low10
Eczema, Contact0low10
Edema0low30
Edema, Cardiac0low10
Edema, Fetal0low10
Edema, Pulmonary0low10
Edemas, Pulmonary0low10
Electrolytes0low20
Elevated Cholesterol0low10
Embolic Infarction, Posterior Cerebral Artery0low10
Embolism, Air0low10
Embolism, Gas0low10
Embolism, Pulmonary0medium405
Embolisms, Pulmonary0medium405
Embryonal Neoplasms0low10
Embryonic Artery, Persistent, Cerebral0low30
Emergencies0low30
Emesis0low10
Emphysema, Pulmonary0low20
Emphysema, Subcutaneous0low10
Emphysemas, Pulmonary0low20
Empyema, Pleural0low10
Empyema, Pleural, Tuberculous0low10
Empyema, Thoracic0low10
Empyema, Tuberculous0low10
Encephalitis, Polio0low10
Encephalon Diseases0low40
Encephalopathy0low40
Encephalopathy, Ischemic0low70
Encephalopathy, Toxic0low30
End-Stage Kidney Disease0medium174
End-Stage Renal Disease0medium174
Endocrine Breast Diseases0medium21
Endodermal Sinus Tumor0low10
Endoleak0low10
Endometrial Diseases0low10
Endotoxin Shock0low10
Enfermedades del Sistema Nervioso Central@es0low10
Enteritis, Granulomatous0low50
Enteritis, Regional0low50
Eosinophilia0low20
Eosinophilia, Pulmonary0low10
Eosinophilia, Tropical0low20
Eosinophilias, Pulmonary0low10
Eosinophilic Pneumonia0low10
Ependymoblastoma0low10
Epidemic Acute Poliomyelitis0low10
Epilepsy0low10
Epilepsy, Akinetic0low10
Epilepsy, Atonic0low10
Epilepsy, Cryptogenic0low10
Epilepsy, Generalized0low10
Epilepsy, Tonic0low10
Epiloia0low10
Epiphora0medium21
Epithelial Neoplasms, Malignant0low50
Epithelial Tumors, Malignant0low50
Epithelioma0low50
Esophageal Achalasia0low10
Esophageal and Gastric Varices0low10
Esophageal Cancer0low40
Esophageal Dysphagia0medium21
Esophageal Neoplasms0low40
Esophageal Perforation0low10
Esophageal Stenosis0low20
Esophageal Stricture0low20
Esophageal Varices0low10
Esophageal Varix0low10
Esophagus Cancer0low40
Esophagus Neoplasm0low40
ESRD0medium174
Ewing Sarcoma0low10
Ewing Tumor0low10
Ewing's Sarcoma0low10
Ewing's Tumor0low10
Exanthem0low20
Exanthema0low20
Exophthalmic Goiter0low10
Experimental Diabetes Mellitus0low40
Experimental Hepatoma0low30
Experimental Hepatomas0low30
Experimental Liver Neoplasms0low30
Experimental Lung Inflammation0low20
Experimental Mammary Neoplasms0low30
Experimental Spinal Cord Ischemia0low10
External Carotid Artery Diseases0medium42
External Carotid Artery Stenosis0low110
Extracranial Primitive Neuroectodermal Tumor0low20
Extrahepatic Cholangiocarcinoma0low50
Extrahepatic Cholestasis0low10
Extramedullary Myeloid Cell Tumor0low10
Extranodal NK-T-Cell Lymphoma0low10
Extranodal NK-T-Cell Lymphoma, Nasal0low10
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type0low10
Extranodal NK-T-Cell Lymphoma, Nasal Type0low10
Extrasystole0low10
Extrasystoles0low10
Extravasation of Contrast Media0low130
Extravasation of Diagnostic and Therapeutic Materials0low130
Extravasation of Diagnostic, Therapeutic Materials0low130
Extravascular Hemolysis0low20
Facial Neoplasms0low10
False Aneurysm0low60
Familial Atrial Fibrillation0low70
Familial Cerebello-Retinal Angiomatosis0low10
Familial Combined Hyperlipoproteinemia0low20
Familial Non-Immune Hydrops Fetalis0low10
Familial Nonhemolytic Jaundice0low10
Familial Primary Pulmonary Hypertension0low10
Familial Turner Syndrome0low10
Fanconi Anemia0low10
Fanconi Hypoplastic Anemia0low10
Fanconi Pancytopenia0low10
Fanconi Panmyelopathy0low10
Fanconi's Anemia0low10
Fascicular Block0low10
Fatty Liver0low20
Fatty Streak, Arterial0low90
Female Genital Diseases0low10
Female Pseudo-Turner Syndrome0low10
Fetal Edema0low10
Fetal Hydrops0low10
Fever, Zika0low10
Fibroadenoma0medium11
Fibroatheroma0low90
Fibroatheromatous Plaques0low90
Fibrocartilaginous Dysplasia of Bone0low10
Fibrocystic Dysplasia of Bone0low10
Fibroid0medium21
Fibroid Tumor0medium21
Fibroid Uterus0medium21
Fibroids, Uterine0medium21
Fibroma0low10
Fibroma, Shope0low10
Fibroma, Uterine0medium21
Fibromatosis0low10
Fibromyoma0medium21
Fibromyxoma0low10
Fibrosis0low40
Fibrosis, Liver0low50
Fibrous Dysplasia of Bone0low10
Fistula0low20
Flatulence0low10
Flatus0low10
Focal Emphysema0low20
Focal Nodular Hyperplasia0low20
Follicular Large-Cell Lymphoma0low20
Follicular Lymphoma0low20
Follicular Lymphoma, Giant0low20
Follicular Lymphoma, Grade 10low20
Follicular Lymphoma, Grade 20low20
Follicular Lymphoma, Grade 30low20
Follicular Mixed-Cell Lymphoma0low20
Forearm Injuries0low10
Foreign Bodies0low30
Foreign Objects0low30
Foreign-Body Granuloma0low10
Foreign-Body Migration0low20
Formication0low10
Fractures, Bone0low10
Functional Gastrointestinal Disorders0low20
Fungal Aneurysm0low10
Fusiform Aneurysm0low40
Gall Bladder Cancer0low10
Gall Bladder Diseases0low10
Gall Stone0low20
Gall Stones0low20
Gall Stones, Common Bile Duct0low20
Gallbladder Cancer0low10
Gallbladder Diseases0low10
Gallbladder Neoplasms0low10
Gallstone0low20
Gallstone Disease0low10
Gallstones0low20
Gallstones, Common Bile Duct0low20
Gastric Cancer0low110
Gastric Cancer, Familial Diffuse0low110
Gastric Neoplasms0low110
Gastric Outlet Obstruction0low10
Gastric Ulcer0low10
Gastric Varices0low10
Gastric Varix0low10
Gastritis, Familial Giant Hypertrophic0low10
Gastritis, Hypertrophic0low10
Gastrointestinal Cancer0low50
Gastrointestinal Diseases0low20
Gastrointestinal Disorders0low20
Gastrointestinal Disorders, Functional0low20
Gastrointestinal Hemorrhage0low70
Gastrointestinal Neoplasms0low50
Gastrointestinal Stromal Neoplasm0low50
Gastrointestinal Stromal Neoplasms0low50
Gastrointestinal Stromal Sarcoma0low50
Gastrointestinal Stromal Tumor0low50
Gastrointestinal Stromal Tumors0low50
Generalized Convulsive Epilepsy0low10
Generalized Nonconvulsive Epilepsy0low10
Generalized Nonconvulsive Seizure Disorder0low10
Generalized Onset Seizure Disorder0low10
Generalized Seizure Disorder, Convulsive0low10
Generalized Seizure Disorder, Nonconvulsive0low10
Genital Diseases, Female0low10
Germ Cell and Embryonal Neoplasms0low10
Germ Cell and Embryonic Neoplasms0low10
Germ Cell Cancer0low10
Germ Cell Neoplasms0low10
Germ Cell Tumor0low10
Germinoblastoma0low40
Giant Cell Glioblastoma0low10
Giant Cell Tumors0low10
Giant Follicular Lymphoma0low20
Giant Hypertrophic Gastritis0low10
Giant Intracranial Aneurysm0medium241
Giant Lymph Node Hyperplasia0low10
Gilbert Disease0low10
Gilbert Syndrome0low10
Gilbert-Lereboullet Syndrome0low10
Gilbert's Disease0low10
Gilbert's Syndrome0low10
Glial Cell Tumors0low20
Glioblastoma0low10
Glioblastoma Multiforme0low10
Glioma0low20
Glomangioma0low10
Glomerulosclerosis, Diabetic0medium22
Glomus Tumor0low10
Gluten Enteropathy0low10
Gluten-Sensitive Enteropathy0low10
Goiter, Exophthalmic0low10
Goldblatt Syndrome0medium41
Gossypiboma0low30
Graft Occlusion, Vascular0medium91
Graft Restenosis, Vascular0medium91
Granuloma, Foreign-Body0low10
Granuloma, Plasma Cell0low10
Granuloma, Pseudopyogenic0low10
Graves Disease0low10
Graves' Disease0low10
Grawitz Tumor0medium211
Gynecologic Diseases0low10
Haemolysis0low20
Hay Fever0low10
Hayfever0low10
HbS Disease0low10
Head and Neck Cancer0medium122
Head and Neck Neoplasm0medium122
Head and Neck Neoplasms0medium122
Head and Neck Squamous Cell Carcinoma0low10
Head And Neck Squamous Cell Carcinomas0low10
Head Cancer0medium122
Head Neoplasm0medium122
Head Neoplasms0medium122
Head, Neck Neoplasms0medium122
Headache, Migraine0low10
Heart Abnormalities0medium102
Heart Aneurysm0low10
Heart Arrest0low10
Heart Attack0medium224
Heart Cancer0low20
Heart Decompensation0medium41
Heart Defect, Congenital0medium102
Heart Defects, Congenital0medium102
Heart Disease, Ischemic0medium51
Heart Diseases0medium42
Heart Disorders0medium42
Heart Failure0medium41
Heart Failure, Congestive0medium41
Heart Failure, Left-Sided0medium41
Heart Failure, Right-Sided0medium41
Heart Injuries0low10
Heart Neoplasms0low20
Heart Rupture, Traumatic0low10
Heart Septal Defects, Atrial0low10
Heart Septal Defects, Ventricular0low20
Heart Tumor0low20
Heart Valve Diseases0low50
Heart Valvular Disease0low50
Heart, Malformation Of0medium102
Hemangioma0low50
Hemangioma, Histiocytoid0low50
Hemangioma, Intramuscular0low50
Hemangioma, Sclerosing0low10
Hemangiosarcoma0low10
Hematochezia0low70
Hematoma0low60
Hematoma, Subdural0low10
Hematuria0medium41
Hemicrania Migraine0low10
Hemiplegia0low20
Hemiplegia, Crossed0low20
Hemiplegia, Flaccid0low20
Hemiplegia, Infantile0low20
Hemiplegia, Post-Ictal0low20
Hemiplegia, Spastic0low20
Hemiplegia, Transient0low20
Hemoglobin S Disease0low10
Hemolysis0low20
Hemopericardium0low30
Hemoptysis0low20
Hemorrhage0low40
Hemorrhage, Cerebral0low30
Hemorrhage, Cerebrum0low30
Hemorrhage, Gastrointestinal0low70
Hemorrhage, Intracranial0low10
Hemorrhage, Oral0low10
Hemorrhage, Postoperative0low10
Hemorrhage, Postpartum0low10
Hemorrhage, Subarachnoid0low90
Hemorrhage, Subdural0low10
Hemorrhages, Postoperative0low10
Hemorrhagic Necrotic Pancreatitis0low40
Hemosiderosis0low10
Hepatic Cancer0medium766
Hepatic Cirrhosis0low50
Hepatic Neoplasms0medium766
Hepatic Vein Thrombosis0medium31
Hepatic Venous Outflow Obstruction0medium31
Hepatitis0low10
Hepatitis B Virus Infection, Chronic0low10
Hepatitis B, Chronic0low10
Hepatitis, Drug-Induced0low30
Hepatitis, Toxic0low30
Hepatocellular Cancer0medium766
Hepatocellular Carcinoma0medium413
Hepatoma0medium413
Hepatoma, Benign0low10
Hepatoma, Experimental0low30
Hepatoma, Morris0low30
Hepatoma, Novikoff0low30
Hepatomas, Experimental0low30
Heritable Pulmonary Arterial Hypertension0low10
Hernia, Diaphragmatic0low10
Hernia, Inguinal0low10
Heterotopic Tissue0low10
High Cholesterol Levels0low10
Hilar Cholangiocarcinoma0low10
Hip Fractures0low10
Hippel-Lindau Disease0low10
Hirschsprung Disease0low10
Hirschsprung's Disease0low10
Histiocytic Lymphoma0low10
Histiocytic Lymphoma, Diffuse0low10
Histiocytic Lymphoma, Nodular0low20
Histiocytoma, Benign Fibrous0low10
Histiocytoma, Cutaneous0low10
Histiocytoma, Fibrous0low10
HIV Coinfection0low10
HIV Infections0low10
HIV-Related Opportunistic Infections0low10
Hives0low20
HNSCC0low10
Hospital-Acquired Condition0low10
HTLV-III Infections0low10
HTLV-III-LAV Infections0low10
Huerthle Cell Tumor0low30
Human Mammary Carcinoma0medium121
Hurthle Cell Tumor0low30
Hydatid Cyst0low10
Hydatid Cyst, Hepatic0low20
Hydatid Disease0low10
Hydatidosis0low10
Hydatidosis, Hepatic0low20
Hydronephrosis0low30
Hydrops0low30
Hydrops Fetalis0low10
Hydrops Fetalis Nonimmune0low10
Hydrops Fetalis, Idiopathic0low10
Hydrops Fetalis, Immune0low10
Hydrops Fetalis, Non-Immune0low10
Hydrops Fetalis, Nonimmune0low10
Hydrothorax0low10
Hyper-beta-Lipoproteinemia0low20
Hyper-Low Density Lipoproteinemia0low20
Hyper-Low-Density-Lipoproteinemia0low20
Hyperbetalipoproteinemia0low20
Hyperbilirubinemia 10low10
Hyperbilirubinemia I0low10
Hyperbilirubinemia, Arias Type0low10
Hypercholesteremia0low10
Hypercholesterolemia0low10
Hypercholesterolemia, Autosomal Dominant0low20
Hypercholesterolemia, Autosomal Dominant, Type B0low20
Hypercholesterolemia, Essential0low20
Hypercholesterolemia, Familial0low20
Hypercholesterolemic Xanthomatosis, Familial0low20
Hypercortisolism0low10
Hyperemia0low10
Hyperlipoproteinemia Type 20low20
Hyperlipoproteinemia Type II0low20
Hyperlipoproteinemia Type IIa0low20
Hyperlipoproteinemia Type IIb0low20
Hyperlipoproteinemia, Type II0low20
Hyperlipoproteinemia, Type IIa0low20
Hypernephroma0medium211
Hyperplasia0medium31
Hyperplasia of Thymus Gland0low10
Hyperplasia, Focal Nodular0low20
Hyperplasia, Giant Lymph Node0low10
Hypersensitivity0medium51
Hypersensitivity, Atopic0low20
Hypersensitivity, Contact0low10
Hypersensitivity, Delayed0medium11
Hypersensitivity, Drug0medium222
Hypersensitivity, Immediate0low20
Hypersensitivity, Tuberculin-Type0medium11
Hypersensitivity, Type I0low20
Hypersensitivity, Type IV0medium11
Hypertension0medium42
Hypertension, Goldblatt0medium41
Hypertension, Portal0low50
Hypertension, Pulmonary0low70
Hypertension, Renovascular0medium41
Hyperthyroid0low30
Hyperthyroidism0low30
Hyperthyroidism, Autoimmune0low10
Hypertrophy, Left Ventricular0medium11
Hypopharyngeal Squamous Cell Carcinoma0low10
Hypotension0medium11
Hypotension, Vascular0medium11
Hypoxemia0low40
Hypoxia0low40
Iatrogenic Disease0low10
Idiopathic Hydrops Fetalis0low10
Idiopathic Pulmonary Arterial Hypertension0low10
Idiopathic Pulmonary Hypertension0low10
IgE-Mediated Hypersensitivity0low20
Ileal Diseases0low10
Ileitis, Regional0low50
Ileitis, Terminal0low50
Ileocolitis0low50
Iliac Aneurysm0low20
Immediate Postpartum Hemorrhage0low10
Immune Hydrops Fetalis0low10
Inclusion Disease0low10
Infantile Paralysis0low10
Infarct0low10
Infarction0low10
Infarction, Cerebral0low30
Infarction, Cerebral, Left Hemisphere0low30
Infarction, Cerebral, Right Hemisphere0low30
Infarction, Left Hemisphere, Cerebral0low30
Infarction, Posterior Cerebral Artery0low10
Infarction, Right Hemisphere, Cerebral0low30
Infected Aneurysm0low10
Infection, Postoperative Wound0low10
Infection, Surgical Wound0low10
Infections, Cytomegalovirus0low10
Infections, Respiratory0low10
Infections, Respiratory Tract0low10
Infections, Tumor Virus0low10
Infections, Upper Respiratory0low10
Infections, Upper Respiratory Tract0low10
Inflammation0low30
Inflammatory Bowel Disease 10low50
Inflammatory Bowel Diseases0low10
Inflammatory Disease, Pelvic0low10
Inflammatory Pelvic Disease0low10
Inflammatory Pseudotumor0low10
Inguinal Hernia0low10
Inguinal Hernia, Direct0low10
Inguinal Hernia, Indirect0low10
Injuries, Abdominal0low30
Injuries, Athletic0low10
Injuries, Blunt0low20
Injuries, Chest0low10
Injuries, Forearm0low10
Injuries, Heart0low10
Injuries, Multiple0low30
Injuries, Nonpenetrating0low20
Injuries, Sports0low10
Injuries, Surgical0low30
Injuries, Tendon0low10
Injuries, Thoracic0low10
Injury, Ischemia-Reperfusion0low30
Injury, Myocardial Reperfusion0medium11
Injury, Reperfusion0low30
Innate Inflammatory Response0low30
Insulin Resistance0low10
Insulin Sensitivity0low10
Internal Carotid Artery Diseases0medium42
Internal Carotid Artery Stenosis0low110
Interstitial Lung Disease0low10
Interstitial Lung Diseases0low10
Intertrochanteric Fractures0low10
Intervertebral Disc Degeneration0low10
Intervertebral Disk Degeneration0low10
Intestinal Cancer0low20
Intestinal Neoplasms0low20
Intestinal Obstruction0low40
Intestinal Perforation0low30
Intestinal Volvulus0low40
Intestines Cancer0low20
Intestines Neoplasms0low20
Intracapillary Glomerulosclerosis0medium22
Intracavitary Tumors of the Heart0low20
Intracerebral Hemorrhage0low30
Intracranial Aneurysm0medium241
Intracranial Angiospasm0low10
Intracranial Arteriovenous Malformation, Ruptured0medium51
Intracranial Arteriovenous Malformations0medium51
Intracranial Arteriovenous Malformations, Congenital0medium51
Intracranial Central Nervous System Disorders0low40
Intracranial CNS Disorders0low40
Intracranial Edema0low30
Intracranial Hemorrhages0low10
Intracranial Neoplasms0low40
Intracranial Vascular Disorders0low70
Intracranial Vascular Spasm0low10
Intracranial Vasospasm0low10
Intraductal Carcinoma, Noninfiltrating0medium11
Intrahepatic Cholangiocarcinoma0low50
Intrahepatic Choledochal Cyst0low10
Intraoperative Complications0low30
Intravascular Hemolysis0low20
Intraventricular Septal Defects0low20
Intussusception0low10
Intususception0low10
Invagination, Intestinal0low10
Invasive Ductal Carcinoma, Breast0medium11
Invasiveness, Neoplasm0low110
Irradiation-Induced Sialadenitis0low30
Ischaemic Stroke0low10
Ischemia0low50
Ischemia-Reperfusion Injury0low30
Ischemia, Cerebral0low70
Ischemia, Myocardial0medium51
Ischemic Attack, Transient0low10
Ischemic Encephalopathy0low70
Ischemic Heart Disease0medium51
Ischemic Myelopathy0low10
Ischemic Stroke0low10
Itching0low20
Jaffe-Lichtenstein Disease0low10
Jaundice, Cholestatic0low10
Jaundice, Mechanical0low10
Jaundice, Obstructive0low10
Jejunal Diseases0low10
Joint Pain0low20
Keskushermoston sairaudet@fi0low10
Kidney Calculi0low10
Kidney Cancer0medium291
Kidney Diseases0medium5620
Kidney Diseases, Cystic0low30
Kidney Failure0medium148
Kidney Failure, Acute0medium4312
Kidney Failure, Chronic0medium174
Kidney Insufficiency0medium148
Kidney Insufficiency, Acute0medium4312
Kidney Insufficiency, Chronic0medium62
Kidney Neoplasms0medium291
Kidney Stones0low10
Kidney, Cystic0low30
Kidney, Polycystic0low10
Kienbock Disease0low10
Kienbock's Disease0low10
Kienboeck Disease0low10
Kienboeck's Disease0low10
Kimmelstiel-Wilson Disease0medium22
Kimmelstiel-Wilson Syndrome0medium22
Klatskin Tumor0low10
Klatskin's Tumor0low10
Klippel Trenaunay Syndrome0low10
Klippel-Trenaunay Disease0low10
Klippel-Trenaunay Syndrome0low10
Klippel-Trenaunay-Weber Syndrome0low10
Klippel-Tru00E9naunay-Weber Syndrome0low10
Kounis Syndrome0low10
KTW Syndrome0low10
Lacerations0low10
Lacrimal Apparatus Diseases0medium21
Lacrimal Duct Obstruction0low10
Large Lymphoid Lymphoma, Diffuse0low10
Large Lymphoid Lymphoma, Nodular0low20
Large-Cell Lymphoma, Diffuse0low10
Large-Cell Lymphoma, Follicular0low20
Laryngeal Cancer0medium21
Laryngeal Neoplasms0medium21
Laryngeal Squamous Cell Carcinoma0low10
Larynx Cancer0medium21
Larynx Neoplasms0medium21
LDL Receptor Disorder0low20
Left Bundle-Branch Block0low10
Left Hemisphere, Cerebral Infarction0low30
Left Hemisphere, Infarction, Cerebral0low30
Left Main Coronary Artery Disease0medium6016
Left Main Coronary Disease0medium6016
Left Main Disease0medium6016
Left Ventricular Dysfunction0low50
Left Ventricular Hypertrophy0medium11
Left Ventricular Outflow Obstruction0low10
Left-Sided Heart Failure0medium41
Leiomyoma0medium21
Leiomyoma, Uterine0medium21
Leiomyosarcoma0low10
Leiomyosarcoma, Epithelioid0low10
Leiomyosarcoma, Myxoid0low10
Leriche Syndrome0low10
Leriche's Syndrome0low10
Leucocythaemia0low10
Leucocythemia0low10
Leukemia0low10
Leukemia, Acute Lymphoblastic0low10
Leukemia, Acute Myelogenous0low20
Leukemia, Acute Myeloid0low20
Leukemia, Lymphoblastic0low10
Leukemia, Lymphoblastic, Acute0low10
Leukemia, Lymphoblastic, Acute, L10low10
Leukemia, Lymphoblastic, Acute, L20low10
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive0low10
Leukemia, Lymphocytic, Acute0low10
Leukemia, Lymphocytic, Acute, L10low10
Leukemia, Lymphocytic, Acute, L20low10
Leukemia, Lymphoid, Acute0low10
Leukemia, Myeloblastic, Acute0low20
Leukemia, Myelocytic, Acute0low20
Leukemia, Myelogenous, Acute0low20
Leukemia, Myeloid, Acute0low20
Leukemia, Myeloid, Acute, M10low20
Leukemia, Myeloid, Acute, M20low20
Leukemia, Nonlymphoblastic, Acute0low20
Leukemia, Nonlymphocytic, Acute0low20
Leukemic Infiltration0low10
Leukoaraiosis0low20
Leukocytosis0low10
Lichtheim's Sign0low10
Lindau Disease0low10
Lindau's Disease0low10
Liposclerotic Mesenteritis0low10
Liver Abscess0low20
Liver Abscess, Pyogenic0low10
Liver Cancer0medium766
Liver Cancer, Adult0medium413
Liver Cell Carcinoma0medium413
Liver Cell Carcinoma, Adult0medium413
Liver Cirrhosis0low50
Liver Diseases0medium153
Liver Dysfunction0medium153
Liver Fibrosis0low50
Liver Injury, Drug-Induced0low30
Liver Injury, Drug-Induced, Acute0low30
Liver Neoplasms0medium766
Liver Neoplasms, Experimental0low30
Liver Steatosis0low20
Lobar Pneumonia0low20
Local Neoplasm Recurrence0medium161
Local Neoplasm Recurrences0medium161
Locoregional Neoplasm Recurrence0medium161
Loeffler Syndrome0low10
Logagnosia0low10
Logamnesia0low10
Logasthenia0low10
Low Back Ache0low10
Low Back Pain0low10
Low Back Pain, Mechanical0low10
Low Back Pain, Posterior Compartment0low10
Low Back Pain, Postural0low10
Low Back Pain, Recurrent0low10
Low Backache0low10
Low Blood Pressure0medium11
Lower Back Pain0low10
Lumbago0low10
Lung Aspergillosis0low20
Lung Cancer0medium273
Lung Collapse0low10
Lung Diseases0low50
Lung Diseases, Interstitial0low10
Lung Inflammation0low20
Lung Malformation, Congenital Cystic Adenomatoid0low10
Lung Malformation, Cystic Adenomatoid, Congenital0low10
Lung Neoplasms0medium273
Lung Sounds0low10
Lymph Node Hyperplasia, Giant0low10
Lymph Node Metastasis0medium212
Lymphatic Diseases0low10
Lymphatic Metastasis0medium212
Lymphatic Sarcoma0low20
Lymphatism0low10
Lymphoblastic Leukemia0low10
Lymphoblastic Leukemia, Acute0low10
Lymphoblastic Leukemia, Acute, Adult0low10
Lymphoblastic Leukemia, Acute, Childhood0low10
Lymphoblastic Leukemia, Acute, L10low10
Lymphoblastic Leukemia, Acute, L20low10
Lymphoblastic Lymphoma0low10
Lymphocytic Leukemia, Acute0low10
Lymphocytic Leukemia, L10low10
Lymphocytic Leukemia, L20low10
Lymphocytic Lymphoma, Diffuse, Poorly Differentiated0low10
Lymphocytic Lymphoma, Diffuse, Poorly-Differentiated0low10
Lymphocytic Lymphoma, Nodular, Poorly Differentiated0low20
Lymphocytic Lymphoma, Nodular, Poorly-Differentiated0low20
Lymphoma0low40
Lymphoma, Atypical Diffuse Small Lymphoid0low20
Lymphoma, Centrocytic Small-Cell0low10
Lymphoma, Diffuse0low20
Lymphoma, Diffuse Large-Cell0low10
Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic0low20
Lymphoma, Extranodal NK-T-Cell0low10
Lymphoma, Follicular0low20
Lymphoma, Follicular Large-Cell0low20
Lymphoma, Follicular, Grade 10low20
Lymphoma, Follicular, Grade 20low20
Lymphoma, Follicular, Grade 30low20
Lymphoma, Follicular, Mixed Cell0low20
Lymphoma, Follicular, Mixed Lymphocytic-Histiocytic0low20
Lymphoma, Follicular, Mixed Small and Large Lymphoid0low20
Lymphoma, Follicular, Small and Large Cleaved Cell0low20
Lymphoma, Follicular, Small and Large Cleaved-Cell0low20
Lymphoma, Giant Follicular0low20
Lymphoma, High-Grade0low20
Lymphoma, Histiocytic0low10
Lymphoma, Histiocytic, Diffuse0low10
Lymphoma, Histiocytic, Nodular0low20
Lymphoma, Intermediate-Grade0low20
Lymphoma, Large B-Cell, Diffuse0low10
Lymphoma, Large Cell, Diffuse0low10
Lymphoma, Large Cell, Follicular0low20
Lymphoma, Large Lymphoid, Diffuse0low10
Lymphoma, Large Lymphoid, Nodular0low20
Lymphoma, Large-Cell, Diffuse0low10
Lymphoma, Large-Cell, Follicular0low20
Lymphoma, Low-Grade0low20
Lymphoma, Lymphoblastic0low10
Lymphoma, Lymphocytic, Diffuse, Intermediate Differentiated0low10
Lymphoma, Lymphocytic, Diffuse, Poorly-Differentiated0low10
Lymphoma, Lymphocytic, Intermediate0low10
Lymphoma, Lymphocytic, Nodular, Poorly Differentiated0low20
Lymphoma, Lymphocytic, Nodular, Poorly-Differentiated0low20
Lymphoma, Malignant0low40
Lymphoma, Mantle-Cell0low10
Lymphoma, Mixed0low20
Lymphoma, Mixed Cell, Diffuse0low20
Lymphoma, Mixed Lymphocytic-Histiocytic0low20
Lymphoma, Mixed Small and Large Cell, Diffuse0low20
Lymphoma, Mixed-Cell0low20
Lymphoma, Mixed-Cell, Diffuse0low20
Lymphoma, Mixed-Cell, Follicular0low20
Lymphoma, Nodular0low20
Lymphoma, Nodular, Large Follicular Center Cell0low20
Lymphoma, Nodular, Large Follicular Center-Cell0low20
Lymphoma, Nodular, Mixed Lymphocytic Histiocytic0low20
Lymphoma, Nodular, Mixed Lymphocytic-Histiocytic0low20
Lymphoma, Nodular, Mixed Small and Large Cell0low20
Lymphoma, Non-Hodgkin0low20
Lymphoma, Non-Hodgkin, Familial0low20
Lymphoma, Non-Hodgkin's0low20
Lymphoma, Non-Hodgkins0low20
Lymphoma, Nonhodgkin's0low20
Lymphoma, Nonhodgkins0low20
Lymphoma, Pleomorphic0low20
Lymphoma, Small and Large Cleaved-Cell, Diffuse0low20
Lymphoma, Small Cleaved Cell, Diffuse0low20
Lymphoma, Small Cleaved Cell, Follicular0low20
Lymphoma, Small Cleaved-Cell, Diffuse0low20
Lymphoma, Small Cleaved-Cell, Follicular0low20
Lymphoma, Small Follicular Center-Cell0low20
Lymphoma, Small Lymphoid, Follicular0low20
Lymphoma, Small Non-Cleaved-Cell0low20
Lymphoma, Small Noncleaved-Cell0low20
Lymphoma, Small-Cell, Centrocytic0low10
Lymphoma, T-Cell0low10
Lymphoma, Undifferentiated0low20
Lymphoma, Undifferentiated, Diffuse0low20
Lymphosarcoma0low20
Maculopapular Drug Eruption0low50
Maculopapular Exanthem0low50
Maladie du systu00E8me nerveux central@fr0low10
Malattie del sistema nervoso centrale@it0low10
Male Turner Syndrome0low10
Malignancy0medium124
Malignant Epithelial Neoplasms0low50
Malignant Glioma0low20
Malignant Melanoma0low20
Malignant Neoplasm of Breast0medium121
Malignant Neoplasms0medium124
Malignant Neoplasms, Brain0low40
Malignant Primary Brain Neoplasms0low40
Malignant Primary Brain Tumors0low40
Malignant Tumor of Breast0medium121
Malignant Tumor of Urinary Bladder0low30
Mammary Cancer0medium121
Mammary Carcinoma, Human0medium121
Mammary Ductal Carcinoma0medium11
Mammary Neoplasm, Human0medium121
Mammary Neoplasms, Experimental0low30
Mammary Neoplasms, Human0medium121
Mandibular Diseases0low10
Mandibular Neoplasms0low10
Mantle-Cell Lymphoma0low10
Mantle-Zone Lymphoma0low10
Margins of Excision0low10
Maturity-Onset Diabetes0low20
Maturity-Onset Diabetes Mellitus0low20
Maxillary Diseases0low10
Maxillary Neoplasms0low10
Mechanical Low Back Pain0low10
Meckel Diverticulum0low20
Meckel's Diverticulum0low20
Mediastinal Cancer0medium21
Mediastinal Neoplasms0medium21
Mediastinitis0low10
Mediastinum Cancer0medium21
Mediastinum Inflammation0low10
Mediastinum Neoplasms0medium21
Medulloepithelioma0low10
Megacolon, Aganglionic0low10
Megacolon, Congenital0low10
Megaesophagus0low10
Melanoma0low20
Menetrier Disease0low10
Menetrier's Disease0low10
Meningitis0low10
Mesenteric Lipodystrophy0low10
Mesenteric Panniculitis0low10
Mesenteric Vascular Occlusion0low10
Mesenteric Weber-Christian Disease0low10
Mesothelioma0low10
Metabolic Acidosis0low10
Metachronous Neoplasms0low10
Metachronous Second Primary Neoplasms0low10
Metastase0low60
Metastases, Neoplasm0low60
Metastasis0low60
Metastasis, Neoplasm0low60
Meulengracht Syndrome0low10
Microangiopathy, Diabetic0low10
Microcalcification0medium241
Microcalcinosis0medium241
Middle Cerebral Artery Aneurysm0medium241
Migraine0low10
Migraine Disorders0low10
Migraine Headache0low10
Migraine Variant0low10
Minimal Disease, Residual0low20
Minimal Residual Disease0low20
Mitral Incompetence0low10
Mitral Insufficiency0low10
Mitral Regurgitation0low10
Mitral Valve Incompetence0low10
Mitral Valve Insufficiency0low10
Mitral Valve Regurgitation0low10
Mixed Glioma0low20
Mixed Salivary Gland Tumor0low20
Mixed Small and Large Cell Lymphoma, Diffuse0low20
Mixed-Cell Lymphoma0low20
Mixed-Cell Lymphoma, Diffuse0low20
Mixed-Cell Lymphoma, Follicular0low20
MODY0low20
Monoplegia0low20
Morbid Obesity0low20
Morbilliform Drug Reaction0low50
Morbilliform Exanthem0low50
Mouth Cancer0low10
Mouth Neoplasms0low10
Moya-Moya Disease0low10
Moyamoya Disease0low10
Moyamoya Disease, Classic0low10
Moyamoya Disease, Primary0low10
Moyamoya Disease, Secondary0low10
Moyamoya Syndrome0low10
MS (Multiple Sclerosis)0low10
Mucocele0low10
Multiple Abnormalities0low10
Multiple Choledochal Cysts0low10
Multiple Injuries0low30
Multiple Sclerosis0low10
Multiple Sclerosis, Acute Fulminating0low10
Multiple Trauma0low30
Muscle Contraction0low10
Muscle Tissue Neoplasms0low10
Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis0low30
Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis0low30
MuSK MG0low30
MuSK Myasthenia Gravis0low30
Myasthenia Gravis0low30
Myasthenia Gravis, Generalized0low30
Myasthenia Gravis, Ocular0low30
Mycotic Aneurysm0low10
Mycotic Aneurysm, Intracranial0medium241
Myeloblastic Leukemia, Acute0low20
Myelocytic Leukemia, Acute0low20
Myelogenous Leukemia, Acute0low20
Myeloid Cell Tumor, Extramedullary0low10
Myeloid Leukemia, Acute0low20
Myeloid Leukemia, Acute, M10low20
Myeloid Leukemia, Acute, M20low20
Myeloid Sarcoma0low10
Myelopathy0medium11
Myeloproliferative Disorders0low10
Myoblastoma0low10
Myocardial Bridging0low20
Myocardial Diseases0low20
Myocardial Diseases, Primary0low20
Myocardial Diseases, Secondary0low20
Myocardial Failure0medium41
Myocardial Infarct0medium224
Myocardial Infarction0medium224
Myocardial Ischemia0medium51
Myocardial Ischemic Reperfusion Injury0medium11
Myocardial Preinfarction Syndrome0low30
Myocardial Reperfusion Injury0medium11
Myocardial Tumors (Rhabdomyomas and Fibromas)0low20
Myocardiopathies0low20
Myoepithelial Tumor0low10
Myoepithelioma0low10
Myofibroblastoma0low10
Myotonia Atrophica0low10
Myotonia Dystrophica0low10
Myotonic Dystrophy0low10
Myotonic Dystrophy 10low10
Myotonic Dystrophy 20low10
Myotonic Dystrophy, Congenital0low10
Myotonic Myopathy, Proximal0low10
Myxofibroma0low10
Nasal Airway Obstruction0low10
Nasal Blockage0low10
Nasal Cancer0low10
Nasal Neoplasms0low10
Nasal Obstruction0low10
Nasolacrimal Duct Obstruction0low10
Nasopharyngeal Cancer0medium41
Nasopharyngeal Carcinoma0low10
Nasopharyngeal Neoplasms0medium41
Nasopharynx Cancer0medium41
Nasopharynx Neoplasms0medium41
Nausea0low20
Neck Cancer0medium122
Neck Neoplasm0medium122
Neck Neoplasms0medium122
Necrosis0low70
Necrosis, Aseptic, of Bone0low10
Necrosis, Avascular, of Bone0low10
Necrotizing Pancreatitis, Acute0low40
Necrotizing Pyelonephritis0low60
Negative Surgical Margins0low10
nemoci centru00E1lnu00EDho nervovu00E9ho systu00E9mu@cs0low10
Neointima0low30
Neointima Formation0low30
Neoplasia0medium124
Neoplasm0medium124
Neoplasm Invasion0low110
Neoplasm Invasiveness0low110
Neoplasm Metastases0low60
Neoplasm Metastasis0low60
Neoplasm Recurrence, Local0medium161
Neoplasm Recurrence, Locoregional0medium161
Neoplasm Recurrences, Local0medium161
Neoplasm Seeding0low10
Neoplasm, Residual0low20
Neoplasms0medium124
Neoplasms of Pelvis0low20
Neoplasms, Adrenal Cortex0low10
Neoplasms, Adrenal Gland0low140
Neoplasms, Benign0medium124
Neoplasms, Bile Duct0low60
Neoplasms, Biliary Tract0low10
Neoplasms, Bladder0low30
Neoplasms, Bone0low20
Neoplasms, Bone Marrow0low10
Neoplasms, Brain0low40
Neoplasms, Brain, Benign0low40
Neoplasms, Brain, Malignant0low40
Neoplasms, Brain, Primary0low40
Neoplasms, Breast0medium121
Neoplasms, Cardiac0low20
Neoplasms, Colonic0low30
Neoplasms, Colorectal0medium141
Neoplasms, Dental Tissue0low10
Neoplasms, Embryonal0low10
Neoplasms, Embryonal and Mixed0low10
Neoplasms, Esophageal0low40
Neoplasms, Experimental Liver0low30
Neoplasms, Experimental Mammary0low30
Neoplasms, Gallbladder0low10
Neoplasms, Gastric0low110
Neoplasms, Gastrointestinal0low50
Neoplasms, Germ Cell0low10
Neoplasms, Germ Cell and Embryonal0low10
Neoplasms, Germ Cell and Embryonic0low10
Neoplasms, Head0medium122
Neoplasms, Head and Neck0medium122
Neoplasms, Heart0low20
Neoplasms, Hepatic0medium766
Neoplasms, Intestinal0low20
Neoplasms, Intracranial0low40
Neoplasms, Kidney0medium291
Neoplasms, Laryngeal0medium21
Neoplasms, Liver0medium766
Neoplasms, Lung0medium273
Neoplasms, Malignant Epithelial0low50
Neoplasms, Mediastinal0medium21
Neoplasms, Metachronous0low10
Neoplasms, Metachronous Second Primary0low10
Neoplasms, Mouth0low10
Neoplasms, Muscle Tissue0low10
Neoplasms, Nasopharyngeal0medium41
Neoplasms, Neck0medium122
Neoplasms, Nose0low10
Neoplasms, Oral0low10
Neoplasms, Ovarian0low20
Neoplasms, Pancreatic0medium252
Neoplasms, Paranasal Sinus0low10
Neoplasms, Parathyroid0low10
Neoplasms, Parotid0low20
Neoplasms, Pharyngeal0low10
Neoplasms, Pharynx0low10
Neoplasms, Pleural0low20
Neoplasms, Primitive Neuroepithelial0low10
Neoplasms, Prostate0low40
Neoplasms, Prostatic0low40
Neoplasms, Pulmonary0medium273
Neoplasms, Radiation-Induced0low10
Neoplasms, Rectal0low60
Neoplasms, Salivary Gland0low10
Neoplasms, Second Primary0low10
Neoplasms, Skull0low10
Neoplasms, Stomach0low110
Neoplasms, Therapy-Associated0low10
Neoplasms, Therapy-Related0low10
Neoplasms, Thymic0low40
Neoplasms, Thymus0low40
Neoplasms, Thyroid0medium21
Neoplasms, Tongue0low10
Neoplasms, Tonsil0low10
Neoplasms, Tonsillar0low10
Neoplasms, Treatment-Associated0low10
Neoplasms, Treatment-Related0low10
Neoplasms, Upper Aerodigestive Tract0medium122
Neoplasms, Urologic0low10
Neoplasms, Uterine0medium11
Neoplasms, Uterus0medium11
Neovascularization, Pathologic0low110
Neovascularization, Pathological0low110
Nephrogenic Fibrosing Dermopathy0low20
Nephrogenic Systemic Fibrosis0low20
Nephroid Carcinoma0medium211
Nephrolith0low10
Nephrotic Syndrome0low10
Nervous System Poisoning0low30
Neurilemmoma0low10
Neurilemoma0low10
Neurinoma0low10
Neuroectodermal Neoplasm, Peripheral Primitive0low20
Neuroectodermal Tumor, Peripheral0low20
Neuroectodermal Tumor, Peripheral Primitive0low20
Neuroectodermal Tumor, Primitive0low10
Neuroectodermal Tumors, Primitive0low10
Neuroectodermal Tumors, Primitive, Peripheral0low20
Neuroendocrine Tumors0low70
Neuroepithelial Neoplasms, Primitive0low10
Neuroepithelial Tumors, Primitive0low10
Neuroepithelioma, Peripheral0low20
Neurogenic Bladder0low10
Neurogenic Bladder Disorder0low10
Neurogenic Bladder, Atonic0low10
Neurogenic Bladder, Spastic0low10
Neurogenic Bladder, Uninhibited0low10
Neurogenic Dysfunction of the Urinary Bladder0low10
Neurogenic Urinary Bladder Disorder0low10
Neurogenic Urinary Bladder, Atonic0low10
Neurogenic Urinary Bladder, Spastic0low10
Neurogenic Urinary Bladder, Uninhibited0low10
Neuropathic Bladder0low10
Neurotoxic Disorders0low30
Neurotoxicity Syndromes0low30
Neurotoxin Diseases0low30
Neurotoxin Disorders0low30
NIDDM0low20
Nodular Glomerulosclerosis0medium22
Nodular Large Follicular Center-Cell Lymphoma0low20
Nodule, Solitary Pulmonary0low50
Nodules, Solitary Pulmonary0low50
Non-Hodgkin Lymphoma0low20
Non-Hodgkin's Lymphoma0low20
Non-Immune Hydrops Fetalis0low10
Non-Small Cell Lung Cancer0medium73
Non-Small Cell Lung Carcinoma0medium73
Non-Small-Cell Lung Carcinoma0medium73
Nonconvulsive Generalized Seizure Disorder0low10
Nonconvulsive Seizure Disorder, Generalized0low10
Noninsulin-Dependent Diabetes Mellitus0low20
Nonlymphoblastic Leukemia, Acute0low20
Nonlymphocytic Leukemia, Acute0low20
Nonpenetrating Injuries0low20
Nonsmall Cell Lung Cancer0medium73
Noonan Syndrome0low10
Noonan Syndrome 10low10
Noonan-Ehmke Syndrome0low10
Nose Cancer0low10
Nose Neoplasms0low10
Obesity0medium21
Obesity, Morbid0low20
Obesity, Severe0low20
Odontogenic Tumors0low10
Oesophageal Squamous Cell Carcinoma0low10
Omental Panniculitis0low10
Oncocytoma0low30
Opportunistic Infections0low10
Opportunistic Infections, AIDS-Related0low10
Opportunistic Infections, HIV-Related0low10
Oral Cancer0low10
Oral Cavity Squamous Cell Carcinoma0low10
Oral Hemorrhage0low10
Oral Neoplasms0low10
Oral Squamous Cell Carcinoma0low10
Oral Squamous Cell Carcinomas0low10
Oral Tongue Squamous Cell Carcinoma0low10
Orbital Neoplasms0low10
Orchitis0low10
Oropharyngeal Dysphagia0medium21
Oropharyngeal Squamous Cell Carcinoma0low10
Orphan Diseases0low20
Osteitis0low10
Osteitis Fibrosa Disseminata0low10
Osteoarthritis Of Hip0low10
Osteoarthritis of the Hip0low10
Osteoarthritis, Hip0low10
Osteogenic Sarcoma0low10
Osteomyelitis0low10
Osteonecrosis0low10
Osteosarcoma0low10
Osteosarcoma Tumor0low10
Ostium Secundum Atrial Septal Defect0low10
Outflow Obstruction, Left Ventricular0low10
Outflow Obstruction, Right Ventricular0low10
Ovarian Cancer0low20
Ovarian Neoplasms0low20
Ovary Cancer0low20
Ovary Neoplasms0low20
Overactive Bladder0low10
Overactive Detrusor0low10
Overactive Detrusor Function0low10
Overactive Urinary Bladder0low10
Oxygen Deficiency0low40
Pachymeningitis0low10
Pain0medium21
Pain, Burning0medium21
Pain, Crushing0medium21
Pain, Migratory0medium21
Pain, Post-operative0low10
Pain, Postoperative0low10
Pain, Radiating0medium21
Pain, Splitting0medium21
Panacinar Emphysema0low20
Pancreas Cancer0medium252
Pancreas Neoplasms0medium252
Pancreatic Cancer0medium252
Pancreatic Cyst0low10
Pancreatic Diseases0medium61
Pancreatic Duct Cell Carcinoma0low40
Pancreatic Ductal Carcinoma0low40
Pancreatic Necrosis0low40
Pancreatic Neoplasms0medium252
Pancreatic Parenchyma with Edema0medium91
Pancreatic Parenchymal Edema0medium91
Pancreatitis0medium91
Pancreatitis Necrotising0low40
Pancreatitis Necrotizing0low40
Pancreatitis, Acute0medium91
Pancreatitis, Acute Edematous0medium91
Pancreatitis, Acute Necrotizing0low40
Panlobular Emphysema0low20
Panniculitis, Peritoneal0low10
Papillary Renal Cell Carcinoma0medium211
Papilloma, Shope0low10
Parageusia0low10
Paragonimiasis0low10
Paragonimus Infection0low10
Paragonimus westermani Infection0low10
Paralysis, Legs0low10
Paralysis, Lower Extremities0low10
Paralysis, Lower Limbs0low10
Paranasal Sinus Cancer0low10
Paranasal Sinus Neoplasms0low10
Paraplegia0low10
Paraplegia, Ataxic0low10
Paraplegia, Cerebral0low10
Paraplegia, Flaccid0low10
Paraplegia, Spastic0low10
Paraplegia, Spinal0low10
Parathyroid Adenoma0low10
Parathyroid Cancer0low10
Parathyroid Carcinoma0low10
Parathyroid Neoplasms0low10
Paresthesia0low10
Paresthesia, Distal0low10
Paresthesia, Painful0low10
Parotid Cancer0low20
Parotid Neoplasms0low20
Paroxysmal Atrial Fibrillation0low70
Passive Hyperemia0low10
Pathologic Angiogenesis0low110
Pathologic Calcification0medium241
Pathologic Constriction0low90
Pathologic Dilatation0low30
Pathologic Dilatations0low30
Pathologic Neovascularization0low110
PCA Infarct0low10
PCA Infarction0low10
Pediatric Respiratory Distress Syndrome0low10
Pelvic Cancer0low20
Pelvic Disease, Inflammatory0low10
Pelvic Inflammatory Disease0low10
Pelvic Neoplasms0low20
Pelvic Pain0low10
Pelvis Cancer0low20
Pelvis Neoplasms0low20
Perforated Appendicitis0low50
Pericardial Effusion0low30
Perigraft Leak0low10
Perihilar Cholangiocarcinoma0low10
Perinatal Subarachnoid Hemorrhage0low90
Peripancreatic Fat Necrosis0medium91
Peripheral Angiopathies0low40
Peripheral Arterial Disease0medium21
Peripheral Arterial Diseases0medium21
Peripheral Artery Disease0medium21
Peripheral Primitive Neuroectodermal Neoplasm0low20
Peripheral Primitive Neuroectodermal Tumor0low20
Peripheral Primitive Neuroectodermal Tumors0low20
Peripheral Vascular Diseases0low40
Periphlebitis0low10
Peroperative Complications0low30
Persistent Atrial Fibrillation0low70
Persistent Cerebral Embryonic Artery0low30
Persistent Ostium Primum0low10
Persistent Postsurgical Pain0low10
Phacomatosis, Bourneville0low10
Phakomatosis, Bourneville0low10
Pharnyx Cancer0low10
Pharyngeal Cancer0low10
Pharyngeal Neoplasms0low10
Pharynx Neoplasms0low10
Pheochromocytoma0low50
Pheochromocytoma, Extra-Adrenal0low50
Phlebitis0low10
Phlebothrombosis0low50
Phlegmasia Alba Dolens0medium32
Plaque, Atherosclerotic0low90
Plaque, Ulcerating, Carotid Artery0low110
Plasma Cell Granuloma0low10
Pleocytosis0low10
Pleural Diseases0low10
Pleural Effusion0low20
Pleural Neoplasms0low20
Pleural Rub0low10
PNET0low10
Pneumonia0low20
Pneumonia, Eosinophilic0low10
Pneumonia, Interstitial0low10
Pneumonia, Lobar0low20
Pneumonitis0low20
Pneumonitis, Interstitial0low10
Pneumoperitoneum0low10
Pneumothorax0low10
Pneumothorax, Primary Spontaneous0low10
Poisoning, Blood0low10
Poisoning, Nervous System0low30
Polio0low10
Polio Encephalitis0low10
Poliomyelitis0low10
Poliomyelitis Infection0low10
Poliomyelitis, Acute0low10
Poliomyelitis, Nonpoliovirus0low10
Poliomyelitis, Preparalytic0low10
Pollen Allergy0low10
Pollinosis0low10
Polyarthralgia0low20
Polycystic Kidney0low10
Polycystic Kidney Disease0low10
Polycystic Kidney Diseases0low10
Polycystic Kidneys0low10
Polycystic Renal Disease0low10
Polyomavirus Infections0low10
Polyps0low10
Polytrauma0low30
Pontine Capillary Telangiectasias0low30
Positive Surgical Margins0low10
Post-operative Pain0low10
Post-operative Pain, Acute0low10
Post-operative Pain, Chronic0low10
Post-surgical Pain0low10
Posterior Cerebral Artery Aneurysm0medium241
Posterior Cerebral Artery Embolic Infarction0low10
Posterior Cerebral Artery Infarction0low10
Posterior Cerebral Artery Stroke0low10
Posterior Cerebral Artery Syndrome0low10
Posterior Cerebral Artery Thrombotic Infarction0low10
Posterior Choroidal Artery Infarction0low30
Posterior Circulation Transient Ischemic Attack0low10
Posterior Communicating Artery Aneurysm0medium241
Posterior Fascicular Block0low10
Posterior Fossa Hemorrhage0low10
Postoperative Complications0low200
Postoperative Hemorrhage0low10
Postoperative Hemorrhages0low10
Postoperative Pain0low10
Postoperative Pain, Acute0low10
Postoperative Pain, Chronic0low10
Postoperative Pulmonary Atelectasis0low10
Postoperative Wound Infection0low10
Postpartum Hemorrhage0low10
Postsurgical Pain0low10
Postural Low Back Pain0low10
Pph1 With Hht0low10
Precordial Catch0low80
Precordial Catch Syndrome0low80
Precursor Cell Lymphoblastic Leukemia-Lymphoma0low10
Pregnancy0low20
Premature Beats0low10
Premature Cardiac Complex0low10
Premature Cardiac Complexes0low10
Pressure Pneumothorax0low10
Primary Adrenal Insufficiency0low20
Primary Adrenocortical Insufficiency0low20
Primary Brain Neoplasms0low40
Primary Cardiac Tumors, Childhood0low20
Primary Hyperthyroidism0low30
Primary Hypoadrenalism0low20
Primary Malignant Brain Neoplasms0low40
Primary Malignant Brain Tumors0low40
Primary Myocardial Diseases0low20
Primary Pulmonary Hypertension0low10
Primary Spontaneous Pneumothorax0low10
Primitive Neuroectodermal Tumor, Extracranial0low20
Primitive Neuroepithelial Neoplasms0low10
Progressive Intracranial Occlusive Arteropathy (Moyamoya)0low10
PROMM (Proximal Myotonic Myopathy)0low10
Prostate Cancer0low40
Prostate Neoplasms0low40
Prostatic Cancer0low40
Prostatic Neoplasms0low40
Proteinuria0medium11
Proximal Myotonic Myopathy0low10
Pruritis0low20
Pruritus0low20
Pseudo-Ullrich-Turner Syndrome0low10
Pseudoaneurysm0low60
Pseudopyogenic Granuloma0low10
Pseudotumor, Inflammatory0low10
Psychic Denial of Blindness0low20
Pulmonary Aspergillosis0low20
Pulmonary Atelectasis0low10
Pulmonary Atresia0low20
Pulmonary Atresias0low20
Pulmonary Cancer0medium273
Pulmonary Coin Lesion0low50
Pulmonary Coin Lesions0low50
Pulmonary Consumption0low20
Pulmonary Disease0low50
Pulmonary Diseases0low50
Pulmonary Edema0low10
Pulmonary Edemas0low10
Pulmonary Embolism0medium405
Pulmonary Embolisms0medium405
Pulmonary Emphysema0low20
Pulmonary Emphysemas0low20
Pulmonary Eosinophilia0low10
Pulmonary Eosinophilias0low10
Pulmonary Hypertension0low70
Pulmonary Hypertension, Primary, 10low10
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia0low10
Pulmonary Hypertension, Primary, Dexfenfluramine-Associated0low10
Pulmonary Hypertension, Primary, Fenfluramine-Associated0low10
Pulmonary Inflammation0low20
Pulmonary Neoplasms0medium273
Pulmonary Nodule, Solitary0low50
Pulmonary Nodules, Solitary0low50
Pulmonary Phthisis0low20
Pulmonary Sequestration0low20
Pulmonary Sequestrations0low20
Pulmonary Stenoses0low10
Pulmonary Stenosis0low10
Pulmonary Thromboembolism0medium405
Pulmonary Thromboembolisms0medium405
Pulmonary Tuberculoses0low20
Pulmonary Tuberculosis0low20
Pulmonary Valve Atresia0low20
Pulmonary Valve Atresias0low20
Pulmonary Valve Stenoses0low10
Pulmonary Valve Stenosis0low10
Pulmonary Venous Return Anomaly0low10
Pulmonic Stenosis0low10
Pustulosis, Exanthematous, Acute Generalized0low20
Pustulosis, Exanthematous, Acute Localized0low20
Pyaemia0low10
Pyelonephritis0low60
Pyelonephritis, Acute Necrotizing0low60
Pyemia0low10
Pyogenic Hepatic Abscess0low10
Pyogenic Liver Abscess0low10
Pyohemia0low10
Pyothorax0low10
Quincke's Edema0low10
Radiation-Induced Cancer0low10
Radiation-Induced Neoplasms0low10
Rales0low10
Rare Diseases0low20
Rash0low20
Raynaud Disease0low10
Raynaud Phenomenon0low10
Raynaud's Disease0low10
Reactive Hyperemia0low10
Recrudescence0medium121
Rectal Cancer0low60
Rectal Diseases0low10
Rectal Disorders0low10
Rectal Neoplasms0low60
Rectal Tumors0low60
Rectosigmoid Aganglionosis0low10
Rectum Cancer0low60
Rectum Neoplasms0low60
Recurrence0medium121
Recurrence, Local Neoplasm0medium161
Recurrence, Locoregional Neoplasm0medium161
Recurrences, Local Neoplasm0medium161
Recurrent Low Back Pain0low10
Regional Enteritis0low50
Relapse0medium121
Remission, Spontaneous0low10
Renal Artery Obstruction0medium102
Renal Artery Stenosis0medium102
Renal Calculi0low10
Renal Calculus0low10
Renal Cancer0medium291
Renal Carcinoma0medium211
Renal Cell Cancer0medium211
Renal Cell Carcinoma0medium211
Renal Cell Carcinoma, Papillary0medium211
Renal Collecting Duct Carcinoma0medium211
Renal Disease, End-Stage0medium174
Renal Failure0medium148
Renal Failure, Acute0medium4312
Renal Failure, Chronic0medium174
Renal Failure, End-Stage0medium174
Renal Insufficiency0medium148
Renal Insufficiency, Acute0medium4312
Renal Insufficiency, Chronic0medium62
Renal Neoplasms0medium291
Reperfusion Damage0low30
Reperfusion Injury0low30
Reperfusion Injury, Myocardial0medium11
Resection Margin0low10
Residual Cancer0low20
Residual Disease, Minimal0low20
Residual Neoplasm0low20
Residual Tumor0low20
Residual Tumour0low20
Resorption Atelectasis0low10
Resorption Pulmonary Atelectasis0low10
Respiratory Aspiration0low10
Respiratory Distress Syndrome0low10
Respiratory Distress Syndrome, Acute0low10
Respiratory Distress Syndrome, Adult0low10
Respiratory Distress Syndrome, Pediatric0low10
Respiratory Infections0low10
Respiratory Sounds0low10
Respiratory Tract Diseases0low10
Respiratory Tract Infections0low10
Response Evaluation Criteria in Solid Tumors0low20
Retained Surgical Instruments0low30
Retained Surgical Items0low30
Retained Surgical Needle0low30
Retained Surgical Sponge0low30
Retained Surgical Tools0low30
Reticulolymphosarcoma0low40
Reticulosarcoma0low20
Reticulum Cell Sarcoma0low20
Reticulum-Cell Sarcoma0low20
Retractile Mesenteritis0low10
Reversible Cortical Blindness0low20
Rhabdomyosarcoma0low10
Rheumatoid Arthritis0low10
Rhinitis, Allergic, Seasonal0low10
Rhonchi0low10
Ricker Syndrome0low10
Right Bundle-Branch Block0low10
Right Hemisphere, Cerebral Infarction0low30
Right Hemisphere, Infarction, Cerebral0low30
Right Ventricular Dysfunction0low70
Right Ventricular Outflow Obstruction0low10
Right-Sided Heart Failure0medium41
Root Resorption0low10
Rupture0low10
Rupture, Spontaneous0low10
Ruptured Aneurysm0low20
Ruptured Aortic Aneurysm0low20
Ruptured Appendicitis0low50
Ruptured Intracranial Arteriovenous Malformation0medium51
Saccular Aneurysm0low40
SAH (Subarachnoid Hemorrhage)0low90
Salivary Gland Calculi0low10
Salivary Gland Cancer0low10
Salivary Gland Diseases0low10
Salivary Gland Inflammation0low30
Salivary Gland Neoplasms0low10
Salivary Gland Stones0low10
Salivary Gland Tumor, Mixed0low20
Salivary Gland Virus Disease0low10
Sarcoma0low10
Sarcoma, Epithelioid0low10
Sarcoma, Ewing0low10
Sarcoma, Ewing's0low10
Sarcoma, Germinoblastic0low40
Sarcoma, Granulocytic0low10
Sarcoma, Lymphatic0low20
Sarcoma, Myeloid0low10
Sarcoma, Osteogenic0low10
Sarcoma, Reticulum-Cell0low20
Sarcoma, Soft Tissue0low10
Sarcoma, Spindle Cell0low10
Sarcoma, Synovial0low20
Sarcomatoid Renal Cell Carcinoma0medium211
Sarcopenia0low10
Scar0low20
Scarring0low20
Scars0low20
Schwannoma0low10
Schwannomatosis, Plexiform0low10
Scimitar Anomaly0low10
Scimitar Syndrome0low10
Scleroderma, Systemic0low10
Sclerosing Mesenteritis0low10
Sclerosis Tuberosa0low10
Sclerosis, Disseminated0low10
Sclerosis, Systemic0low10
Seasonal Allergic Rhinitis0low10
Second Cancer0low10
Second Malignancy0low10
Second Neoplasm0low10
Second Primary Neoplasms0low10
Second Primary Neoplasms, Metachronous0low10
Secondary Myocardial Diseases0low20
Seeding, Neoplasm0low10
Seizure Disorder0low10
Seizure Disorder, Convulsive, Generalized0low10
Seizure Disorder, Generalized0low10
Seizure Disorder, Generalized Nonconvulsive0low10
Seizure Disorder, Generalized Onset0low10
Seizure Disorder, Generalized, Convulsive0low10
Seizure Disorder, Nonconvulsive Generalized0low10
Sensitivity and Specificity0medium24827
Sensitivity, Contact0low10
Sepsis0low10
Septic Shock0low10
Septicemia0low10
Sequestration, Bronchopulmonary0low20
Sequestration, Pulmonary0low20
Sequestrations, Bronchopulmonary0low20
Sequestrations, Pulmonary0low20
Severe Sepsis0low10
Shock Lung0low10
Shock, Anaphylactic0low80
Shock, Endotoxic0low10
Shock, Septic0low10
Shock, Toxic0low10
Shortness of Breath0low40
Shoulder Injuries0medium21
Shoulder Pain0medium11
Sialadenitis0low30
Sialitis0low30
Sialoadenitis0low30
Sialolithiasis0low10
Sialoliths0low10
Sick Headache0low10
Sickle Cell Anemia0low10
Sickle Cell Disease0low10
Sickle Cell Disorders0low10
Sickling Disorder Due to Hemoglobin S0low10
Side Effects of Drugs0medium61
Sigmoid Colon Diseases0low20
Sigmoid Diseases0low20
Simple Pulmonary Eosinophilia0low10
Situs Inversus0low10
Situs Inversus Viscerum0low10
Skin and Subcutaneous Tissue Disorders0low20
Skin Diseases0low20
Skin Rash0low20
Skull Neoplasms0low10
SLAP Tears0medium21
Small Cleaved-Cell Lymphoma, Diffuse0low20
Small Cleaved-Cell Lymphoma, Follicular0low20
Small Follicular Center-Cell Lymphoma0low20
Small Non-Cleaved-Cell Lymphoma0low20
Small Noncleaved-Cell Lymphoma0low20
Soft Tissue Neoplasms0low40
Solitary Fibrous Tumors0low20
Solitary Pulmonary Nodule0low50
Solitary Pulmonary Nodules0low50
Spastic Paraplegia0low10
Spinal Cord Diseases0medium11
Spinal Cord Disorders0medium11
Spinal Cord Ischemia0low10
Spinal Cord Ischemia, Experimental0low10
Spinal Neoplasms0low10
Spiral Fractures0low10
Splenosis0low10
Spongioblastoma0low10
Spontaneous Pneumothorax0low10
Sports Injuries0low10
Sprue0low10
Sprue, Celiac0low10
Sprue, Nontropical0low10
Squamous Cell Carcinoma0low120
Squamous Cell Carcinoma of Head and Neck0low10
Squamous Cell Carcinoma of Larynx0low10
Squamous Cell Carcinoma of the Head and Neck0low10
Squamous Cell Carcinoma of the Larynx0low10
Squamous Cell Carcinoma of the Mouth0low10
Squamous Cell Carcinoma of the Nasal Cavity0low10
Squamous Cell Carcinoma, Head And Neck0low10
SREDIu0160NJI u017DIVu010CANI SUSTAV, BOLESTI@hr0low10
ST Elevated Myocardial Infarction0low10
ST Elevation Myocardial Infarction0low10
ST Segment Elevation Myocardial Infarction0low10
Status Asthmaticus0low10
Status Lymphaticus0low10
Status Migrainosus0low10
Steatohepatitis0low20
Steatosis of Liver0low20
Steinert Disease0low10
Steinert Myotonic Dystrophy0low10
Steinert's Disease0low10
STEMI0low10
Stenocardia0low70
Stenoses, Pulmonary0low10
Stenoses, Pulmonary Valve0low10
Stenosis0low90
Stenosis, Common Carotid Artery0low110
Stenosis, Esophageal0low20
Stenosis, External Carotid Artery0low110
Stenosis, Pulmonary0low10
Stenosis, Pulmonary Valve0low10
Stomach Cancer0low110
Stomach Neoplasms0low110
Stomach Ulcer0low10
Streptozocin Diabetes0low40
Streptozotocin Diabetes0low40
Stricture0low90
Stridor0low10
Stroke0medium51
Stroke, Acute0medium51
Stroke, Posterior Cerebral Artery0low10
Subarachnoid Hemorrhage0low90
Subarachnoid Hemorrhage, Aneurysmal0low90
Subarachnoid Hemorrhage, Intracranial0low90
Subarachnoid Hemorrhage, Spontaneous0low90
Subclavian Artery Stenosis0low10
Subclavian Steal0low10
Subclavian Steal Phenomenon0low10
Subclavian Steal Syndrome0low10
Subclavian-Carotid Artery Steal Syndrome0low10
Subcortical Infarction0low30
Subcutaneous Emphysema0low10
Subdural Hematoma0low10
Subdural Hematoma, Traumatic0low10
Submandibular Gland Diseases0low30
Subtrochanteric Fractures0low10
Sudden Visual Loss0low10
Suffering, Physical0medium21
Superior Labrum from Anterior to Posterior Injuries0medium21
Superior Vena Cava Obstruction0low10
Superior Vena Cava Syndrome0low10
Superior Vena Cava Thrombosis0low10
Surgical Injuries0low30
Surgical Margins0low10
Surgical Site Infection0low10
Surgical Wound Dehiscence0low10
Surgical Wound Infection0low10
Swallowing Disorders0medium21
Sykdommer i sentralnervesystemet@no0low10
Symptom Cluster0medium91
Symptomatic Generalized Epilepsy0low10
Syndrome0medium91
Synovioma0low20
Syringoma, Chondroid0low20
Systemic Scleroderma0low10
Systemic Sclerosis0low10
T-Cell Lymphoma0low10
T-Lymphotropic Virus Type III Infections, Human0low10
TAPVR0low10
TAPVR10low10
Taste, Altered0low10
Taste, Distorted0low10
Tear Duct Obstruction0low10
Temporomandibular Disorders0low10
Temporomandibular Joint Diseases0low10
Temporomandibular Joint Disorders0low10
Tendinitis0low10
Tendinopathy0low10
Tendinosis0low10
Tendon Injuries0low10
Tendonitis0low10
Tendonopathy0low10
Tendonosis0low10
Tension Pneumothorax0low10
Texidor's Twinge0low80
Textiloma0low30
Theca Cell Tumor0low10
Thecoma0low10
Therapy-Associated Cancer0low10
Therapy-Associated Neoplasms0low10
Therapy-Related Cancer0low10
Therapy-Related Neoplasms0low10
Thoracic Injuries0low10
Thoracoabdominal Aortic Aneurysm0low50
Thrombocytopenia0low10
Thromboembolism, Pulmonary0medium405
Thromboembolisms, Pulmonary0medium405
Thrombopenia0low10
Thrombophlebitis0medium32
Thrombosis0medium91
Thrombosis, Coronary0low30
Thrombosis, Deep Vein0low50
Thrombosis, Venous0low50
Thrombotic Infarction, Posterior Cerebral Artery0low10
Thrombus0medium91
Thymic Cancer0low40
Thymic Hyperplasia0low10
Thymic Neoplasms0low40
Thymic Tumors0low40
Thymoma0low20
Thymus Cancer0low40
Thymus Hyperplasia0low10
Thymus Neoplasms0low40
Thymus Tumors0low40
Thyroid Adenoma0medium21
Thyroid Cancer0medium21
Thyroid Carcinoma0medium21
Thyroid Diseases0low10
Thyroid Neoplasms0medium21
Thyrotoxicosis0low10
TIA (Transient Ischemic Attack)0low10
TMJ Diseases0low10
TMJ Disorders0low10
Tongue Cancer0low10
Tongue Neoplasms0low10
Tonsil Cancer0low10
Tonsil Neoplasms0low10
Tonsillar Cancer0low10
Tonsillar Neoplasms0low10
Torsion Abnormality0low10
Torsion Fractures0low10
Total Anomalous Pulmonary Venous Return0low10
Total Anomalous Pulmonary Venous Return 10low10
Total Colonic Aganglionosis0low10
Toxic Encephalitis0low30
Toxic Hepatitis0low30
Toxic Shock0low10
Toxic Shock Syndrome0low10
Toxicity, Drug0medium61
Tracheal Diseases0low20
Tracheal Stenosis0low40
Transient Anton's Syndrome0low20
Transient Ischemic Attack0low10
Transient Ischemic Attack, Anterior Circulation0low10
Transient Ischemic Attack, Brain Stem0low10
Transient Ischemic Attack, Brainstem0low10
Transient Ischemic Attack, Carotid Circulation0low10
Transient Ischemic Attack, Posterior Circulation0low10
Transient Ischemic Attack, Vertebrobasilar Circulation0low10
Transient Ischemic Attacks, Crescendo0low10
Translocation, Chromosomal0low10
Translocation, Genetic0low10
Trauma, Multiple0low30
Treatment-Associated Cancer0low10
Treatment-Associated Neoplasms0low10
Treatment-Related Cancer0low10
Treatment-Related Neoplasms0low10
Trochanteric Fractures0low10
Tropical Eosinophilia0low20
Tropical Eosinophilic Pneumonia0low10
Tuberculin-Type Hypersensitivity0medium11
Tuberculoses, Pulmonary0low20
Tuberculosis, Drug-Resistant0low10
Tuberculosis, Endocrine0low20
Tuberculosis, MDR0low10
Tuberculosis, Multi-Drug Resistant0low10
Tuberculosis, Multidrug-Resistant0low10
Tuberculosis, Pulmonary0low20
Tuberose Sclerosis0low10
Tuberous Sclerosis0low10
Tuberous Sclerosis Complex0low10
Tumor Virus Infections0low10
Tumor-Free Margins0low10
Tumors0medium124
Tumors, Breast0medium121
Turner Phenotype with Normal Karyotype0low10
Turner Syndrome, Male0low10
Turner-Like Syndrome0low10
Turner's Phenotype, Karyotype Normal0low10
Turner's Syndrome, Male0low10
Type 2 Diabetes0low20
Type 2 Diabetes Mellitus0low20
Type I Hypersensitivity0low20
Type IV Hypersensitivity0medium11
u041Du0415u0420u0412u041Du041Eu0419 u0421u0418u0421u0422u0415u041Cu042B u0426u0415u041Du0422u0420u0410u041Bu042Cu041Du041Eu0419 u0411u041Eu041Bu0415u0417u041Du0418@ru0low10
u4E2Du67A2u795Eu7D4Cu7CFBu75BEu60A3@ja0low10
UADT Neoplasm0medium122
UADT Neoplasms0medium122
Ulcerating Plaque, Carotid Artery0low110
Ullrich-Noonan Syndrome0low10
Unconjugated Benign Bilirubinemia0low10
Unconscious State0low10
Unconsciousness0low10
Undifferentiated Lymphoma0low20
Unilateral Blindness0low10
Unilateral Nasal Obstruction0low10
Unstable Angina0low30
Upper Aerodigestive Tract Neoplasm0medium122
Upper Aerodigestive Tract Neoplasms0medium122
Upper Respiratory Infections0low10
Upper Respiratory Tract Infection0low10
Upper Respiratory Tract Infections0low10
Ureteral Obstruction0low20
Urinary Bladder Cancer0low30
Urinary Bladder Disorder, Neurogenic0low10
Urinary Bladder Neoplasms0low30
Urinary Bladder Neurogenesis0low10
Urinary Bladder Neurogenic Dysfunction0low10
Urinary Bladder, Neurogenic0low10
Urinary Bladder, Overactive0low10
Urinary Calculi0low10
Urinary Stones0low10
Urinary Tract Cancer0low10
Urinary Tract Diseases0medium31
Urinary Tract Neoplasms0low10
Urinary Tract Stones0low10
Urologic Cancer0low10
Urologic Diseases0medium31
Urologic Neoplasms0low10
Urological Cancer0low10
Urological Diseases0medium31
Urological Neoplasms0low10
Urticaria0low20
Urticaria, Giant0low10
Uterine Cancer0medium11
Uterine Diseases0low10
Uterine Neoplasms0medium11
Uterus Cancer0medium11
Uterus Neoplasms0medium11
Uveal Neoplasms0low10
Valvular Heart Diseases0low50
Valvular Pulmonic Stenosis0low10
Varices0low20
Varicose Veins0low20
Varix0low20
Vascular Accident, Brain0medium51
Vascular Anomalies, Central Nervous System0low30
Vascular Calcification0low10
Vascular Calcinosis0low10
Vascular Diseases, Intracranial0low70
Vascular Diseases, Peripheral0low40
Vascular Fistula0low10
Vascular Graft Occlusion0medium91
Vascular Graft Restenosis0medium91
Vascular Hypotension0medium11
Vascular Injuries0low10
Vascular Malformations0low10
Vascular Malformations, Brain0low30
Vascular Malformations, Central Nervous System0low30
Vascular Malformations, Congenital, Nervous System0low30
Vascular System Injuries0low10
Vasogenic Brain Edema0low30
Vasogenic Cerebral Edema0low30
Vasospasm, Intracranial0low10
Venous Congestion0low10
Venous Engorgement0low10
Venous Thrombosis0low50
Ventricular Dysfunction, Left0low50
Ventricular Dysfunction, Right0low70
Ventricular Fibrillation0low30
Ventricular Hypertrophy, Left0medium11
Ventricular Outflow Obstruction0low10
Ventricular Outflow Obstruction, Left0low10
Ventricular Outflow Obstruction, Right0low10
Ventricular Septal Defect0low20
Ventricular Septal Defects0low20
Vertebral Artery Insufficiency0medium21
Vertebral Artery Ischemia0medium21
Vertebral Artery Stenosis0medium21
Vertebro-Basilar Insufficiency0medium21
Vertebro-Basilar Ischemia0medium21
Vertebrobasilar Circulation Transient Ischemic Attack0low10
Vertebrobasilar Dolichoectasia0medium21
Vertebrobasilar Insufficiency0medium21
Vertebrobasilar Ischemia0medium21
Vesico-Ureteral Reflux0low10
Vesicoureteral Reflux0low10
Vesicoureteral Reflux 10low10
VHL Syndrome0low10
Visceral Steatosis0low20
Volvulus0low40
Volvulus, Intestine0low40
Vomiting0low10
von Hippel-Lindau Disease0low10
von Hippel-Lindau Syndrome0low10
Wake-up Stroke0low10
Warthin Tumor0low20
Wet Lung0low10
Wheezing0low10
Word Deafness0low10
Wound Dehiscence, Surgical0low10
Wound Infection, Postoperative0low10
Wound Infection, Surgical0low10
Wounds, Multiple0low30
Wounds, Nonpenetrating0low20
Wounds, Penetrating0low10
Yolk Sac Tumor0low10
Zentralnervensystemkrankheiten@de0low10
Ziekte, centraalzenuwstelsel-@nl0low10
Zika Fever0low10
Zika Virus Disease0low10
Zika Virus Infection0low10
ZikV Infection0low10

Research Highlights

Safety/Toxicity (43)

ArticleYear
Differences in Hypersensitivity Reactions to Iodinated Contrast Media: Analysis of the US Food and Drug Administration Adverse Event Reporting System Database.
The journal of allergy and clinical immunology. In practice, Volume: 11, Issue: 5		2023
Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney Functio
Medical science monitor : international medical journal of experimental and clinical research, Sep-06, Volume: 23		2017
The impact of iodinated X-ray contrast agents on formation and toxicity of disinfection by-products in drinking water.
Journal of environmental sciences (China), Volume: 58		2017
Long-Term Adverse Effects of Low-Osmolar Compared With Iso-Osmolar Contrast Media After Coronary Angiography.
The American journal of cardiology, Oct-01, Volume: 118, Issue: 7		2016
Safety and efficacy of a novel iopromide-based paclitaxel-eluting balloon following bare metal stent implantation in rabbit aorta abdominalis.
Bio-medical materials and engineering, Volume: 26, Issue: 1-2		2015
Changes in mutagenicity and acute toxicity of solutions of iodinated X-ray contrast media during chlorination.
Chemosphere, Volume: 135		2015
Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients.
Acta radiologica (Stockholm, Sweden : 1987), Volume: 55, Issue: 6		2014
Contrast-induced neurotoxicity after coronary angiography.
Herz, Volume: 39, Issue: 4		2014
Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
Radiology, Volume: 267, Issue: 1		2013
The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
Investigative radiology, Volume: 47, Issue: 9		2012
Intracoronary local paclitaxel delivery by X-ray contrast media for in-stent restenosis: a clinical pilot study to assess safety and tolerability.
Minerva cardioangiologica, Volume: 60, Issue: 4		2012
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology, Volume: 7, Issue: 12		2011
Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE).
Acta radiologica (Stockholm, Sweden : 1987), Mar-01, Volume: 53, Issue: 2		2012
Toxic effects of a high dose of non-ionic iodinated contrast media on renal glomerular and aortic endothelial cells in aged rats in vivo.
Toxicology letters, May-10, Volume: 202, Issue: 3		2011
Is herniography useful and safe?
European journal of radiology, Volume: 80, Issue: 2		2011
Efficacy and safety of lanthanoids as X-ray contrast agents.
European journal of radiology, Volume: 80, Issue: 2		2011
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Journal of cardiovascular medicine (Hagerstown, Md.), Volume: 11, Issue: 3		2010
Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Radiology, Volume: 250, Issue: 1		2009
A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, Dec-01, Volume: 72, Issue: 7		2008
I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity.
AJR. American journal of roentgenology, Volume: 189, Issue: 3		2007
Iodide mumps after contrast media imaging: a rare adverse effect to iodine.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, Volume: 99, Issue: 1		2007
Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
Clinical nephrology, Volume: 66, Issue: 5		2006
Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial.
Radiology, Volume: 240, Issue: 1		2006
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Current drug discovery technologies, Volume: 1, Issue: 4		2004
Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital.
AJR. American journal of roentgenology, Volume: 184, Issue: 1		2005
Open radio-frequency thermal ablation of renal VX2 tumors in a rabbit model using a cooled-tip electrode: feasibility, safety, and effectiveness.
European radiology, Volume: 13, Issue: 6		2003
Comparative cytotoxicity of low-osmolar nonionic and high-osmolar ionic contrast media to dog gallbladder epithelial cells.
Gastrointestinal endoscopy, Volume: 55, Issue: 3		2002
[Stability of iodinated contrast media in UV-laser irradiation and toxicity of the photoproducts].
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, Volume: 169, Issue: 5		1998
Acute side effects of iopromide and diatrizoate in urography.
Acta radiologica (Stockholm, Sweden : 1987), Volume: 39, Issue: 6		1998
Iopentol (Imagopaque 300) compared with iopromide (Ultravist 300) in pediatric angiocardiography. A clinical trial assessing adverse events, ECG and diagnostic information.
European radiology, Volume: 7 Suppl 4		1997
Iopentol (Imagopaque 300) compared with iopromide (Ultravist 300) in abdominal CT. A multi-centre monitoring trial assessing adverse events and diagnostic information--results from 518 patients in Spain.
European radiology, Volume: 7 Suppl 4		1997
Preclinical safety assessment of contrast media: predictive value.
European radiology, Volume: 6 Suppl 2		1996
Neurotolerability of nonionic X-ray contrast media. The role of chemotoxicity.
Investigative radiology, Volume: 31, Issue: 6		1996
[Contrast media in peripheral angiography: does cost reduction mean loss of quality and safety? A reevaluation based on a randomized double-blind comparative study of ioxaglate versus iopromide].
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, Volume: 164, Issue: 5		1996
Double-blind study of the safety, tolerance, and diagnostic efficacy of iopromide as compared with iopamidol and iohexol in patients requiring aortography and visceral angiography.
Investigative radiology, Volume: 29 Suppl 1		1994
Safety and efficacy of iopromide in cerebral arteriography.
Investigative radiology, Volume: 29 Suppl 1		1994
Efficacy and safety of iopromide for excretory urography.
Investigative radiology, Volume: 29 Suppl 1		1994
Neurotoxicity of non-ionic X-ray contrast media after intracisternal administration in rats.
European journal of radiology, Volume: 19, Issue: 3		1995
[Undesirable side effects of contrast media during i.v. DSA--a comparison of 2 nonionic contrast media].
Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie, Volume: 43, Issue: 4		1990
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (73)

ArticleYear
Diagnostic Performance of Adaptive 4D Volume Perfusion CT for Detecting Metastatic Cervical Lymph Nodes in Head and Neck Squamous Cell Carcinoma.
AJR. American journal of roentgenology, Volume: 211, Issue: 5		2018
Dual-Energy CT-Derived Volumetric Iodine Concentration for the Assessment of Therapeutic Response after Microwave Ablation in a Rabbit Model with Intrahepatic VX2 Tumor.
Journal of vascular and interventional radiology : JVIR, Volume: 29, Issue: 10		2018
Differentiation of renal cell carcinoma subtypes with different iodine quantification methods using single-phase contrast-enhanced dual-energy CT: areal vs. volumetric analyses.
Abdominal radiology (New York), Volume: 43, Issue: 3		2018
Whole-volume vs. segmental CT texture analysis of the liver to assess metachronous colorectal liver metastases.
Abdominal radiology (New York), Volume: 42, Issue: 11		2017
Increased image quality and reduced radiation dose and contrast media volume: a holistic approach to intracranial CTA.
Clinical radiology, Volume: 72, Issue: 9		2017
A semi-automated volumetric software for segmentation and perfusion parameter quantification of brain tumors using 320-row multidetector computed tomography: a validation study.
Neuroradiology, Volume: 59, Issue: 5		2017
Carotid and cerebral CT angiography using low volume of iodinated contrast material and low tube voltage.
Diagnostic and interventional imaging, Volume: 97, Issue: 11		2016
Computed Tomography Angiography of Coronary Artery Bypass Grafts: Low Contrast Media Volume Protocols Adapted to Tube Voltage.
Investigative radiology, Volume: 51, Issue: 4		2016
Cerebral CT Venography Using a 320-MDCT Scanner With a Time-Density Curve Technique and Low Volume of Contrast Agent: Comparison With Fixed Time-Delay Technique.
AJR. American journal of roentgenology, Volume: 205, Issue: 6		2015
Correlation of volumetric perfusion CT parameters with hypoxia inducible factor-1 alpha expression in a rabbit VX2 tumor model.
Acta radiologica (Stockholm, Sweden : 1987), Volume: 57, Issue: 6		2016
Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
Acta radiologica (Stockholm, Sweden : 1987), Volume: 57, Issue: 1		2016
Cerebral computed tomography angiography using a 70 kVp protocol: improved vascular enhancement with a reduced volume of contrast medium and radiation dose.
European radiology, Volume: 25, Issue: 5		2015
Revisiting the relationship between tumour volume and diameter in advanced NSCLC patients: An exercise to maximize the utility of each measure to assess response to therapy.
Clinical radiology, Volume: 69, Issue: 8		2014
Assessment of tumor grade and angiogenesis in colorectal cancer: whole-volume perfusion CT.
Academic radiology, Volume: 21, Issue: 6		2014
Low tube voltage and low contrast material volume cerebral CT angiography.
European radiology, Volume: 24, Issue: 7		2014
Contrast layering: late clearance of contrast dye--a novel angiographic phenomenon of early atherosclerosis.
Angiology, Volume: 66, Issue: 2		2015
128-slice acceletated-pitch dual energy CT angiography of the head and neck: comparison of different low contrast medium volumes.
PloS one, Volume: 8, Issue: 11		2013
Feasibility of semiautomated MR volumetry using gadoxetic acid-enhanced MRI at hepatobiliary phase for living liver donors.
Magnetic resonance in medicine, Volume: 72, Issue: 3		2014
Association between the volume of carotid artery plaque and its subcomponents and the volume of white matter lesions in patients selected for endarterectomy.
AJR. American journal of roentgenology, Volume: 201, Issue: 5		2013
Cerebral aneurysms: accuracy of 320-detector row nonsubtracted and subtracted volumetric CT angiography for diagnosis.
Radiology, Volume: 269, Issue: 3		2013
Evaluation of the relationship between extremity soft tissue sarcomas and adjacent major vessels using contrast-enhanced multidetector CT and three-dimensional volume-rendered CT angiography: a preliminary study.
Acta radiologica (Stockholm, Sweden : 1987), Volume: 54, Issue: 8		2013
Adaptive 4D volume perfusion CT of lung cancer: effects of computerized motion correction and the range of volume coverage on measurement reproducibility.
AJR. American journal of roentgenology, Volume: 200, Issue: 6		2013
Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
Investigative radiology, Volume: 48, Issue: 10		2013
A reduced contrast volume acquisition regimen based on cardiovascular dynamics improves visualisation of head and neck vasculature with carotid MDCT angiography.
European journal of radiology, Volume: 82, Issue: 2		2013
Perfusion and flow extraction product as potential discriminators in untreated follicular and diffuse large B cell lymphomas using volume perfusion CT with attempt at histopathologic explanation.
AJR. American journal of roentgenology, Volume: 198, Issue: 6		2012
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
AJR. American journal of roentgenology, Volume: 198, Issue: 2		2012
Usefulness of semi-automatic volumetry compared to established linear measurements in predicting lymph node metastases in MSCT.
Acta radiologica (Stockholm, Sweden : 1987), Jun-01, Volume: 52, Issue: 5		2011
Low-dose triple-rule-out using 320-row-detector volume MDCT--less contrast medium and lower radiation exposure.
European radiology, Volume: 21, Issue: 7		2011
CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool.
Academic radiology, Volume: 18, Issue: 1		2011
The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, Aug-01, Volume: 78, Issue: 2		2011
Prediction of lymph node manifestations in malignant lymphoma: significant role of volumetric compared with established metric lymph node analysis in multislice computed tomography.
Journal of computer assisted tomography, Volume: 34, Issue: 4		2010
Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
The American journal of gastroenterology, Volume: 105, Issue: 8		2010
Dual-energy MDCT: comparison of pulmonary artery enhancement on dedicated CT pulmonary angiography, routine and low contrast volume studies.
European journal of radiology, Volume: 79, Issue: 2		2011
Comparison of volume and diameter measurement in assessing small abdominal aortic aneurysm expansion examined using computed tomographic angiography.
European journal of radiology, Volume: 79, Issue: 1		2011
Physicochemical determinants of human renal clearance.
Journal of medicinal chemistry, Aug-13, Volume: 52, Issue: 15		2009
Effect of different saline chaser volumes and flow rates on intravascular contrast enhancement in CT using a circulation phantom.
European journal of radiology, Volume: 73, Issue: 3		2010
[Automated pulmonary nodule volumetry with an optimized algorithm. Accuracy at different slice thicknesses compared to unidimensional and bidimensional measurements].
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, Volume: 180, Issue: 9		2008
Dose reduction in dynamic perfusion CT of the brain: effects of the scan frequency on measurements of cerebral blood flow, cerebral blood volume, and mean transit time.
European radiology, Volume: 18, Issue: 12		2008
Cost-effectiveness and patient tolerance of low-attenuation oral contrast material: milk versus VoLumen.
AJR. American journal of roentgenology, Volume: 190, Issue: 5		2008
Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], Volume: 184, Issue: 5		2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 36, Issue: 7		2008
Left ventricular and left atrial dimensions and volumes: comparison between dual-source CT and echocardiography.
Investigative radiology, Volume: 43, Issue: 5		2008
Assessment of changes in non-calcified atherosclerotic plaque volume in the left main and left anterior descending coronary arteries over time by 64-slice computed tomography.
The American journal of cardiology, Mar-01, Volume: 101, Issue: 5		2008
Color-coded perfused blood volume imaging using multidetector CT: initial results of whole-brain perfusion analysis in acute cerebral ischemia.
European radiology, Volume: 17, Issue: 9		2007
Influence of partial volume on venous output and arterial input function.
AJNR. American journal of neuroradiology, Volume: 27, Issue: 1		2006
Gastric cancer staging at multi-detector row CT gastrography: comparison of transverse and volumetric CT scanning.
Radiology, Volume: 236, Issue: 3		2005
Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis.
Nature medicine, Volume: 10, Issue: 10		2004
Prospective comparison of 3-dimensional volume rendered computerized tomography and conventional renal arteriography for surgical planning in patients undergoing laparoscopic donor nephrectomy.
The Journal of urology, Volume: 170, Issue: 1		2003
Measurement of glomerular filtration rate by low-dose iopromide plasma clearance.
Acta radiologica (Stockholm, Sweden : 1987), Volume: 44, Issue: 2		2003
Lopromide one-sample clearance as a measure of glomerular filtration rate.
Clinical physiology and functional imaging, Volume: 22, Issue: 2		2002
Contrast media clearance in a single kidney measured on multiphasic helical CT: results in 50 patients without acute renal disorder.
AJR. American journal of roentgenology, Volume: 178, Issue: 1		2002
Measurement of single kidney contrast media clearance by multiphasic spiral computed tomography: preliminary results.
European journal of radiology, Volume: 39, Issue: 3		2001
Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patients.
Critical care medicine, Volume: 29, Issue: 8		2001
Quantitative and qualitative evaluation of volume of low osmolality contrast medium needed for routine helical abdominal CT.
AJR. American journal of roentgenology, Volume: 176, Issue: 3		2001
Pharmacokinetics and tolerability of iopromide 240 after lumbar myelography.
Investigative radiology, Volume: 34, Issue: 11		1999
Application of pharmacokinetics to electron-beam tomography of the abdomen.
Academic radiology, Volume: 6, Issue: 8		1999
[Transfemoral pelvic vein angiography with CO2: experiences with pressure- and volume-controlled injections].
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, Volume: 170, Issue: 4		1999
Clearance of iopromide during haemodialysis with high- and low-flux membranes.
Acta radiologica (Stockholm, Sweden : 1987), Volume: 40, Issue: 2		1999
Accuracy of cartilage volume and thickness measurements with magnetic resonance imaging.
Clinical orthopaedics and related research, Issue: 352		1998
[Evaluation of iopromide (Ultravist) clearance as a marker of glomerular filtration].
Polskie Archiwum Medycyny Wewnetrznej, Volume: 98, Issue: 7		1997
Dual-phase helical CT of the liver: effects of bolus tracking and different volumes of contrast material.
Radiology, Volume: 201, Issue: 2		1996
Dose proportionality of iopromide pharmacokinetics and tolerability after i.v. injection in healthy volunteers.
European journal of clinical pharmacology, Volume: 46, Issue: 4		1994
Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate.
Journal of the American Society of Nephrology : JASN, Volume: 6, Issue: 2		1995
Pharmacokinetics of iopromide liposomes in rabbits.
Pharmaceutical research, Volume: 12, Issue: 7		1995
Pharmacokinetics of iohexol, iopamidol, iopromide, and iosimide compared with meglumine diatrizoate.
Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband, Volume: 128		1989
[Contrast medium clearance as a measure of kidney function in patients with renal artery stenoses].
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, Volume: 155, Issue: 1		1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (3)

ArticleYear
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology, Volume: 96, Issue: 5		2019
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
The Journal of biological chemistry, 11-15, Volume: 294, Issue: 46		2019
Drug-coated percutaneous balloon catheters.
Critical reviews in biomedical engineering, Volume: 42, Issue: 3-4		2014
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (25)

ArticleYear
A new method for using radiopaque sclerosing foam to treat venous malformations.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], Volume: 41, Issue: 6		2015
Optimizing contrast media injection protocols in state-of-the art computed tomographic angiography.
Investigative radiology, Volume: 50, Issue: 3		2015
Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
Investigative radiology, Volume: 48, Issue: 10		2013
Isolation and identification of an iopromide-degrading strain and its application in an A2/O system.
Bioresource technology, Volume: 134		2013
The effect of iodinated contrast agent properties on renal kinetics and oxygenation.
Investigative radiology, Volume: 48, Issue: 4		2013
Dual-source CT coronary angiography involving injection protocol with iodine load tailored to patient body weight and body mass index: estimation of optimal contrast material dose.
Acta radiologica (Stockholm, Sweden : 1987), Mar-01, Volume: 54, Issue: 2		2013
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Nov-22, Volume: 8, Issue: 7		2012
Contrast material injection protocol with the flow rate adjusted to the heart rate for dual source CT coronary angiography.
The international journal of cardiovascular imaging, Volume: 28, Issue: 6		2012
Changes of renal water diffusion coefficient after application of iodinated contrast agents: effect of viscosity.
Investigative radiology, Volume: 46, Issue: 12		2011
Factors influencing delay time and coronary arterial density during coronary angiography with DSCT.
Acta radiologica (Stockholm, Sweden : 1987), Feb-01, Volume: 52, Issue: 1		2011
Risk of nephropathy after consumption of nonionic contrast media by children undergoing cardiac angiography: a prospective study.
Pediatric cardiology, Volume: 31, Issue: 5		2010
Gastro intestinal tracking and gastric emptying of solid dosage forms in rats using X-ray imaging.
International journal of pharmaceutics, Mar-30, Volume: 388, Issue: 1-2		2010
Evaluation of contrast-enhanced digital mammography.
European journal of radiology, Volume: 78, Issue: 1		2011
Ozonation and reductive deiodination of iopromide to reduce the environmental burden of iodinated X-ray contrast media.
Water science and technology : a journal of the International Association on Water Pollution Research, Volume: 56, Issue: 11		2007
[A differentiated approach to the diagnosis of pulmonary embolism and deep venous thrombosis using multi-slice CT].
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, Volume: 174, Issue: 3		2002
Application of pharmacokinetics to electron-beam tomography of the abdomen.
Academic radiology, Volume: 6, Issue: 8		1999
Are iodinated contrast agents detrimental in acute cerebral ischemia? An experimental study in rats.
Radiology, Volume: 206, Issue: 1		1998
A double-blind study of iopromide 300 for peripheral arteriography. Results of a multi-institutional comparison of iopromide with iohexol and iopamidol.
Investigative radiology, Volume: 29 Suppl 1		1994
Iomeprol versus iopromide for intravenous urography.
The British journal of radiology, Volume: 67, Issue: 802		1994
[Optimizing intravenous bolus contrast medium injection in cervical CT diagnosis].
Aktuelle Radiologie, Volume: 4, Issue: 5		1994
[The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy].
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, Volume: 160, Issue: 5		1994
Iopromide dosage and urographic image quality: is there an optimal dose?
Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband, Volume: 128		1989
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (5)

ArticleYear
Feasibility study of iterative model reconstruction combined with low tube voltage, low iodine load, and low iodine delivery rate in craniocervical CT angiography.
Clinical radiology, Volume: 73, Issue: 2		2018
Low-Dose Scanning Technology Combined with Low-Concentration Contrast Material in Renal Computed Tomography Angiography (CTA): A Preliminary Study.
Medical science monitor : international medical journal of experimental and clinical research, Sep-09, Volume: 23		2017
Evaluation of a High Concentrated Contrast Media Injection Protocol in Combination with Low Tube Current for Dose Reduction in Coronary Computed Tomography Angiography: A Randomized, Two-center Prospective Study.
Academic radiology, Volume: 24, Issue: 12		2017
[Applied research of CT angiography of lower extremities by using 100 kVp and iodixanol(270 mg I/ml) combined with iDose(4) iterative reconstruction technique].
Zhonghua yi xue za zhi, Dec-15, Volume: 95, Issue: 47		2015
Optimizing computed tomography pulmonary angiography using right atrium bolus monitoring combined with spontaneous respiration.
European radiology, Volume: 25, Issue: 9		2015
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]